Missed Out on the FAANG Stocks? Consider Buying These PfANG Stocks Instead._老虎社区_美港股上老虎

Missed Out on the FAANG Stocks? Consider Buying These PfANG Stocks Instead.

Motley Fool2021-08-02

What's worse than the fear of missing out? I'd put the fear of having already missed out high on the list. There's nothing you can do once an opportunity is gone. Some investors might be feeling as if...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

282

SieCW
·2021-08-02
Another new kids on the block?🤔
回复
点赞
举报
Eric_7864
·2021-08-02
lol,interesting,but make no sence
回复
点赞
举报
JohnsonYeo
·2021-08-02
Wow
回复
点赞
举报
DLIM
·2021-08-02
Nano-X company background and product data information raise red flags
回复
1
举报
jaster
·2021-08-02
I really wouldn't put Pfizer in the same group as Apple, Amazon, and the like. What makes those stocks really strong are the lack of scaling costs (meaning they can scale up easily), and strong network effects leading to high barriers of entry (no one can easily compete with them). Pfizer doesn't have any of these advantages, it's recent performance is largely driven by the covid pandemic - which is temporary by nature.
回复
3
举报
STKG
·2021-08-02
Creative. Ha
回复
1
举报
Mml
·2021-08-02
Informative
回复
4
举报
收起
- Mml:
  Pls help to like
  2021-08-02
  回复
  举报
- Phyusin:
  [Miser]
  2021-08-02
  回复
  举报
BruceLyy
·2021-08-02
Please like and comment, thank you
回复
2
举报
收起
- Shininglight:
  ok
  2021-08-02
  回复
  举报
HLPA
·2021-08-02
What a bloody FOOL indeed
回复
4
举报
glorify
·2021-08-02
I strongly support Apple. It has great potential & strong foundamental . 💪💪🍎🚀🚀🚀
回复
6
举报
收起
- Willretard8:
  Good M1 chip
  2021-08-02
  回复
  举报
1moretime
·2021-08-02
Nice!
回复
3
举报
SilentWarrio
·2021-08-02
New opportunities...
回复
1
举报
Bry8950
·2021-08-02
Like
回复
4
举报
simivan154
·2021-08-02
Nice
回复
8
举报
收起
- Andrew168:
  Like back
  2021-08-03
  回复
  举报
- simivan154:
  Yes
  2021-08-03
  回复
  举报
- Andrew168:
  👌
  2021-08-23
  回复
  举报
GGWP
·2021-08-02
Nice
回复
4
举报
收起
- GGWP:
  A
  2021-08-02
  回复
  举报
Baby Step 4
·2021-08-02
👍🏽👍🏽
回复
5
举报
收起
- NEWBIE:
  yes
  2021-08-02
  回复
  举报
Yingyingloo
·2021-08-02
Like and commment
回复
10
举报
收起
- Brsje:
  DOnE
  2021-08-02
  回复
  举报
- 492a70ed:
  ok
  2021-08-02
  回复
  举报
- Huathk:
  Gd
  2021-08-02
  回复
  举报
JKKT
·2021-08-02
Pls like and comment
回复
6
举报
收起
- Yingyingloo:
  Like
  2021-08-02
  回复
  举报
- Brsje:
  Done
  2021-08-02
  回复
  举报
- 492a70ed:
  ok
  2021-08-02
  回复
  举报
查看更多 1 条评论
kungpao
·2021-08-02
This is funny [开心]
回复
4
举报
收起
- JKKT:
  Yeah Damn funny
  2021-08-02
  回复
  举报
money2me
·2021-08-02
😂😂😂 any chance for 10x?
回复
4
举报
收起
- kungpao:
  lol idk
  2021-08-02
  回复
  举报

热议股票

7x24

全部

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/2156169749?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-08-02 08:38","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2156169749","market":"us","top_or_hot":-1,"title":"Missed Out on the FAANG Stocks? Consider Buying These PfANG Stocks Instead.","media":"Motley Fool","content":"<div>\n<p>What's worse than the fear of missing out? I'd put the fear of having already missed out high on the list. There's nothing you can do once an opportunity is gone.\nSome investors might be feeling as if...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/01/missed-out-on-the-faang-stocks-consider-buying-the/\">网页链接</a>\n\n</div>\n","source":"fool_stock","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Missed Out on the FAANG Stocks? Consider Buying These PfANG Stocks Instead.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMissed Out on the FAANG Stocks? Consider Buying These PfANG Stocks Instead.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-02 08:38 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/01/missed-out-on-the-faang-stocks-consider-buying-the/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>What's worse than the fear of missing out? I'd put the fear of having already missed out high on the list. There's nothing you can do once an opportunity is gone.\nSome investors might be feeling as if...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/01/missed-out-on-the-faang-stocks-consider-buying-the/\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"GOOGL","symbol_name":"谷歌A","start_time":0,"source_url":"https://www.fool.com/investing/2021/08/01/missed-out-on-the-faang-stocks-consider-buying-the/","article_id":"2156169749","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2156169749","pubTimestamp":1627864728,"sourceInfo":{"source_id":"fool_stock","name":"Motley Fool"},"weMediaInfo":null,"summary":"There's both rhyme and reason for checking out these four stocks.","collect":0,"end_time":0,"defaultTopTitle":"fool.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"GOOGL":"谷歌A","NFLX":"奈飞","AMZN":"亚马逊","NNOX":"Nano-X Imaging Ltd.","AAPL":"苹果","ALGN":"艾利科技","GH":"Guardant Health Inc.","GOOG":"谷歌","PFE":"辉瑞"},"translate_title":"错过了FAANG股票？考虑购买这些PfANG股票。","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AAPL":0.9,"ALGN":0.9,"AMZN":0.9,"FB":0.9,"GH":0.9,"GOOG":0.9,"GOOGL":0.9,"NFLX":0.9,"NNOX":0.9,"PFE":0.9},"content_text":"What's worse than the fear of missing out? I'd put the fear of having already missed out high on the list. There's nothing you can do once an opportunity is gone.\nSome investors might be feeling as if they've already missed out on the FAANG stocks. After all, four of them --  Apple (NASDAQ:AAPL), Alphabet (NASDAQ:GOOG) (NASDAQ:GOOGL) (whose Google unit is the \"G\" in FAANG), Amazon.com (NASDAQ:AMZN), and Facebook (NASDAQ:FB) -- rank among the top 10 biggest companies in the world. Only Netflix (NASDAQ:NFLX) lags behind, but the streaming company still has a market cap of close to $230 billion.\nIf you're concerned that you've missed out on a great opportunity with the FAANG stocks, don't worry. Consider buying these PfANG stocks instead.\nImage source: Getty Images.\nIntroducing the PfANG stocks\nAside from the fact that they're all now huge, the FAANG stocks have something else in common: They're all tech stocks. While technology remains a hot area for investors, the healthcare sector also offers tremendous growth prospects. Each of the PfANG stocks ranks as a leader in healthcare, albeit in very different ways.\nPfizer (NYSE:PFE) contributes the \"Pf\" in PfANG. The company is by far the best known of the group. Pfizer, of course, markets a blockbuster COVID-19 vaccine along with its partner, BioNTech. The company also has a product lineup that's loaded with other successful drugs and vaccines.\nAlign Technology (NASDAQ:ALGN) pioneered the clear dental aligner market. The company's Invisalign clear aligners have been used to straighten the teeth of nearly 11 million patients so far. Align also markets intraoral scanners used to create 3D images of teeth.\nNano-X Imaging (NASDAQ:NNOX) expects to disrupt the medical imaging market with its digital X-ray devices. The company recently filed for U.S. Food and Drug Administration (FDA) clearance of the first version of its multisource digital system.\nGuardant Health (NASDAQ:GH) is a leader in developing liquid biopsy tests for cancer. The company's first products on the market help match patients with the best cancer therapy and enable drugmakers to develop new therapies.\nWhat sets these stocks apart\nA catchy name that sounds just like FAANG doesn't make these four stocks great picks, of course. However, there are two specific things that set these stocks apart:\n\nThey all target a massive potential market.\nThey all have a head start in that market.\n\nPfizer has been around a long time and is by far the biggest of the PfANG stocks. The company still has multiple growth opportunities, though. One of the most significant of these is in messenger RNA (mRNA) therapies and vaccines.\nThe company continues to work closely with BioNTech on its mRNA COVID-19 vaccine program and an mRNA flu vaccine. Pfizer plans to move forward with mRNA development on its own as well.\nCEO Albert Bourla stated in the company's Q2 conference call last week that Pfizer's strategy is to \"advance and unlock the full potential of mRNA.\" This strategy includes expanding its COVID-19 vaccine franchise and developing mRNA candidates targeting other infectious diseases, rare diseases, and cancer.\nAlign Technology has generated impressive growth in recent years. The company, though, still has only captured 11% of the addressable market for clear aligners.\nNano-X doesn't plan to compete for market share in the $21 billion medical imaging market; it fully intends to expand that market. The company's mobile devices cost only a fraction of current X-ray systems. Two-thirds of the world population have no meaningful access to medical imaging. Nano-X's opportunity is wide open.\nGuardant Health targets a $70 billion-plus potential market in cancer therapy selection, recurrence monitoring, and early screening. There are other companies going after this market as well. However, Guardant stands as one of the leaders and already has strong adoption for its initial liquid biopsy products.\nStill some bite left in the FAANG stocks, too\nI think that the PfANG stocks could deliver market-beating returns over the long term. But you don't really need to worry about having already missed out on the FAANG stocks.\nAugmented reality and virtual reality present big growth opportunities for Facebook and Apple. Artificial intelligence should serve as a growth driver for both of these stocks as well as Alphabet. Netflix is moving into gaming. These FAANG stocks should still have some bite left in them.","kind":null,"is_publish_news":false,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":804915250,"gmtCreate":1627915828370,"gmtModify":1633755288139,"author":{"id":"3586079929346346","authorId":"3586079929346346","name":"SieCW","avatar":"https://static.tigerbbs.com/b1efb98bcad0f6eb05f4d8529555d042","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3586079929346346","idStr":"3586079929346346"},"htmlText":"Another new kids on the block?🤔","listText":"Another new kids on the block?🤔","text":"Another new kids on the block?🤔","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/804915250","repostId":2156169749,"repostType":4,"repost":{"id":"2156169749","pubTimestamp":1627864728,"share":"https://www.laohu8.com/m/news/2156169749?lang=&edition=full","pubTime":"2021-08-02 08:38","market":"us","language":"en","title":"Missed Out on the FAANG Stocks? Consider Buying These PfANG Stocks Instead.","url":"https://stock-news.laohu8.com/highlight/detail?id=2156169749","media":"Motley Fool","summary":"There's both rhyme and reason for checking out these four stocks.","content":"<p>What's worse than the fear of missing out? I'd put the fear of having already missed out high on the list. There's nothing you can do once an opportunity is gone.</p>\n<p>Some investors might be feeling as if they've already missed out on the FAANG stocks. After all, four of them --&nbsp; <b>Apple</b> (NASDAQ:AAPL), <b>Alphabet</b> (NASDAQ:GOOG) (NASDAQ:GOOGL) (whose Google unit is the \"G\" in FAANG), <b>Amazon.com</b> (NASDAQ:AMZN), and&nbsp;<b><a href=\"https://laohu8.com/S/FB\">Facebook</a></b> (NASDAQ:FB) -- rank among the top 10 biggest companies in the world. Only&nbsp;<b>Netflix</b> (NASDAQ:NFLX) lags behind, but the streaming company still has a market cap of close to $230 billion.</p>\n<p>If you're concerned that you've missed out on a great opportunity with the FAANG stocks, don't worry. Consider buying these PfANG stocks instead.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/5160b68a97ec192124c08475ad420b61\" tg-width=\"700\" tg-height=\"467\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>Introducing the PfANG stocks</h2>\n<p>Aside from the fact that they're all now huge, the FAANG stocks have something else in common: They're all tech stocks. While technology remains a hot area for investors, the healthcare sector also offers tremendous growth prospects. Each of the PfANG stocks ranks as a leader in healthcare, albeit in very different ways.</p>\n<p><b>Pfizer</b> (NYSE:PFE) contributes the \"Pf\" in PfANG. The company is by far the best known of the group. Pfizer, of course, markets a blockbuster COVID-19 vaccine along with its partner, <b>BioNTech</b>. The company also has a product lineup that's loaded with other successful drugs and vaccines.</p>\n<p><b>Align Technology </b>(NASDAQ:ALGN) pioneered the clear dental aligner market. The company's Invisalign clear aligners have been used to straighten the teeth of nearly 11 million patients so far. Align also markets intraoral scanners used to create 3D images of teeth.</p>\n<p><b>Nano-X Imaging</b> (NASDAQ:NNOX) expects to disrupt the medical imaging market with its digital X-ray devices. The company recently filed for U.S. Food and Drug Administration (FDA) clearance of the first version of its multisource digital system.</p>\n<p><b>Guardant Health</b> (NASDAQ:GH) is a leader in developing liquid biopsy tests for cancer. The company's first products on the market help match patients with the best cancer therapy and enable drugmakers to develop new therapies.</p>\n<h2>What sets these stocks apart</h2>\n<p>A catchy name that sounds just like FAANG doesn't make these four stocks great picks, of course. However, there are two specific things that set these stocks apart:</p>\n<ol>\n <li>They all target a massive potential market.</li>\n <li>They all have a head start in that market.</li>\n</ol>\n<p>Pfizer has been around a long time and is by far the biggest of the PfANG stocks. The company still has multiple growth opportunities, though. One of the most significant of these is in messenger RNA (mRNA) therapies and vaccines.</p>\n<p>The company continues to work closely with BioNTech on its mRNA COVID-19 vaccine program and an mRNA flu vaccine. Pfizer plans to move forward with mRNA development on its own as well.</p>\n<p>CEO Albert Bourla stated in the company's Q2 conference call last week that Pfizer's strategy is to \"advance and unlock the full potential of mRNA.\" This strategy includes expanding its COVID-19 vaccine franchise and developing mRNA candidates targeting other infectious diseases, rare diseases, and cancer.</p>\n<p>Align Technology has generated impressive growth in recent years. The company, though, still has only captured 11% of the addressable market for clear aligners.</p>\n<p>Nano-X doesn't plan to compete for market share in the $21 billion medical imaging market; it fully intends to expand that market. The company's mobile devices cost only a fraction of current X-ray systems. <a href=\"https://laohu8.com/S/TWOA.U\">Two</a>-thirds of the world population have no meaningful access to medical imaging. Nano-X's opportunity is wide open.</p>\n<p>Guardant Health targets a $70 billion-plus potential market in cancer therapy selection, recurrence monitoring, and early screening. There are other companies going after this market as well. However, Guardant stands as <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the leaders and already has strong adoption for its initial liquid biopsy products.</p>\n<h2>Still some bite left in the FAANG stocks, too</h2>\n<p>I think that the PfANG stocks could deliver market-beating returns over the long term. But you don't really need to worry about having already missed out on the FAANG stocks.</p>\n<p>Augmented reality and virtual reality present big growth opportunities for Facebook and Apple. Artificial intelligence should serve as a growth driver for both of these stocks as well as Alphabet. Netflix is moving into gaming. These FAANG stocks should still have some bite left in them.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Missed Out on the FAANG Stocks? Consider Buying These PfANG Stocks Instead.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMissed Out on the FAANG Stocks? Consider Buying These PfANG Stocks Instead.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-02 08:38 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/01/missed-out-on-the-faang-stocks-consider-buying-the/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>What's worse than the fear of missing out? I'd put the fear of having already missed out high on the list. There's nothing you can do once an opportunity is gone.\nSome investors might be feeling as if...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/01/missed-out-on-the-faang-stocks-consider-buying-the/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMZN":"亚马逊","AAPL":"苹果","NFLX":"奈飞","GH":"Guardant Health Inc.","GOOG":"谷歌","PFE":"辉瑞","ALGN":"艾利科技","GOOGL":"谷歌A","NNOX":"Nano-X Imaging Ltd."},"source_url":"https://www.fool.com/investing/2021/08/01/missed-out-on-the-faang-stocks-consider-buying-the/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2156169749","content_text":"What's worse than the fear of missing out? I'd put the fear of having already missed out high on the list. There's nothing you can do once an opportunity is gone.\nSome investors might be feeling as if they've already missed out on the FAANG stocks. After all, four of them --  Apple (NASDAQ:AAPL), Alphabet (NASDAQ:GOOG) (NASDAQ:GOOGL) (whose Google unit is the \"G\" in FAANG), Amazon.com (NASDAQ:AMZN), and Facebook (NASDAQ:FB) -- rank among the top 10 biggest companies in the world. Only Netflix (NASDAQ:NFLX) lags behind, but the streaming company still has a market cap of close to $230 billion.\nIf you're concerned that you've missed out on a great opportunity with the FAANG stocks, don't worry. Consider buying these PfANG stocks instead.\nImage source: Getty Images.\nIntroducing the PfANG stocks\nAside from the fact that they're all now huge, the FAANG stocks have something else in common: They're all tech stocks. While technology remains a hot area for investors, the healthcare sector also offers tremendous growth prospects. Each of the PfANG stocks ranks as a leader in healthcare, albeit in very different ways.\nPfizer (NYSE:PFE) contributes the \"Pf\" in PfANG. The company is by far the best known of the group. Pfizer, of course, markets a blockbuster COVID-19 vaccine along with its partner, BioNTech. The company also has a product lineup that's loaded with other successful drugs and vaccines.\nAlign Technology (NASDAQ:ALGN) pioneered the clear dental aligner market. The company's Invisalign clear aligners have been used to straighten the teeth of nearly 11 million patients so far. Align also markets intraoral scanners used to create 3D images of teeth.\nNano-X Imaging (NASDAQ:NNOX) expects to disrupt the medical imaging market with its digital X-ray devices. The company recently filed for U.S. Food and Drug Administration (FDA) clearance of the first version of its multisource digital system.\nGuardant Health (NASDAQ:GH) is a leader in developing liquid biopsy tests for cancer. The company's first products on the market help match patients with the best cancer therapy and enable drugmakers to develop new therapies.\nWhat sets these stocks apart\nA catchy name that sounds just like FAANG doesn't make these four stocks great picks, of course. However, there are two specific things that set these stocks apart:\n\nThey all target a massive potential market.\nThey all have a head start in that market.\n\nPfizer has been around a long time and is by far the biggest of the PfANG stocks. The company still has multiple growth opportunities, though. One of the most significant of these is in messenger RNA (mRNA) therapies and vaccines.\nThe company continues to work closely with BioNTech on its mRNA COVID-19 vaccine program and an mRNA flu vaccine. Pfizer plans to move forward with mRNA development on its own as well.\nCEO Albert Bourla stated in the company's Q2 conference call last week that Pfizer's strategy is to \"advance and unlock the full potential of mRNA.\" This strategy includes expanding its COVID-19 vaccine franchise and developing mRNA candidates targeting other infectious diseases, rare diseases, and cancer.\nAlign Technology has generated impressive growth in recent years. The company, though, still has only captured 11% of the addressable market for clear aligners.\nNano-X doesn't plan to compete for market share in the $21 billion medical imaging market; it fully intends to expand that market. The company's mobile devices cost only a fraction of current X-ray systems. Two-thirds of the world population have no meaningful access to medical imaging. Nano-X's opportunity is wide open.\nGuardant Health targets a $70 billion-plus potential market in cancer therapy selection, recurrence monitoring, and early screening. There are other companies going after this market as well. However, Guardant stands as one of the leaders and already has strong adoption for its initial liquid biopsy products.\nStill some bite left in the FAANG stocks, too\nI think that the PfANG stocks could deliver market-beating returns over the long term. But you don't really need to worry about having already missed out on the FAANG stocks.\nAugmented reality and virtual reality present big growth opportunities for Facebook and Apple. Artificial intelligence should serve as a growth driver for both of these stocks as well as Alphabet. Netflix is moving into gaming. These FAANG stocks should still have some bite left in them.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":804055539,"gmtCreate":1627913506721,"gmtModify":1627913506721,"author":{"id":"3575523761597092","authorId":"3575523761597092","name":"Eric_7864","avatar":"https://static.tigerbbs.com/82726ce88d054c7d69480e81689a6770","vip":1,"crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"3575523761597092","idStr":"3575523761597092"},"htmlText":"lol,interesting,but make no sence","listText":"lol,interesting,but make no sence","text":"lol,interesting,but make no sence","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/804055539","repostId":2156169749,"repostType":4,"repost":{"id":"2156169749","pubTimestamp":1627864728,"share":"https://www.laohu8.com/m/news/2156169749?lang=&edition=full","pubTime":"2021-08-02 08:38","market":"us","language":"en","title":"Missed Out on the FAANG Stocks? Consider Buying These PfANG Stocks Instead.","url":"https://stock-news.laohu8.com/highlight/detail?id=2156169749","media":"Motley Fool","summary":"There's both rhyme and reason for checking out these four stocks.","content":"<p>What's worse than the fear of missing out? I'd put the fear of having already missed out high on the list. There's nothing you can do once an opportunity is gone.</p>\n<p>Some investors might be feeling as if they've already missed out on the FAANG stocks. After all, four of them --&nbsp; <b>Apple</b> (NASDAQ:AAPL), <b>Alphabet</b> (NASDAQ:GOOG) (NASDAQ:GOOGL) (whose Google unit is the \"G\" in FAANG), <b>Amazon.com</b> (NASDAQ:AMZN), and&nbsp;<b><a href=\"https://laohu8.com/S/FB\">Facebook</a></b> (NASDAQ:FB) -- rank among the top 10 biggest companies in the world. Only&nbsp;<b>Netflix</b> (NASDAQ:NFLX) lags behind, but the streaming company still has a market cap of close to $230 billion.</p>\n<p>If you're concerned that you've missed out on a great opportunity with the FAANG stocks, don't worry. Consider buying these PfANG stocks instead.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/5160b68a97ec192124c08475ad420b61\" tg-width=\"700\" tg-height=\"467\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>Introducing the PfANG stocks</h2>\n<p>Aside from the fact that they're all now huge, the FAANG stocks have something else in common: They're all tech stocks. While technology remains a hot area for investors, the healthcare sector also offers tremendous growth prospects. Each of the PfANG stocks ranks as a leader in healthcare, albeit in very different ways.</p>\n<p><b>Pfizer</b> (NYSE:PFE) contributes the \"Pf\" in PfANG. The company is by far the best known of the group. Pfizer, of course, markets a blockbuster COVID-19 vaccine along with its partner, <b>BioNTech</b>. The company also has a product lineup that's loaded with other successful drugs and vaccines.</p>\n<p><b>Align Technology </b>(NASDAQ:ALGN) pioneered the clear dental aligner market. The company's Invisalign clear aligners have been used to straighten the teeth of nearly 11 million patients so far. Align also markets intraoral scanners used to create 3D images of teeth.</p>\n<p><b>Nano-X Imaging</b> (NASDAQ:NNOX) expects to disrupt the medical imaging market with its digital X-ray devices. The company recently filed for U.S. Food and Drug Administration (FDA) clearance of the first version of its multisource digital system.</p>\n<p><b>Guardant Health</b> (NASDAQ:GH) is a leader in developing liquid biopsy tests for cancer. The company's first products on the market help match patients with the best cancer therapy and enable drugmakers to develop new therapies.</p>\n<h2>What sets these stocks apart</h2>\n<p>A catchy name that sounds just like FAANG doesn't make these four stocks great picks, of course. However, there are two specific things that set these stocks apart:</p>\n<ol>\n <li>They all target a massive potential market.</li>\n <li>They all have a head start in that market.</li>\n</ol>\n<p>Pfizer has been around a long time and is by far the biggest of the PfANG stocks. The company still has multiple growth opportunities, though. One of the most significant of these is in messenger RNA (mRNA) therapies and vaccines.</p>\n<p>The company continues to work closely with BioNTech on its mRNA COVID-19 vaccine program and an mRNA flu vaccine. Pfizer plans to move forward with mRNA development on its own as well.</p>\n<p>CEO Albert Bourla stated in the company's Q2 conference call last week that Pfizer's strategy is to \"advance and unlock the full potential of mRNA.\" This strategy includes expanding its COVID-19 vaccine franchise and developing mRNA candidates targeting other infectious diseases, rare diseases, and cancer.</p>\n<p>Align Technology has generated impressive growth in recent years. The company, though, still has only captured 11% of the addressable market for clear aligners.</p>\n<p>Nano-X doesn't plan to compete for market share in the $21 billion medical imaging market; it fully intends to expand that market. The company's mobile devices cost only a fraction of current X-ray systems. <a href=\"https://laohu8.com/S/TWOA.U\">Two</a>-thirds of the world population have no meaningful access to medical imaging. Nano-X's opportunity is wide open.</p>\n<p>Guardant Health targets a $70 billion-plus potential market in cancer therapy selection, recurrence monitoring, and early screening. There are other companies going after this market as well. However, Guardant stands as <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the leaders and already has strong adoption for its initial liquid biopsy products.</p>\n<h2>Still some bite left in the FAANG stocks, too</h2>\n<p>I think that the PfANG stocks could deliver market-beating returns over the long term. But you don't really need to worry about having already missed out on the FAANG stocks.</p>\n<p>Augmented reality and virtual reality present big growth opportunities for Facebook and Apple. Artificial intelligence should serve as a growth driver for both of these stocks as well as Alphabet. Netflix is moving into gaming. These FAANG stocks should still have some bite left in them.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Missed Out on the FAANG Stocks? Consider Buying These PfANG Stocks Instead.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMissed Out on the FAANG Stocks? Consider Buying These PfANG Stocks Instead.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-02 08:38 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/01/missed-out-on-the-faang-stocks-consider-buying-the/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>What's worse than the fear of missing out? I'd put the fear of having already missed out high on the list. There's nothing you can do once an opportunity is gone.\nSome investors might be feeling as if...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/01/missed-out-on-the-faang-stocks-consider-buying-the/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMZN":"亚马逊","AAPL":"苹果","NFLX":"奈飞","GH":"Guardant Health Inc.","GOOG":"谷歌","PFE":"辉瑞","ALGN":"艾利科技","GOOGL":"谷歌A","NNOX":"Nano-X Imaging Ltd."},"source_url":"https://www.fool.com/investing/2021/08/01/missed-out-on-the-faang-stocks-consider-buying-the/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2156169749","content_text":"What's worse than the fear of missing out? I'd put the fear of having already missed out high on the list. There's nothing you can do once an opportunity is gone.\nSome investors might be feeling as if they've already missed out on the FAANG stocks. After all, four of them --  Apple (NASDAQ:AAPL), Alphabet (NASDAQ:GOOG) (NASDAQ:GOOGL) (whose Google unit is the \"G\" in FAANG), Amazon.com (NASDAQ:AMZN), and Facebook (NASDAQ:FB) -- rank among the top 10 biggest companies in the world. Only Netflix (NASDAQ:NFLX) lags behind, but the streaming company still has a market cap of close to $230 billion.\nIf you're concerned that you've missed out on a great opportunity with the FAANG stocks, don't worry. Consider buying these PfANG stocks instead.\nImage source: Getty Images.\nIntroducing the PfANG stocks\nAside from the fact that they're all now huge, the FAANG stocks have something else in common: They're all tech stocks. While technology remains a hot area for investors, the healthcare sector also offers tremendous growth prospects. Each of the PfANG stocks ranks as a leader in healthcare, albeit in very different ways.\nPfizer (NYSE:PFE) contributes the \"Pf\" in PfANG. The company is by far the best known of the group. Pfizer, of course, markets a blockbuster COVID-19 vaccine along with its partner, BioNTech. The company also has a product lineup that's loaded with other successful drugs and vaccines.\nAlign Technology (NASDAQ:ALGN) pioneered the clear dental aligner market. The company's Invisalign clear aligners have been used to straighten the teeth of nearly 11 million patients so far. Align also markets intraoral scanners used to create 3D images of teeth.\nNano-X Imaging (NASDAQ:NNOX) expects to disrupt the medical imaging market with its digital X-ray devices. The company recently filed for U.S. Food and Drug Administration (FDA) clearance of the first version of its multisource digital system.\nGuardant Health (NASDAQ:GH) is a leader in developing liquid biopsy tests for cancer. The company's first products on the market help match patients with the best cancer therapy and enable drugmakers to develop new therapies.\nWhat sets these stocks apart\nA catchy name that sounds just like FAANG doesn't make these four stocks great picks, of course. However, there are two specific things that set these stocks apart:\n\nThey all target a massive potential market.\nThey all have a head start in that market.\n\nPfizer has been around a long time and is by far the biggest of the PfANG stocks. The company still has multiple growth opportunities, though. One of the most significant of these is in messenger RNA (mRNA) therapies and vaccines.\nThe company continues to work closely with BioNTech on its mRNA COVID-19 vaccine program and an mRNA flu vaccine. Pfizer plans to move forward with mRNA development on its own as well.\nCEO Albert Bourla stated in the company's Q2 conference call last week that Pfizer's strategy is to \"advance and unlock the full potential of mRNA.\" This strategy includes expanding its COVID-19 vaccine franchise and developing mRNA candidates targeting other infectious diseases, rare diseases, and cancer.\nAlign Technology has generated impressive growth in recent years. The company, though, still has only captured 11% of the addressable market for clear aligners.\nNano-X doesn't plan to compete for market share in the $21 billion medical imaging market; it fully intends to expand that market. The company's mobile devices cost only a fraction of current X-ray systems. Two-thirds of the world population have no meaningful access to medical imaging. Nano-X's opportunity is wide open.\nGuardant Health targets a $70 billion-plus potential market in cancer therapy selection, recurrence monitoring, and early screening. There are other companies going after this market as well. However, Guardant stands as one of the leaders and already has strong adoption for its initial liquid biopsy products.\nStill some bite left in the FAANG stocks, too\nI think that the PfANG stocks could deliver market-beating returns over the long term. But you don't really need to worry about having already missed out on the FAANG stocks.\nAugmented reality and virtual reality present big growth opportunities for Facebook and Apple. Artificial intelligence should serve as a growth driver for both of these stocks as well as Alphabet. Netflix is moving into gaming. These FAANG stocks should still have some bite left in them.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":805709954,"gmtCreate":1627903947078,"gmtModify":1633755455381,"author":{"id":"3581577540266884","authorId":"3581577540266884","name":"JohnsonYeo","avatar":"https://static.tigerbbs.com/7139a0ce522ecb24fe97876b7ccfa905","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3581577540266884","idStr":"3581577540266884"},"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/805709954","repostId":2156169749,"repostType":4,"repost":{"id":"2156169749","pubTimestamp":1627864728,"share":"https://www.laohu8.com/m/news/2156169749?lang=&edition=full","pubTime":"2021-08-02 08:38","market":"us","language":"en","title":"Missed Out on the FAANG Stocks? Consider Buying These PfANG Stocks Instead.","url":"https://stock-news.laohu8.com/highlight/detail?id=2156169749","media":"Motley Fool","summary":"There's both rhyme and reason for checking out these four stocks.","content":"<p>What's worse than the fear of missing out? I'd put the fear of having already missed out high on the list. There's nothing you can do once an opportunity is gone.</p>\n<p>Some investors might be feeling as if they've already missed out on the FAANG stocks. After all, four of them --&nbsp; <b>Apple</b> (NASDAQ:AAPL), <b>Alphabet</b> (NASDAQ:GOOG) (NASDAQ:GOOGL) (whose Google unit is the \"G\" in FAANG), <b>Amazon.com</b> (NASDAQ:AMZN), and&nbsp;<b><a href=\"https://laohu8.com/S/FB\">Facebook</a></b> (NASDAQ:FB) -- rank among the top 10 biggest companies in the world. Only&nbsp;<b>Netflix</b> (NASDAQ:NFLX) lags behind, but the streaming company still has a market cap of close to $230 billion.</p>\n<p>If you're concerned that you've missed out on a great opportunity with the FAANG stocks, don't worry. Consider buying these PfANG stocks instead.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/5160b68a97ec192124c08475ad420b61\" tg-width=\"700\" tg-height=\"467\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>Introducing the PfANG stocks</h2>\n<p>Aside from the fact that they're all now huge, the FAANG stocks have something else in common: They're all tech stocks. While technology remains a hot area for investors, the healthcare sector also offers tremendous growth prospects. Each of the PfANG stocks ranks as a leader in healthcare, albeit in very different ways.</p>\n<p><b>Pfizer</b> (NYSE:PFE) contributes the \"Pf\" in PfANG. The company is by far the best known of the group. Pfizer, of course, markets a blockbuster COVID-19 vaccine along with its partner, <b>BioNTech</b>. The company also has a product lineup that's loaded with other successful drugs and vaccines.</p>\n<p><b>Align Technology </b>(NASDAQ:ALGN) pioneered the clear dental aligner market. The company's Invisalign clear aligners have been used to straighten the teeth of nearly 11 million patients so far. Align also markets intraoral scanners used to create 3D images of teeth.</p>\n<p><b>Nano-X Imaging</b> (NASDAQ:NNOX) expects to disrupt the medical imaging market with its digital X-ray devices. The company recently filed for U.S. Food and Drug Administration (FDA) clearance of the first version of its multisource digital system.</p>\n<p><b>Guardant Health</b> (NASDAQ:GH) is a leader in developing liquid biopsy tests for cancer. The company's first products on the market help match patients with the best cancer therapy and enable drugmakers to develop new therapies.</p>\n<h2>What sets these stocks apart</h2>\n<p>A catchy name that sounds just like FAANG doesn't make these four stocks great picks, of course. However, there are two specific things that set these stocks apart:</p>\n<ol>\n <li>They all target a massive potential market.</li>\n <li>They all have a head start in that market.</li>\n</ol>\n<p>Pfizer has been around a long time and is by far the biggest of the PfANG stocks. The company still has multiple growth opportunities, though. One of the most significant of these is in messenger RNA (mRNA) therapies and vaccines.</p>\n<p>The company continues to work closely with BioNTech on its mRNA COVID-19 vaccine program and an mRNA flu vaccine. Pfizer plans to move forward with mRNA development on its own as well.</p>\n<p>CEO Albert Bourla stated in the company's Q2 conference call last week that Pfizer's strategy is to \"advance and unlock the full potential of mRNA.\" This strategy includes expanding its COVID-19 vaccine franchise and developing mRNA candidates targeting other infectious diseases, rare diseases, and cancer.</p>\n<p>Align Technology has generated impressive growth in recent years. The company, though, still has only captured 11% of the addressable market for clear aligners.</p>\n<p>Nano-X doesn't plan to compete for market share in the $21 billion medical imaging market; it fully intends to expand that market. The company's mobile devices cost only a fraction of current X-ray systems. <a href=\"https://laohu8.com/S/TWOA.U\">Two</a>-thirds of the world population have no meaningful access to medical imaging. Nano-X's opportunity is wide open.</p>\n<p>Guardant Health targets a $70 billion-plus potential market in cancer therapy selection, recurrence monitoring, and early screening. There are other companies going after this market as well. However, Guardant stands as <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the leaders and already has strong adoption for its initial liquid biopsy products.</p>\n<h2>Still some bite left in the FAANG stocks, too</h2>\n<p>I think that the PfANG stocks could deliver market-beating returns over the long term. But you don't really need to worry about having already missed out on the FAANG stocks.</p>\n<p>Augmented reality and virtual reality present big growth opportunities for Facebook and Apple. Artificial intelligence should serve as a growth driver for both of these stocks as well as Alphabet. Netflix is moving into gaming. These FAANG stocks should still have some bite left in them.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Missed Out on the FAANG Stocks? Consider Buying These PfANG Stocks Instead.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMissed Out on the FAANG Stocks? Consider Buying These PfANG Stocks Instead.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-02 08:38 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/01/missed-out-on-the-faang-stocks-consider-buying-the/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>What's worse than the fear of missing out? I'd put the fear of having already missed out high on the list. There's nothing you can do once an opportunity is gone.\nSome investors might be feeling as if...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/01/missed-out-on-the-faang-stocks-consider-buying-the/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMZN":"亚马逊","AAPL":"苹果","NFLX":"奈飞","GH":"Guardant Health Inc.","GOOG":"谷歌","PFE":"辉瑞","ALGN":"艾利科技","GOOGL":"谷歌A","NNOX":"Nano-X Imaging Ltd."},"source_url":"https://www.fool.com/investing/2021/08/01/missed-out-on-the-faang-stocks-consider-buying-the/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2156169749","content_text":"What's worse than the fear of missing out? I'd put the fear of having already missed out high on the list. There's nothing you can do once an opportunity is gone.\nSome investors might be feeling as if they've already missed out on the FAANG stocks. After all, four of them --  Apple (NASDAQ:AAPL), Alphabet (NASDAQ:GOOG) (NASDAQ:GOOGL) (whose Google unit is the \"G\" in FAANG), Amazon.com (NASDAQ:AMZN), and Facebook (NASDAQ:FB) -- rank among the top 10 biggest companies in the world. Only Netflix (NASDAQ:NFLX) lags behind, but the streaming company still has a market cap of close to $230 billion.\nIf you're concerned that you've missed out on a great opportunity with the FAANG stocks, don't worry. Consider buying these PfANG stocks instead.\nImage source: Getty Images.\nIntroducing the PfANG stocks\nAside from the fact that they're all now huge, the FAANG stocks have something else in common: They're all tech stocks. While technology remains a hot area for investors, the healthcare sector also offers tremendous growth prospects. Each of the PfANG stocks ranks as a leader in healthcare, albeit in very different ways.\nPfizer (NYSE:PFE) contributes the \"Pf\" in PfANG. The company is by far the best known of the group. Pfizer, of course, markets a blockbuster COVID-19 vaccine along with its partner, BioNTech. The company also has a product lineup that's loaded with other successful drugs and vaccines.\nAlign Technology (NASDAQ:ALGN) pioneered the clear dental aligner market. The company's Invisalign clear aligners have been used to straighten the teeth of nearly 11 million patients so far. Align also markets intraoral scanners used to create 3D images of teeth.\nNano-X Imaging (NASDAQ:NNOX) expects to disrupt the medical imaging market with its digital X-ray devices. The company recently filed for U.S. Food and Drug Administration (FDA) clearance of the first version of its multisource digital system.\nGuardant Health (NASDAQ:GH) is a leader in developing liquid biopsy tests for cancer. The company's first products on the market help match patients with the best cancer therapy and enable drugmakers to develop new therapies.\nWhat sets these stocks apart\nA catchy name that sounds just like FAANG doesn't make these four stocks great picks, of course. However, there are two specific things that set these stocks apart:\n\nThey all target a massive potential market.\nThey all have a head start in that market.\n\nPfizer has been around a long time and is by far the biggest of the PfANG stocks. The company still has multiple growth opportunities, though. One of the most significant of these is in messenger RNA (mRNA) therapies and vaccines.\nThe company continues to work closely with BioNTech on its mRNA COVID-19 vaccine program and an mRNA flu vaccine. Pfizer plans to move forward with mRNA development on its own as well.\nCEO Albert Bourla stated in the company's Q2 conference call last week that Pfizer's strategy is to \"advance and unlock the full potential of mRNA.\" This strategy includes expanding its COVID-19 vaccine franchise and developing mRNA candidates targeting other infectious diseases, rare diseases, and cancer.\nAlign Technology has generated impressive growth in recent years. The company, though, still has only captured 11% of the addressable market for clear aligners.\nNano-X doesn't plan to compete for market share in the $21 billion medical imaging market; it fully intends to expand that market. The company's mobile devices cost only a fraction of current X-ray systems. Two-thirds of the world population have no meaningful access to medical imaging. Nano-X's opportunity is wide open.\nGuardant Health targets a $70 billion-plus potential market in cancer therapy selection, recurrence monitoring, and early screening. There are other companies going after this market as well. However, Guardant stands as one of the leaders and already has strong adoption for its initial liquid biopsy products.\nStill some bite left in the FAANG stocks, too\nI think that the PfANG stocks could deliver market-beating returns over the long term. But you don't really need to worry about having already missed out on the FAANG stocks.\nAugmented reality and virtual reality present big growth opportunities for Facebook and Apple. Artificial intelligence should serve as a growth driver for both of these stocks as well as Alphabet. Netflix is moving into gaming. These FAANG stocks should still have some bite left in them.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":805563567,"gmtCreate":1627892339659,"gmtModify":1633755541465,"author":{"id":"3583811401087980","authorId":"3583811401087980","name":"DLIM","avatar":"https://static.tigerbbs.com/140bf807c414ea069de5f87b2b1509cd","vip":1,"crmLevel":7,"crmLevelSwitch":0,"authorIdStr":"3583811401087980","idStr":"3583811401087980"},"htmlText":"Nano-X company background and product data information raise red flags","listText":"Nano-X company background and product data information raise red flags","text":"Nano-X company background and product data information raise red flags","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/805563567","repostId":2156169749,"repostType":4,"repost":{"id":"2156169749","pubTimestamp":1627864728,"share":"https://www.laohu8.com/m/news/2156169749?lang=&edition=full","pubTime":"2021-08-02 08:38","market":"us","language":"en","title":"Missed Out on the FAANG Stocks? Consider Buying These PfANG Stocks Instead.","url":"https://stock-news.laohu8.com/highlight/detail?id=2156169749","media":"Motley Fool","summary":"There's both rhyme and reason for checking out these four stocks.","content":"<p>What's worse than the fear of missing out? I'd put the fear of having already missed out high on the list. There's nothing you can do once an opportunity is gone.</p>\n<p>Some investors might be feeling as if they've already missed out on the FAANG stocks. After all, four of them --&nbsp; <b>Apple</b> (NASDAQ:AAPL), <b>Alphabet</b> (NASDAQ:GOOG) (NASDAQ:GOOGL) (whose Google unit is the \"G\" in FAANG), <b>Amazon.com</b> (NASDAQ:AMZN), and&nbsp;<b><a href=\"https://laohu8.com/S/FB\">Facebook</a></b> (NASDAQ:FB) -- rank among the top 10 biggest companies in the world. Only&nbsp;<b>Netflix</b> (NASDAQ:NFLX) lags behind, but the streaming company still has a market cap of close to $230 billion.</p>\n<p>If you're concerned that you've missed out on a great opportunity with the FAANG stocks, don't worry. Consider buying these PfANG stocks instead.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/5160b68a97ec192124c08475ad420b61\" tg-width=\"700\" tg-height=\"467\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>Introducing the PfANG stocks</h2>\n<p>Aside from the fact that they're all now huge, the FAANG stocks have something else in common: They're all tech stocks. While technology remains a hot area for investors, the healthcare sector also offers tremendous growth prospects. Each of the PfANG stocks ranks as a leader in healthcare, albeit in very different ways.</p>\n<p><b>Pfizer</b> (NYSE:PFE) contributes the \"Pf\" in PfANG. The company is by far the best known of the group. Pfizer, of course, markets a blockbuster COVID-19 vaccine along with its partner, <b>BioNTech</b>. The company also has a product lineup that's loaded with other successful drugs and vaccines.</p>\n<p><b>Align Technology </b>(NASDAQ:ALGN) pioneered the clear dental aligner market. The company's Invisalign clear aligners have been used to straighten the teeth of nearly 11 million patients so far. Align also markets intraoral scanners used to create 3D images of teeth.</p>\n<p><b>Nano-X Imaging</b> (NASDAQ:NNOX) expects to disrupt the medical imaging market with its digital X-ray devices. The company recently filed for U.S. Food and Drug Administration (FDA) clearance of the first version of its multisource digital system.</p>\n<p><b>Guardant Health</b> (NASDAQ:GH) is a leader in developing liquid biopsy tests for cancer. The company's first products on the market help match patients with the best cancer therapy and enable drugmakers to develop new therapies.</p>\n<h2>What sets these stocks apart</h2>\n<p>A catchy name that sounds just like FAANG doesn't make these four stocks great picks, of course. However, there are two specific things that set these stocks apart:</p>\n<ol>\n <li>They all target a massive potential market.</li>\n <li>They all have a head start in that market.</li>\n</ol>\n<p>Pfizer has been around a long time and is by far the biggest of the PfANG stocks. The company still has multiple growth opportunities, though. One of the most significant of these is in messenger RNA (mRNA) therapies and vaccines.</p>\n<p>The company continues to work closely with BioNTech on its mRNA COVID-19 vaccine program and an mRNA flu vaccine. Pfizer plans to move forward with mRNA development on its own as well.</p>\n<p>CEO Albert Bourla stated in the company's Q2 conference call last week that Pfizer's strategy is to \"advance and unlock the full potential of mRNA.\" This strategy includes expanding its COVID-19 vaccine franchise and developing mRNA candidates targeting other infectious diseases, rare diseases, and cancer.</p>\n<p>Align Technology has generated impressive growth in recent years. The company, though, still has only captured 11% of the addressable market for clear aligners.</p>\n<p>Nano-X doesn't plan to compete for market share in the $21 billion medical imaging market; it fully intends to expand that market. The company's mobile devices cost only a fraction of current X-ray systems. <a href=\"https://laohu8.com/S/TWOA.U\">Two</a>-thirds of the world population have no meaningful access to medical imaging. Nano-X's opportunity is wide open.</p>\n<p>Guardant Health targets a $70 billion-plus potential market in cancer therapy selection, recurrence monitoring, and early screening. There are other companies going after this market as well. However, Guardant stands as <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the leaders and already has strong adoption for its initial liquid biopsy products.</p>\n<h2>Still some bite left in the FAANG stocks, too</h2>\n<p>I think that the PfANG stocks could deliver market-beating returns over the long term. But you don't really need to worry about having already missed out on the FAANG stocks.</p>\n<p>Augmented reality and virtual reality present big growth opportunities for Facebook and Apple. Artificial intelligence should serve as a growth driver for both of these stocks as well as Alphabet. Netflix is moving into gaming. These FAANG stocks should still have some bite left in them.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Missed Out on the FAANG Stocks? Consider Buying These PfANG Stocks Instead.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMissed Out on the FAANG Stocks? Consider Buying These PfANG Stocks Instead.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-02 08:38 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/01/missed-out-on-the-faang-stocks-consider-buying-the/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>What's worse than the fear of missing out? I'd put the fear of having already missed out high on the list. There's nothing you can do once an opportunity is gone.\nSome investors might be feeling as if...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/01/missed-out-on-the-faang-stocks-consider-buying-the/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMZN":"亚马逊","AAPL":"苹果","NFLX":"奈飞","GH":"Guardant Health Inc.","GOOG":"谷歌","PFE":"辉瑞","ALGN":"艾利科技","GOOGL":"谷歌A","NNOX":"Nano-X Imaging Ltd."},"source_url":"https://www.fool.com/investing/2021/08/01/missed-out-on-the-faang-stocks-consider-buying-the/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2156169749","content_text":"What's worse than the fear of missing out? I'd put the fear of having already missed out high on the list. There's nothing you can do once an opportunity is gone.\nSome investors might be feeling as if they've already missed out on the FAANG stocks. After all, four of them --  Apple (NASDAQ:AAPL), Alphabet (NASDAQ:GOOG) (NASDAQ:GOOGL) (whose Google unit is the \"G\" in FAANG), Amazon.com (NASDAQ:AMZN), and Facebook (NASDAQ:FB) -- rank among the top 10 biggest companies in the world. Only Netflix (NASDAQ:NFLX) lags behind, but the streaming company still has a market cap of close to $230 billion.\nIf you're concerned that you've missed out on a great opportunity with the FAANG stocks, don't worry. Consider buying these PfANG stocks instead.\nImage source: Getty Images.\nIntroducing the PfANG stocks\nAside from the fact that they're all now huge, the FAANG stocks have something else in common: They're all tech stocks. While technology remains a hot area for investors, the healthcare sector also offers tremendous growth prospects. Each of the PfANG stocks ranks as a leader in healthcare, albeit in very different ways.\nPfizer (NYSE:PFE) contributes the \"Pf\" in PfANG. The company is by far the best known of the group. Pfizer, of course, markets a blockbuster COVID-19 vaccine along with its partner, BioNTech. The company also has a product lineup that's loaded with other successful drugs and vaccines.\nAlign Technology (NASDAQ:ALGN) pioneered the clear dental aligner market. The company's Invisalign clear aligners have been used to straighten the teeth of nearly 11 million patients so far. Align also markets intraoral scanners used to create 3D images of teeth.\nNano-X Imaging (NASDAQ:NNOX) expects to disrupt the medical imaging market with its digital X-ray devices. The company recently filed for U.S. Food and Drug Administration (FDA) clearance of the first version of its multisource digital system.\nGuardant Health (NASDAQ:GH) is a leader in developing liquid biopsy tests for cancer. The company's first products on the market help match patients with the best cancer therapy and enable drugmakers to develop new therapies.\nWhat sets these stocks apart\nA catchy name that sounds just like FAANG doesn't make these four stocks great picks, of course. However, there are two specific things that set these stocks apart:\n\nThey all target a massive potential market.\nThey all have a head start in that market.\n\nPfizer has been around a long time and is by far the biggest of the PfANG stocks. The company still has multiple growth opportunities, though. One of the most significant of these is in messenger RNA (mRNA) therapies and vaccines.\nThe company continues to work closely with BioNTech on its mRNA COVID-19 vaccine program and an mRNA flu vaccine. Pfizer plans to move forward with mRNA development on its own as well.\nCEO Albert Bourla stated in the company's Q2 conference call last week that Pfizer's strategy is to \"advance and unlock the full potential of mRNA.\" This strategy includes expanding its COVID-19 vaccine franchise and developing mRNA candidates targeting other infectious diseases, rare diseases, and cancer.\nAlign Technology has generated impressive growth in recent years. The company, though, still has only captured 11% of the addressable market for clear aligners.\nNano-X doesn't plan to compete for market share in the $21 billion medical imaging market; it fully intends to expand that market. The company's mobile devices cost only a fraction of current X-ray systems. Two-thirds of the world population have no meaningful access to medical imaging. Nano-X's opportunity is wide open.\nGuardant Health targets a $70 billion-plus potential market in cancer therapy selection, recurrence monitoring, and early screening. There are other companies going after this market as well. However, Guardant stands as one of the leaders and already has strong adoption for its initial liquid biopsy products.\nStill some bite left in the FAANG stocks, too\nI think that the PfANG stocks could deliver market-beating returns over the long term. But you don't really need to worry about having already missed out on the FAANG stocks.\nAugmented reality and virtual reality present big growth opportunities for Facebook and Apple. Artificial intelligence should serve as a growth driver for both of these stocks as well as Alphabet. Netflix is moving into gaming. These FAANG stocks should still have some bite left in them.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":805518351,"gmtCreate":1627891472473,"gmtModify":1631883895490,"author":{"id":"3582105537582633","authorId":"3582105537582633","name":"jaster","avatar":"https://static.tigerbbs.com/b92224d225d7e1526b126af370834bb3","vip":1,"crmLevel":4,"crmLevelSwitch":0,"authorIdStr":"3582105537582633","idStr":"3582105537582633"},"htmlText":"I really wouldn't put Pfizer in the same group as Apple, Amazon, and the like. What makes those stocks really strong&nbsp;are the lack of scaling costs (meaning they can scale up easily), and strong network effects leading to high barriers of entry (no one can easily compete with them). Pfizer doesn't have any of these advantages, it's recent performance is largely driven by the covid pandemic - which is temporary by nature.","listText":"I really wouldn't put Pfizer in the same group as Apple, Amazon, and the like. What makes those stocks really strong&nbsp;are the lack of scaling costs (meaning they can scale up easily), and strong network effects leading to high barriers of entry (no one can easily compete with them). Pfizer doesn't have any of these advantages, it's recent performance is largely driven by the covid pandemic - which is temporary by nature.","text":"I really wouldn't put Pfizer in the same group as Apple, Amazon, and the like. What makes those stocks really strong are the lack of scaling costs (meaning they can scale up easily), and strong network effects leading to high barriers of entry (no one can easily compete with them). Pfizer doesn't have any of these advantages, it's recent performance is largely driven by the covid pandemic - which is temporary by nature.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/805518351","repostId":2156169749,"repostType":4,"repost":{"id":"2156169749","pubTimestamp":1627864728,"share":"https://www.laohu8.com/m/news/2156169749?lang=&edition=full","pubTime":"2021-08-02 08:38","market":"us","language":"en","title":"Missed Out on the FAANG Stocks? Consider Buying These PfANG Stocks Instead.","url":"https://stock-news.laohu8.com/highlight/detail?id=2156169749","media":"Motley Fool","summary":"There's both rhyme and reason for checking out these four stocks.","content":"<p>What's worse than the fear of missing out? I'd put the fear of having already missed out high on the list. There's nothing you can do once an opportunity is gone.</p>\n<p>Some investors might be feeling as if they've already missed out on the FAANG stocks. After all, four of them --&nbsp; <b>Apple</b> (NASDAQ:AAPL), <b>Alphabet</b> (NASDAQ:GOOG) (NASDAQ:GOOGL) (whose Google unit is the \"G\" in FAANG), <b>Amazon.com</b> (NASDAQ:AMZN), and&nbsp;<b><a href=\"https://laohu8.com/S/FB\">Facebook</a></b> (NASDAQ:FB) -- rank among the top 10 biggest companies in the world. Only&nbsp;<b>Netflix</b> (NASDAQ:NFLX) lags behind, but the streaming company still has a market cap of close to $230 billion.</p>\n<p>If you're concerned that you've missed out on a great opportunity with the FAANG stocks, don't worry. Consider buying these PfANG stocks instead.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/5160b68a97ec192124c08475ad420b61\" tg-width=\"700\" tg-height=\"467\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>Introducing the PfANG stocks</h2>\n<p>Aside from the fact that they're all now huge, the FAANG stocks have something else in common: They're all tech stocks. While technology remains a hot area for investors, the healthcare sector also offers tremendous growth prospects. Each of the PfANG stocks ranks as a leader in healthcare, albeit in very different ways.</p>\n<p><b>Pfizer</b> (NYSE:PFE) contributes the \"Pf\" in PfANG. The company is by far the best known of the group. Pfizer, of course, markets a blockbuster COVID-19 vaccine along with its partner, <b>BioNTech</b>. The company also has a product lineup that's loaded with other successful drugs and vaccines.</p>\n<p><b>Align Technology </b>(NASDAQ:ALGN) pioneered the clear dental aligner market. The company's Invisalign clear aligners have been used to straighten the teeth of nearly 11 million patients so far. Align also markets intraoral scanners used to create 3D images of teeth.</p>\n<p><b>Nano-X Imaging</b> (NASDAQ:NNOX) expects to disrupt the medical imaging market with its digital X-ray devices. The company recently filed for U.S. Food and Drug Administration (FDA) clearance of the first version of its multisource digital system.</p>\n<p><b>Guardant Health</b> (NASDAQ:GH) is a leader in developing liquid biopsy tests for cancer. The company's first products on the market help match patients with the best cancer therapy and enable drugmakers to develop new therapies.</p>\n<h2>What sets these stocks apart</h2>\n<p>A catchy name that sounds just like FAANG doesn't make these four stocks great picks, of course. However, there are two specific things that set these stocks apart:</p>\n<ol>\n <li>They all target a massive potential market.</li>\n <li>They all have a head start in that market.</li>\n</ol>\n<p>Pfizer has been around a long time and is by far the biggest of the PfANG stocks. The company still has multiple growth opportunities, though. One of the most significant of these is in messenger RNA (mRNA) therapies and vaccines.</p>\n<p>The company continues to work closely with BioNTech on its mRNA COVID-19 vaccine program and an mRNA flu vaccine. Pfizer plans to move forward with mRNA development on its own as well.</p>\n<p>CEO Albert Bourla stated in the company's Q2 conference call last week that Pfizer's strategy is to \"advance and unlock the full potential of mRNA.\" This strategy includes expanding its COVID-19 vaccine franchise and developing mRNA candidates targeting other infectious diseases, rare diseases, and cancer.</p>\n<p>Align Technology has generated impressive growth in recent years. The company, though, still has only captured 11% of the addressable market for clear aligners.</p>\n<p>Nano-X doesn't plan to compete for market share in the $21 billion medical imaging market; it fully intends to expand that market. The company's mobile devices cost only a fraction of current X-ray systems. <a href=\"https://laohu8.com/S/TWOA.U\">Two</a>-thirds of the world population have no meaningful access to medical imaging. Nano-X's opportunity is wide open.</p>\n<p>Guardant Health targets a $70 billion-plus potential market in cancer therapy selection, recurrence monitoring, and early screening. There are other companies going after this market as well. However, Guardant stands as <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the leaders and already has strong adoption for its initial liquid biopsy products.</p>\n<h2>Still some bite left in the FAANG stocks, too</h2>\n<p>I think that the PfANG stocks could deliver market-beating returns over the long term. But you don't really need to worry about having already missed out on the FAANG stocks.</p>\n<p>Augmented reality and virtual reality present big growth opportunities for Facebook and Apple. Artificial intelligence should serve as a growth driver for both of these stocks as well as Alphabet. Netflix is moving into gaming. These FAANG stocks should still have some bite left in them.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Missed Out on the FAANG Stocks? Consider Buying These PfANG Stocks Instead.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMissed Out on the FAANG Stocks? Consider Buying These PfANG Stocks Instead.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-02 08:38 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/01/missed-out-on-the-faang-stocks-consider-buying-the/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>What's worse than the fear of missing out? I'd put the fear of having already missed out high on the list. There's nothing you can do once an opportunity is gone.\nSome investors might be feeling as if...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/01/missed-out-on-the-faang-stocks-consider-buying-the/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMZN":"亚马逊","AAPL":"苹果","NFLX":"奈飞","GH":"Guardant Health Inc.","GOOG":"谷歌","PFE":"辉瑞","ALGN":"艾利科技","GOOGL":"谷歌A","NNOX":"Nano-X Imaging Ltd."},"source_url":"https://www.fool.com/investing/2021/08/01/missed-out-on-the-faang-stocks-consider-buying-the/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2156169749","content_text":"What's worse than the fear of missing out? I'd put the fear of having already missed out high on the list. There's nothing you can do once an opportunity is gone.\nSome investors might be feeling as if they've already missed out on the FAANG stocks. After all, four of them --  Apple (NASDAQ:AAPL), Alphabet (NASDAQ:GOOG) (NASDAQ:GOOGL) (whose Google unit is the \"G\" in FAANG), Amazon.com (NASDAQ:AMZN), and Facebook (NASDAQ:FB) -- rank among the top 10 biggest companies in the world. Only Netflix (NASDAQ:NFLX) lags behind, but the streaming company still has a market cap of close to $230 billion.\nIf you're concerned that you've missed out on a great opportunity with the FAANG stocks, don't worry. Consider buying these PfANG stocks instead.\nImage source: Getty Images.\nIntroducing the PfANG stocks\nAside from the fact that they're all now huge, the FAANG stocks have something else in common: They're all tech stocks. While technology remains a hot area for investors, the healthcare sector also offers tremendous growth prospects. Each of the PfANG stocks ranks as a leader in healthcare, albeit in very different ways.\nPfizer (NYSE:PFE) contributes the \"Pf\" in PfANG. The company is by far the best known of the group. Pfizer, of course, markets a blockbuster COVID-19 vaccine along with its partner, BioNTech. The company also has a product lineup that's loaded with other successful drugs and vaccines.\nAlign Technology (NASDAQ:ALGN) pioneered the clear dental aligner market. The company's Invisalign clear aligners have been used to straighten the teeth of nearly 11 million patients so far. Align also markets intraoral scanners used to create 3D images of teeth.\nNano-X Imaging (NASDAQ:NNOX) expects to disrupt the medical imaging market with its digital X-ray devices. The company recently filed for U.S. Food and Drug Administration (FDA) clearance of the first version of its multisource digital system.\nGuardant Health (NASDAQ:GH) is a leader in developing liquid biopsy tests for cancer. The company's first products on the market help match patients with the best cancer therapy and enable drugmakers to develop new therapies.\nWhat sets these stocks apart\nA catchy name that sounds just like FAANG doesn't make these four stocks great picks, of course. However, there are two specific things that set these stocks apart:\n\nThey all target a massive potential market.\nThey all have a head start in that market.\n\nPfizer has been around a long time and is by far the biggest of the PfANG stocks. The company still has multiple growth opportunities, though. One of the most significant of these is in messenger RNA (mRNA) therapies and vaccines.\nThe company continues to work closely with BioNTech on its mRNA COVID-19 vaccine program and an mRNA flu vaccine. Pfizer plans to move forward with mRNA development on its own as well.\nCEO Albert Bourla stated in the company's Q2 conference call last week that Pfizer's strategy is to \"advance and unlock the full potential of mRNA.\" This strategy includes expanding its COVID-19 vaccine franchise and developing mRNA candidates targeting other infectious diseases, rare diseases, and cancer.\nAlign Technology has generated impressive growth in recent years. The company, though, still has only captured 11% of the addressable market for clear aligners.\nNano-X doesn't plan to compete for market share in the $21 billion medical imaging market; it fully intends to expand that market. The company's mobile devices cost only a fraction of current X-ray systems. Two-thirds of the world population have no meaningful access to medical imaging. Nano-X's opportunity is wide open.\nGuardant Health targets a $70 billion-plus potential market in cancer therapy selection, recurrence monitoring, and early screening. There are other companies going after this market as well. However, Guardant stands as one of the leaders and already has strong adoption for its initial liquid biopsy products.\nStill some bite left in the FAANG stocks, too\nI think that the PfANG stocks could deliver market-beating returns over the long term. But you don't really need to worry about having already missed out on the FAANG stocks.\nAugmented reality and virtual reality present big growth opportunities for Facebook and Apple. Artificial intelligence should serve as a growth driver for both of these stocks as well as Alphabet. Netflix is moving into gaming. These FAANG stocks should still have some bite left in them.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":805531353,"gmtCreate":1627890350372,"gmtModify":1633755562672,"author":{"id":"3586131488444401","authorId":"3586131488444401","name":"STKG","avatar":"https://static.tigerbbs.com/730c2482b43ac1909a601868b378a6e4","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3586131488444401","idStr":"3586131488444401"},"htmlText":"Creative. Ha","listText":"Creative. Ha","text":"Creative. Ha","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/805531353","repostId":2156169749,"repostType":4,"repost":{"id":"2156169749","pubTimestamp":1627864728,"share":"https://www.laohu8.com/m/news/2156169749?lang=&edition=full","pubTime":"2021-08-02 08:38","market":"us","language":"en","title":"Missed Out on the FAANG Stocks? Consider Buying These PfANG Stocks Instead.","url":"https://stock-news.laohu8.com/highlight/detail?id=2156169749","media":"Motley Fool","summary":"There's both rhyme and reason for checking out these four stocks.","content":"<p>What's worse than the fear of missing out? I'd put the fear of having already missed out high on the list. There's nothing you can do once an opportunity is gone.</p>\n<p>Some investors might be feeling as if they've already missed out on the FAANG stocks. After all, four of them --&nbsp; <b>Apple</b> (NASDAQ:AAPL), <b>Alphabet</b> (NASDAQ:GOOG) (NASDAQ:GOOGL) (whose Google unit is the \"G\" in FAANG), <b>Amazon.com</b> (NASDAQ:AMZN), and&nbsp;<b><a href=\"https://laohu8.com/S/FB\">Facebook</a></b> (NASDAQ:FB) -- rank among the top 10 biggest companies in the world. Only&nbsp;<b>Netflix</b> (NASDAQ:NFLX) lags behind, but the streaming company still has a market cap of close to $230 billion.</p>\n<p>If you're concerned that you've missed out on a great opportunity with the FAANG stocks, don't worry. Consider buying these PfANG stocks instead.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/5160b68a97ec192124c08475ad420b61\" tg-width=\"700\" tg-height=\"467\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>Introducing the PfANG stocks</h2>\n<p>Aside from the fact that they're all now huge, the FAANG stocks have something else in common: They're all tech stocks. While technology remains a hot area for investors, the healthcare sector also offers tremendous growth prospects. Each of the PfANG stocks ranks as a leader in healthcare, albeit in very different ways.</p>\n<p><b>Pfizer</b> (NYSE:PFE) contributes the \"Pf\" in PfANG. The company is by far the best known of the group. Pfizer, of course, markets a blockbuster COVID-19 vaccine along with its partner, <b>BioNTech</b>. The company also has a product lineup that's loaded with other successful drugs and vaccines.</p>\n<p><b>Align Technology </b>(NASDAQ:ALGN) pioneered the clear dental aligner market. The company's Invisalign clear aligners have been used to straighten the teeth of nearly 11 million patients so far. Align also markets intraoral scanners used to create 3D images of teeth.</p>\n<p><b>Nano-X Imaging</b> (NASDAQ:NNOX) expects to disrupt the medical imaging market with its digital X-ray devices. The company recently filed for U.S. Food and Drug Administration (FDA) clearance of the first version of its multisource digital system.</p>\n<p><b>Guardant Health</b> (NASDAQ:GH) is a leader in developing liquid biopsy tests for cancer. The company's first products on the market help match patients with the best cancer therapy and enable drugmakers to develop new therapies.</p>\n<h2>What sets these stocks apart</h2>\n<p>A catchy name that sounds just like FAANG doesn't make these four stocks great picks, of course. However, there are two specific things that set these stocks apart:</p>\n<ol>\n <li>They all target a massive potential market.</li>\n <li>They all have a head start in that market.</li>\n</ol>\n<p>Pfizer has been around a long time and is by far the biggest of the PfANG stocks. The company still has multiple growth opportunities, though. One of the most significant of these is in messenger RNA (mRNA) therapies and vaccines.</p>\n<p>The company continues to work closely with BioNTech on its mRNA COVID-19 vaccine program and an mRNA flu vaccine. Pfizer plans to move forward with mRNA development on its own as well.</p>\n<p>CEO Albert Bourla stated in the company's Q2 conference call last week that Pfizer's strategy is to \"advance and unlock the full potential of mRNA.\" This strategy includes expanding its COVID-19 vaccine franchise and developing mRNA candidates targeting other infectious diseases, rare diseases, and cancer.</p>\n<p>Align Technology has generated impressive growth in recent years. The company, though, still has only captured 11% of the addressable market for clear aligners.</p>\n<p>Nano-X doesn't plan to compete for market share in the $21 billion medical imaging market; it fully intends to expand that market. The company's mobile devices cost only a fraction of current X-ray systems. <a href=\"https://laohu8.com/S/TWOA.U\">Two</a>-thirds of the world population have no meaningful access to medical imaging. Nano-X's opportunity is wide open.</p>\n<p>Guardant Health targets a $70 billion-plus potential market in cancer therapy selection, recurrence monitoring, and early screening. There are other companies going after this market as well. However, Guardant stands as <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the leaders and already has strong adoption for its initial liquid biopsy products.</p>\n<h2>Still some bite left in the FAANG stocks, too</h2>\n<p>I think that the PfANG stocks could deliver market-beating returns over the long term. But you don't really need to worry about having already missed out on the FAANG stocks.</p>\n<p>Augmented reality and virtual reality present big growth opportunities for Facebook and Apple. Artificial intelligence should serve as a growth driver for both of these stocks as well as Alphabet. Netflix is moving into gaming. These FAANG stocks should still have some bite left in them.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Missed Out on the FAANG Stocks? Consider Buying These PfANG Stocks Instead.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMissed Out on the FAANG Stocks? Consider Buying These PfANG Stocks Instead.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-02 08:38 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/01/missed-out-on-the-faang-stocks-consider-buying-the/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>What's worse than the fear of missing out? I'd put the fear of having already missed out high on the list. There's nothing you can do once an opportunity is gone.\nSome investors might be feeling as if...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/01/missed-out-on-the-faang-stocks-consider-buying-the/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMZN":"亚马逊","AAPL":"苹果","NFLX":"奈飞","GH":"Guardant Health Inc.","GOOG":"谷歌","PFE":"辉瑞","ALGN":"艾利科技","GOOGL":"谷歌A","NNOX":"Nano-X Imaging Ltd."},"source_url":"https://www.fool.com/investing/2021/08/01/missed-out-on-the-faang-stocks-consider-buying-the/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2156169749","content_text":"What's worse than the fear of missing out? I'd put the fear of having already missed out high on the list. There's nothing you can do once an opportunity is gone.\nSome investors might be feeling as if they've already missed out on the FAANG stocks. After all, four of them --  Apple (NASDAQ:AAPL), Alphabet (NASDAQ:GOOG) (NASDAQ:GOOGL) (whose Google unit is the \"G\" in FAANG), Amazon.com (NASDAQ:AMZN), and Facebook (NASDAQ:FB) -- rank among the top 10 biggest companies in the world. Only Netflix (NASDAQ:NFLX) lags behind, but the streaming company still has a market cap of close to $230 billion.\nIf you're concerned that you've missed out on a great opportunity with the FAANG stocks, don't worry. Consider buying these PfANG stocks instead.\nImage source: Getty Images.\nIntroducing the PfANG stocks\nAside from the fact that they're all now huge, the FAANG stocks have something else in common: They're all tech stocks. While technology remains a hot area for investors, the healthcare sector also offers tremendous growth prospects. Each of the PfANG stocks ranks as a leader in healthcare, albeit in very different ways.\nPfizer (NYSE:PFE) contributes the \"Pf\" in PfANG. The company is by far the best known of the group. Pfizer, of course, markets a blockbuster COVID-19 vaccine along with its partner, BioNTech. The company also has a product lineup that's loaded with other successful drugs and vaccines.\nAlign Technology (NASDAQ:ALGN) pioneered the clear dental aligner market. The company's Invisalign clear aligners have been used to straighten the teeth of nearly 11 million patients so far. Align also markets intraoral scanners used to create 3D images of teeth.\nNano-X Imaging (NASDAQ:NNOX) expects to disrupt the medical imaging market with its digital X-ray devices. The company recently filed for U.S. Food and Drug Administration (FDA) clearance of the first version of its multisource digital system.\nGuardant Health (NASDAQ:GH) is a leader in developing liquid biopsy tests for cancer. The company's first products on the market help match patients with the best cancer therapy and enable drugmakers to develop new therapies.\nWhat sets these stocks apart\nA catchy name that sounds just like FAANG doesn't make these four stocks great picks, of course. However, there are two specific things that set these stocks apart:\n\nThey all target a massive potential market.\nThey all have a head start in that market.\n\nPfizer has been around a long time and is by far the biggest of the PfANG stocks. The company still has multiple growth opportunities, though. One of the most significant of these is in messenger RNA (mRNA) therapies and vaccines.\nThe company continues to work closely with BioNTech on its mRNA COVID-19 vaccine program and an mRNA flu vaccine. Pfizer plans to move forward with mRNA development on its own as well.\nCEO Albert Bourla stated in the company's Q2 conference call last week that Pfizer's strategy is to \"advance and unlock the full potential of mRNA.\" This strategy includes expanding its COVID-19 vaccine franchise and developing mRNA candidates targeting other infectious diseases, rare diseases, and cancer.\nAlign Technology has generated impressive growth in recent years. The company, though, still has only captured 11% of the addressable market for clear aligners.\nNano-X doesn't plan to compete for market share in the $21 billion medical imaging market; it fully intends to expand that market. The company's mobile devices cost only a fraction of current X-ray systems. Two-thirds of the world population have no meaningful access to medical imaging. Nano-X's opportunity is wide open.\nGuardant Health targets a $70 billion-plus potential market in cancer therapy selection, recurrence monitoring, and early screening. There are other companies going after this market as well. However, Guardant stands as one of the leaders and already has strong adoption for its initial liquid biopsy products.\nStill some bite left in the FAANG stocks, too\nI think that the PfANG stocks could deliver market-beating returns over the long term. But you don't really need to worry about having already missed out on the FAANG stocks.\nAugmented reality and virtual reality present big growth opportunities for Facebook and Apple. Artificial intelligence should serve as a growth driver for both of these stocks as well as Alphabet. Netflix is moving into gaming. These FAANG stocks should still have some bite left in them.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":805597664,"gmtCreate":1627889921258,"gmtModify":1633755564793,"author":{"id":"3584863771682470","authorId":"3584863771682470","name":"Mml","avatar":"https://static.tigerbbs.com/f24c9f80edf3964f1c5ee7b551e05463","vip":1,"crmLevel":4,"crmLevelSwitch":0,"authorIdStr":"3584863771682470","idStr":"3584863771682470"},"htmlText":"Informative&nbsp;","listText":"Informative&nbsp;","text":"Informative","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/805597664","repostId":2156169749,"repostType":4,"repost":{"id":"2156169749","pubTimestamp":1627864728,"share":"https://www.laohu8.com/m/news/2156169749?lang=&edition=full","pubTime":"2021-08-02 08:38","market":"us","language":"en","title":"Missed Out on the FAANG Stocks? Consider Buying These PfANG Stocks Instead.","url":"https://stock-news.laohu8.com/highlight/detail?id=2156169749","media":"Motley Fool","summary":"There's both rhyme and reason for checking out these four stocks.","content":"<p>What's worse than the fear of missing out? I'd put the fear of having already missed out high on the list. There's nothing you can do once an opportunity is gone.</p>\n<p>Some investors might be feeling as if they've already missed out on the FAANG stocks. After all, four of them --&nbsp; <b>Apple</b> (NASDAQ:AAPL), <b>Alphabet</b> (NASDAQ:GOOG) (NASDAQ:GOOGL) (whose Google unit is the \"G\" in FAANG), <b>Amazon.com</b> (NASDAQ:AMZN), and&nbsp;<b><a href=\"https://laohu8.com/S/FB\">Facebook</a></b> (NASDAQ:FB) -- rank among the top 10 biggest companies in the world. Only&nbsp;<b>Netflix</b> (NASDAQ:NFLX) lags behind, but the streaming company still has a market cap of close to $230 billion.</p>\n<p>If you're concerned that you've missed out on a great opportunity with the FAANG stocks, don't worry. Consider buying these PfANG stocks instead.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/5160b68a97ec192124c08475ad420b61\" tg-width=\"700\" tg-height=\"467\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>Introducing the PfANG stocks</h2>\n<p>Aside from the fact that they're all now huge, the FAANG stocks have something else in common: They're all tech stocks. While technology remains a hot area for investors, the healthcare sector also offers tremendous growth prospects. Each of the PfANG stocks ranks as a leader in healthcare, albeit in very different ways.</p>\n<p><b>Pfizer</b> (NYSE:PFE) contributes the \"Pf\" in PfANG. The company is by far the best known of the group. Pfizer, of course, markets a blockbuster COVID-19 vaccine along with its partner, <b>BioNTech</b>. The company also has a product lineup that's loaded with other successful drugs and vaccines.</p>\n<p><b>Align Technology </b>(NASDAQ:ALGN) pioneered the clear dental aligner market. The company's Invisalign clear aligners have been used to straighten the teeth of nearly 11 million patients so far. Align also markets intraoral scanners used to create 3D images of teeth.</p>\n<p><b>Nano-X Imaging</b> (NASDAQ:NNOX) expects to disrupt the medical imaging market with its digital X-ray devices. The company recently filed for U.S. Food and Drug Administration (FDA) clearance of the first version of its multisource digital system.</p>\n<p><b>Guardant Health</b> (NASDAQ:GH) is a leader in developing liquid biopsy tests for cancer. The company's first products on the market help match patients with the best cancer therapy and enable drugmakers to develop new therapies.</p>\n<h2>What sets these stocks apart</h2>\n<p>A catchy name that sounds just like FAANG doesn't make these four stocks great picks, of course. However, there are two specific things that set these stocks apart:</p>\n<ol>\n <li>They all target a massive potential market.</li>\n <li>They all have a head start in that market.</li>\n</ol>\n<p>Pfizer has been around a long time and is by far the biggest of the PfANG stocks. The company still has multiple growth opportunities, though. One of the most significant of these is in messenger RNA (mRNA) therapies and vaccines.</p>\n<p>The company continues to work closely with BioNTech on its mRNA COVID-19 vaccine program and an mRNA flu vaccine. Pfizer plans to move forward with mRNA development on its own as well.</p>\n<p>CEO Albert Bourla stated in the company's Q2 conference call last week that Pfizer's strategy is to \"advance and unlock the full potential of mRNA.\" This strategy includes expanding its COVID-19 vaccine franchise and developing mRNA candidates targeting other infectious diseases, rare diseases, and cancer.</p>\n<p>Align Technology has generated impressive growth in recent years. The company, though, still has only captured 11% of the addressable market for clear aligners.</p>\n<p>Nano-X doesn't plan to compete for market share in the $21 billion medical imaging market; it fully intends to expand that market. The company's mobile devices cost only a fraction of current X-ray systems. <a href=\"https://laohu8.com/S/TWOA.U\">Two</a>-thirds of the world population have no meaningful access to medical imaging. Nano-X's opportunity is wide open.</p>\n<p>Guardant Health targets a $70 billion-plus potential market in cancer therapy selection, recurrence monitoring, and early screening. There are other companies going after this market as well. However, Guardant stands as <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the leaders and already has strong adoption for its initial liquid biopsy products.</p>\n<h2>Still some bite left in the FAANG stocks, too</h2>\n<p>I think that the PfANG stocks could deliver market-beating returns over the long term. But you don't really need to worry about having already missed out on the FAANG stocks.</p>\n<p>Augmented reality and virtual reality present big growth opportunities for Facebook and Apple. Artificial intelligence should serve as a growth driver for both of these stocks as well as Alphabet. Netflix is moving into gaming. These FAANG stocks should still have some bite left in them.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Missed Out on the FAANG Stocks? Consider Buying These PfANG Stocks Instead.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMissed Out on the FAANG Stocks? Consider Buying These PfANG Stocks Instead.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-02 08:38 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/01/missed-out-on-the-faang-stocks-consider-buying-the/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>What's worse than the fear of missing out? I'd put the fear of having already missed out high on the list. There's nothing you can do once an opportunity is gone.\nSome investors might be feeling as if...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/01/missed-out-on-the-faang-stocks-consider-buying-the/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMZN":"亚马逊","AAPL":"苹果","NFLX":"奈飞","GH":"Guardant Health Inc.","GOOG":"谷歌","PFE":"辉瑞","ALGN":"艾利科技","GOOGL":"谷歌A","NNOX":"Nano-X Imaging Ltd."},"source_url":"https://www.fool.com/investing/2021/08/01/missed-out-on-the-faang-stocks-consider-buying-the/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2156169749","content_text":"What's worse than the fear of missing out? I'd put the fear of having already missed out high on the list. There's nothing you can do once an opportunity is gone.\nSome investors might be feeling as if they've already missed out on the FAANG stocks. After all, four of them --  Apple (NASDAQ:AAPL), Alphabet (NASDAQ:GOOG) (NASDAQ:GOOGL) (whose Google unit is the \"G\" in FAANG), Amazon.com (NASDAQ:AMZN), and Facebook (NASDAQ:FB) -- rank among the top 10 biggest companies in the world. Only Netflix (NASDAQ:NFLX) lags behind, but the streaming company still has a market cap of close to $230 billion.\nIf you're concerned that you've missed out on a great opportunity with the FAANG stocks, don't worry. Consider buying these PfANG stocks instead.\nImage source: Getty Images.\nIntroducing the PfANG stocks\nAside from the fact that they're all now huge, the FAANG stocks have something else in common: They're all tech stocks. While technology remains a hot area for investors, the healthcare sector also offers tremendous growth prospects. Each of the PfANG stocks ranks as a leader in healthcare, albeit in very different ways.\nPfizer (NYSE:PFE) contributes the \"Pf\" in PfANG. The company is by far the best known of the group. Pfizer, of course, markets a blockbuster COVID-19 vaccine along with its partner, BioNTech. The company also has a product lineup that's loaded with other successful drugs and vaccines.\nAlign Technology (NASDAQ:ALGN) pioneered the clear dental aligner market. The company's Invisalign clear aligners have been used to straighten the teeth of nearly 11 million patients so far. Align also markets intraoral scanners used to create 3D images of teeth.\nNano-X Imaging (NASDAQ:NNOX) expects to disrupt the medical imaging market with its digital X-ray devices. The company recently filed for U.S. Food and Drug Administration (FDA) clearance of the first version of its multisource digital system.\nGuardant Health (NASDAQ:GH) is a leader in developing liquid biopsy tests for cancer. The company's first products on the market help match patients with the best cancer therapy and enable drugmakers to develop new therapies.\nWhat sets these stocks apart\nA catchy name that sounds just like FAANG doesn't make these four stocks great picks, of course. However, there are two specific things that set these stocks apart:\n\nThey all target a massive potential market.\nThey all have a head start in that market.\n\nPfizer has been around a long time and is by far the biggest of the PfANG stocks. The company still has multiple growth opportunities, though. One of the most significant of these is in messenger RNA (mRNA) therapies and vaccines.\nThe company continues to work closely with BioNTech on its mRNA COVID-19 vaccine program and an mRNA flu vaccine. Pfizer plans to move forward with mRNA development on its own as well.\nCEO Albert Bourla stated in the company's Q2 conference call last week that Pfizer's strategy is to \"advance and unlock the full potential of mRNA.\" This strategy includes expanding its COVID-19 vaccine franchise and developing mRNA candidates targeting other infectious diseases, rare diseases, and cancer.\nAlign Technology has generated impressive growth in recent years. The company, though, still has only captured 11% of the addressable market for clear aligners.\nNano-X doesn't plan to compete for market share in the $21 billion medical imaging market; it fully intends to expand that market. The company's mobile devices cost only a fraction of current X-ray systems. Two-thirds of the world population have no meaningful access to medical imaging. Nano-X's opportunity is wide open.\nGuardant Health targets a $70 billion-plus potential market in cancer therapy selection, recurrence monitoring, and early screening. There are other companies going after this market as well. However, Guardant stands as one of the leaders and already has strong adoption for its initial liquid biopsy products.\nStill some bite left in the FAANG stocks, too\nI think that the PfANG stocks could deliver market-beating returns over the long term. But you don't really need to worry about having already missed out on the FAANG stocks.\nAugmented reality and virtual reality present big growth opportunities for Facebook and Apple. Artificial intelligence should serve as a growth driver for both of these stocks as well as Alphabet. Netflix is moving into gaming. These FAANG stocks should still have some bite left in them.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5401285,"gmtCreate":1627889935737,"gmtModify":1635162118702,"authorId":3584863771682470,"author":{"id":3584863771682470,"idStr":"3584863771682470","authorId":3584863771682470,"name":"Mml","avatar":"https://static.tigerbbs.com/f24c9f80edf3964f1c5ee7b551e05463","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":805597664,"type":1,"supId":0,"prevId":0,"content":"Pls help to like","text":"Pls help to like","html":"Pls help to like"},{"id":5401801,"gmtCreate":1627893584951,"gmtModify":1635162081852,"authorId":3584490239949882,"author":{"id":3584490239949882,"idStr":"3584490239949882","authorId":3584490239949882,"name":"Phyusin","avatar":"https://static.tigerbbs.com/73d7e61a3a910d1d25acb7dcee29f7ca","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":805597664,"type":1,"supId":0,"prevId":0,"content":"[Miser]","text":"[Miser]","html":"[Miser]"}],"langContent":"EN"},{"id":805591474,"gmtCreate":1627889572998,"gmtModify":1633755567796,"author":{"id":"3581945658596754","authorId":"3581945658596754","name":"BruceLyy","avatar":"https://static.tigerbbs.com/f6ddb500d252a42653a15b13d42f82ae","vip":1,"crmLevel":5,"crmLevelSwitch":0,"authorIdStr":"3581945658596754","idStr":"3581945658596754"},"htmlText":"Please like and comment, thank you","listText":"Please like and comment, thank you","text":"Please like and comment, thank you","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/805591474","repostId":2156169749,"repostType":4,"repost":{"id":"2156169749","pubTimestamp":1627864728,"share":"https://www.laohu8.com/m/news/2156169749?lang=&edition=full","pubTime":"2021-08-02 08:38","market":"us","language":"en","title":"Missed Out on the FAANG Stocks? Consider Buying These PfANG Stocks Instead.","url":"https://stock-news.laohu8.com/highlight/detail?id=2156169749","media":"Motley Fool","summary":"There's both rhyme and reason for checking out these four stocks.","content":"<p>What's worse than the fear of missing out? I'd put the fear of having already missed out high on the list. There's nothing you can do once an opportunity is gone.</p>\n<p>Some investors might be feeling as if they've already missed out on the FAANG stocks. After all, four of them --&nbsp; <b>Apple</b> (NASDAQ:AAPL), <b>Alphabet</b> (NASDAQ:GOOG) (NASDAQ:GOOGL) (whose Google unit is the \"G\" in FAANG), <b>Amazon.com</b> (NASDAQ:AMZN), and&nbsp;<b><a href=\"https://laohu8.com/S/FB\">Facebook</a></b> (NASDAQ:FB) -- rank among the top 10 biggest companies in the world. Only&nbsp;<b>Netflix</b> (NASDAQ:NFLX) lags behind, but the streaming company still has a market cap of close to $230 billion.</p>\n<p>If you're concerned that you've missed out on a great opportunity with the FAANG stocks, don't worry. Consider buying these PfANG stocks instead.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/5160b68a97ec192124c08475ad420b61\" tg-width=\"700\" tg-height=\"467\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>Introducing the PfANG stocks</h2>\n<p>Aside from the fact that they're all now huge, the FAANG stocks have something else in common: They're all tech stocks. While technology remains a hot area for investors, the healthcare sector also offers tremendous growth prospects. Each of the PfANG stocks ranks as a leader in healthcare, albeit in very different ways.</p>\n<p><b>Pfizer</b> (NYSE:PFE) contributes the \"Pf\" in PfANG. The company is by far the best known of the group. Pfizer, of course, markets a blockbuster COVID-19 vaccine along with its partner, <b>BioNTech</b>. The company also has a product lineup that's loaded with other successful drugs and vaccines.</p>\n<p><b>Align Technology </b>(NASDAQ:ALGN) pioneered the clear dental aligner market. The company's Invisalign clear aligners have been used to straighten the teeth of nearly 11 million patients so far. Align also markets intraoral scanners used to create 3D images of teeth.</p>\n<p><b>Nano-X Imaging</b> (NASDAQ:NNOX) expects to disrupt the medical imaging market with its digital X-ray devices. The company recently filed for U.S. Food and Drug Administration (FDA) clearance of the first version of its multisource digital system.</p>\n<p><b>Guardant Health</b> (NASDAQ:GH) is a leader in developing liquid biopsy tests for cancer. The company's first products on the market help match patients with the best cancer therapy and enable drugmakers to develop new therapies.</p>\n<h2>What sets these stocks apart</h2>\n<p>A catchy name that sounds just like FAANG doesn't make these four stocks great picks, of course. However, there are two specific things that set these stocks apart:</p>\n<ol>\n <li>They all target a massive potential market.</li>\n <li>They all have a head start in that market.</li>\n</ol>\n<p>Pfizer has been around a long time and is by far the biggest of the PfANG stocks. The company still has multiple growth opportunities, though. One of the most significant of these is in messenger RNA (mRNA) therapies and vaccines.</p>\n<p>The company continues to work closely with BioNTech on its mRNA COVID-19 vaccine program and an mRNA flu vaccine. Pfizer plans to move forward with mRNA development on its own as well.</p>\n<p>CEO Albert Bourla stated in the company's Q2 conference call last week that Pfizer's strategy is to \"advance and unlock the full potential of mRNA.\" This strategy includes expanding its COVID-19 vaccine franchise and developing mRNA candidates targeting other infectious diseases, rare diseases, and cancer.</p>\n<p>Align Technology has generated impressive growth in recent years. The company, though, still has only captured 11% of the addressable market for clear aligners.</p>\n<p>Nano-X doesn't plan to compete for market share in the $21 billion medical imaging market; it fully intends to expand that market. The company's mobile devices cost only a fraction of current X-ray systems. <a href=\"https://laohu8.com/S/TWOA.U\">Two</a>-thirds of the world population have no meaningful access to medical imaging. Nano-X's opportunity is wide open.</p>\n<p>Guardant Health targets a $70 billion-plus potential market in cancer therapy selection, recurrence monitoring, and early screening. There are other companies going after this market as well. However, Guardant stands as <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the leaders and already has strong adoption for its initial liquid biopsy products.</p>\n<h2>Still some bite left in the FAANG stocks, too</h2>\n<p>I think that the PfANG stocks could deliver market-beating returns over the long term. But you don't really need to worry about having already missed out on the FAANG stocks.</p>\n<p>Augmented reality and virtual reality present big growth opportunities for Facebook and Apple. Artificial intelligence should serve as a growth driver for both of these stocks as well as Alphabet. Netflix is moving into gaming. These FAANG stocks should still have some bite left in them.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Missed Out on the FAANG Stocks? Consider Buying These PfANG Stocks Instead.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMissed Out on the FAANG Stocks? Consider Buying These PfANG Stocks Instead.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-02 08:38 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/01/missed-out-on-the-faang-stocks-consider-buying-the/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>What's worse than the fear of missing out? I'd put the fear of having already missed out high on the list. There's nothing you can do once an opportunity is gone.\nSome investors might be feeling as if...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/01/missed-out-on-the-faang-stocks-consider-buying-the/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMZN":"亚马逊","AAPL":"苹果","NFLX":"奈飞","GH":"Guardant Health Inc.","GOOG":"谷歌","PFE":"辉瑞","ALGN":"艾利科技","GOOGL":"谷歌A","NNOX":"Nano-X Imaging Ltd."},"source_url":"https://www.fool.com/investing/2021/08/01/missed-out-on-the-faang-stocks-consider-buying-the/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2156169749","content_text":"What's worse than the fear of missing out? I'd put the fear of having already missed out high on the list. There's nothing you can do once an opportunity is gone.\nSome investors might be feeling as if they've already missed out on the FAANG stocks. After all, four of them --  Apple (NASDAQ:AAPL), Alphabet (NASDAQ:GOOG) (NASDAQ:GOOGL) (whose Google unit is the \"G\" in FAANG), Amazon.com (NASDAQ:AMZN), and Facebook (NASDAQ:FB) -- rank among the top 10 biggest companies in the world. Only Netflix (NASDAQ:NFLX) lags behind, but the streaming company still has a market cap of close to $230 billion.\nIf you're concerned that you've missed out on a great opportunity with the FAANG stocks, don't worry. Consider buying these PfANG stocks instead.\nImage source: Getty Images.\nIntroducing the PfANG stocks\nAside from the fact that they're all now huge, the FAANG stocks have something else in common: They're all tech stocks. While technology remains a hot area for investors, the healthcare sector also offers tremendous growth prospects. Each of the PfANG stocks ranks as a leader in healthcare, albeit in very different ways.\nPfizer (NYSE:PFE) contributes the \"Pf\" in PfANG. The company is by far the best known of the group. Pfizer, of course, markets a blockbuster COVID-19 vaccine along with its partner, BioNTech. The company also has a product lineup that's loaded with other successful drugs and vaccines.\nAlign Technology (NASDAQ:ALGN) pioneered the clear dental aligner market. The company's Invisalign clear aligners have been used to straighten the teeth of nearly 11 million patients so far. Align also markets intraoral scanners used to create 3D images of teeth.\nNano-X Imaging (NASDAQ:NNOX) expects to disrupt the medical imaging market with its digital X-ray devices. The company recently filed for U.S. Food and Drug Administration (FDA) clearance of the first version of its multisource digital system.\nGuardant Health (NASDAQ:GH) is a leader in developing liquid biopsy tests for cancer. The company's first products on the market help match patients with the best cancer therapy and enable drugmakers to develop new therapies.\nWhat sets these stocks apart\nA catchy name that sounds just like FAANG doesn't make these four stocks great picks, of course. However, there are two specific things that set these stocks apart:\n\nThey all target a massive potential market.\nThey all have a head start in that market.\n\nPfizer has been around a long time and is by far the biggest of the PfANG stocks. The company still has multiple growth opportunities, though. One of the most significant of these is in messenger RNA (mRNA) therapies and vaccines.\nThe company continues to work closely with BioNTech on its mRNA COVID-19 vaccine program and an mRNA flu vaccine. Pfizer plans to move forward with mRNA development on its own as well.\nCEO Albert Bourla stated in the company's Q2 conference call last week that Pfizer's strategy is to \"advance and unlock the full potential of mRNA.\" This strategy includes expanding its COVID-19 vaccine franchise and developing mRNA candidates targeting other infectious diseases, rare diseases, and cancer.\nAlign Technology has generated impressive growth in recent years. The company, though, still has only captured 11% of the addressable market for clear aligners.\nNano-X doesn't plan to compete for market share in the $21 billion medical imaging market; it fully intends to expand that market. The company's mobile devices cost only a fraction of current X-ray systems. Two-thirds of the world population have no meaningful access to medical imaging. Nano-X's opportunity is wide open.\nGuardant Health targets a $70 billion-plus potential market in cancer therapy selection, recurrence monitoring, and early screening. There are other companies going after this market as well. However, Guardant stands as one of the leaders and already has strong adoption for its initial liquid biopsy products.\nStill some bite left in the FAANG stocks, too\nI think that the PfANG stocks could deliver market-beating returns over the long term. But you don't really need to worry about having already missed out on the FAANG stocks.\nAugmented reality and virtual reality present big growth opportunities for Facebook and Apple. Artificial intelligence should serve as a growth driver for both of these stocks as well as Alphabet. Netflix is moving into gaming. These FAANG stocks should still have some bite left in them.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5401429,"gmtCreate":1627891269378,"gmtModify":1635162108140,"authorId":3563607262597606,"author":{"id":3563607262597606,"idStr":"3563607262597606","authorId":3563607262597606,"name":"Shininglight","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":805591474,"type":1,"supId":0,"prevId":0,"content":"<u>ok</u>","text":"<u>ok</u>","html":"<u>ok</u>"}],"langContent":"EN"},{"id":805593140,"gmtCreate":1627889403980,"gmtModify":1633755568813,"author":{"id":"3569274903458035","authorId":"3569274903458035","name":"HLPA","avatar":"https://static.tigerbbs.com/07e7b987a9127c5a47dbc3ae02db548b","vip":1,"crmLevel":8,"crmLevelSwitch":0,"authorIdStr":"3569274903458035","idStr":"3569274903458035"},"htmlText":"What a bloody FOOL&nbsp; indeed","listText":"What a bloody FOOL&nbsp; indeed","text":"What a bloody FOOL indeed","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/805593140","repostId":2156169749,"repostType":4,"repost":{"id":"2156169749","pubTimestamp":1627864728,"share":"https://www.laohu8.com/m/news/2156169749?lang=&edition=full","pubTime":"2021-08-02 08:38","market":"us","language":"en","title":"Missed Out on the FAANG Stocks? Consider Buying These PfANG Stocks Instead.","url":"https://stock-news.laohu8.com/highlight/detail?id=2156169749","media":"Motley Fool","summary":"There's both rhyme and reason for checking out these four stocks.","content":"<p>What's worse than the fear of missing out? I'd put the fear of having already missed out high on the list. There's nothing you can do once an opportunity is gone.</p>\n<p>Some investors might be feeling as if they've already missed out on the FAANG stocks. After all, four of them --&nbsp; <b>Apple</b> (NASDAQ:AAPL), <b>Alphabet</b> (NASDAQ:GOOG) (NASDAQ:GOOGL) (whose Google unit is the \"G\" in FAANG), <b>Amazon.com</b> (NASDAQ:AMZN), and&nbsp;<b><a href=\"https://laohu8.com/S/FB\">Facebook</a></b> (NASDAQ:FB) -- rank among the top 10 biggest companies in the world. Only&nbsp;<b>Netflix</b> (NASDAQ:NFLX) lags behind, but the streaming company still has a market cap of close to $230 billion.</p>\n<p>If you're concerned that you've missed out on a great opportunity with the FAANG stocks, don't worry. Consider buying these PfANG stocks instead.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/5160b68a97ec192124c08475ad420b61\" tg-width=\"700\" tg-height=\"467\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>Introducing the PfANG stocks</h2>\n<p>Aside from the fact that they're all now huge, the FAANG stocks have something else in common: They're all tech stocks. While technology remains a hot area for investors, the healthcare sector also offers tremendous growth prospects. Each of the PfANG stocks ranks as a leader in healthcare, albeit in very different ways.</p>\n<p><b>Pfizer</b> (NYSE:PFE) contributes the \"Pf\" in PfANG. The company is by far the best known of the group. Pfizer, of course, markets a blockbuster COVID-19 vaccine along with its partner, <b>BioNTech</b>. The company also has a product lineup that's loaded with other successful drugs and vaccines.</p>\n<p><b>Align Technology </b>(NASDAQ:ALGN) pioneered the clear dental aligner market. The company's Invisalign clear aligners have been used to straighten the teeth of nearly 11 million patients so far. Align also markets intraoral scanners used to create 3D images of teeth.</p>\n<p><b>Nano-X Imaging</b> (NASDAQ:NNOX) expects to disrupt the medical imaging market with its digital X-ray devices. The company recently filed for U.S. Food and Drug Administration (FDA) clearance of the first version of its multisource digital system.</p>\n<p><b>Guardant Health</b> (NASDAQ:GH) is a leader in developing liquid biopsy tests for cancer. The company's first products on the market help match patients with the best cancer therapy and enable drugmakers to develop new therapies.</p>\n<h2>What sets these stocks apart</h2>\n<p>A catchy name that sounds just like FAANG doesn't make these four stocks great picks, of course. However, there are two specific things that set these stocks apart:</p>\n<ol>\n <li>They all target a massive potential market.</li>\n <li>They all have a head start in that market.</li>\n</ol>\n<p>Pfizer has been around a long time and is by far the biggest of the PfANG stocks. The company still has multiple growth opportunities, though. One of the most significant of these is in messenger RNA (mRNA) therapies and vaccines.</p>\n<p>The company continues to work closely with BioNTech on its mRNA COVID-19 vaccine program and an mRNA flu vaccine. Pfizer plans to move forward with mRNA development on its own as well.</p>\n<p>CEO Albert Bourla stated in the company's Q2 conference call last week that Pfizer's strategy is to \"advance and unlock the full potential of mRNA.\" This strategy includes expanding its COVID-19 vaccine franchise and developing mRNA candidates targeting other infectious diseases, rare diseases, and cancer.</p>\n<p>Align Technology has generated impressive growth in recent years. The company, though, still has only captured 11% of the addressable market for clear aligners.</p>\n<p>Nano-X doesn't plan to compete for market share in the $21 billion medical imaging market; it fully intends to expand that market. The company's mobile devices cost only a fraction of current X-ray systems. <a href=\"https://laohu8.com/S/TWOA.U\">Two</a>-thirds of the world population have no meaningful access to medical imaging. Nano-X's opportunity is wide open.</p>\n<p>Guardant Health targets a $70 billion-plus potential market in cancer therapy selection, recurrence monitoring, and early screening. There are other companies going after this market as well. However, Guardant stands as <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the leaders and already has strong adoption for its initial liquid biopsy products.</p>\n<h2>Still some bite left in the FAANG stocks, too</h2>\n<p>I think that the PfANG stocks could deliver market-beating returns over the long term. But you don't really need to worry about having already missed out on the FAANG stocks.</p>\n<p>Augmented reality and virtual reality present big growth opportunities for Facebook and Apple. Artificial intelligence should serve as a growth driver for both of these stocks as well as Alphabet. Netflix is moving into gaming. These FAANG stocks should still have some bite left in them.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Missed Out on the FAANG Stocks? Consider Buying These PfANG Stocks Instead.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMissed Out on the FAANG Stocks? Consider Buying These PfANG Stocks Instead.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-02 08:38 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/01/missed-out-on-the-faang-stocks-consider-buying-the/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>What's worse than the fear of missing out? I'd put the fear of having already missed out high on the list. There's nothing you can do once an opportunity is gone.\nSome investors might be feeling as if...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/01/missed-out-on-the-faang-stocks-consider-buying-the/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMZN":"亚马逊","AAPL":"苹果","NFLX":"奈飞","GH":"Guardant Health Inc.","GOOG":"谷歌","PFE":"辉瑞","ALGN":"艾利科技","GOOGL":"谷歌A","NNOX":"Nano-X Imaging Ltd."},"source_url":"https://www.fool.com/investing/2021/08/01/missed-out-on-the-faang-stocks-consider-buying-the/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2156169749","content_text":"What's worse than the fear of missing out? I'd put the fear of having already missed out high on the list. There's nothing you can do once an opportunity is gone.\nSome investors might be feeling as if they've already missed out on the FAANG stocks. After all, four of them --  Apple (NASDAQ:AAPL), Alphabet (NASDAQ:GOOG) (NASDAQ:GOOGL) (whose Google unit is the \"G\" in FAANG), Amazon.com (NASDAQ:AMZN), and Facebook (NASDAQ:FB) -- rank among the top 10 biggest companies in the world. Only Netflix (NASDAQ:NFLX) lags behind, but the streaming company still has a market cap of close to $230 billion.\nIf you're concerned that you've missed out on a great opportunity with the FAANG stocks, don't worry. Consider buying these PfANG stocks instead.\nImage source: Getty Images.\nIntroducing the PfANG stocks\nAside from the fact that they're all now huge, the FAANG stocks have something else in common: They're all tech stocks. While technology remains a hot area for investors, the healthcare sector also offers tremendous growth prospects. Each of the PfANG stocks ranks as a leader in healthcare, albeit in very different ways.\nPfizer (NYSE:PFE) contributes the \"Pf\" in PfANG. The company is by far the best known of the group. Pfizer, of course, markets a blockbuster COVID-19 vaccine along with its partner, BioNTech. The company also has a product lineup that's loaded with other successful drugs and vaccines.\nAlign Technology (NASDAQ:ALGN) pioneered the clear dental aligner market. The company's Invisalign clear aligners have been used to straighten the teeth of nearly 11 million patients so far. Align also markets intraoral scanners used to create 3D images of teeth.\nNano-X Imaging (NASDAQ:NNOX) expects to disrupt the medical imaging market with its digital X-ray devices. The company recently filed for U.S. Food and Drug Administration (FDA) clearance of the first version of its multisource digital system.\nGuardant Health (NASDAQ:GH) is a leader in developing liquid biopsy tests for cancer. The company's first products on the market help match patients with the best cancer therapy and enable drugmakers to develop new therapies.\nWhat sets these stocks apart\nA catchy name that sounds just like FAANG doesn't make these four stocks great picks, of course. However, there are two specific things that set these stocks apart:\n\nThey all target a massive potential market.\nThey all have a head start in that market.\n\nPfizer has been around a long time and is by far the biggest of the PfANG stocks. The company still has multiple growth opportunities, though. One of the most significant of these is in messenger RNA (mRNA) therapies and vaccines.\nThe company continues to work closely with BioNTech on its mRNA COVID-19 vaccine program and an mRNA flu vaccine. Pfizer plans to move forward with mRNA development on its own as well.\nCEO Albert Bourla stated in the company's Q2 conference call last week that Pfizer's strategy is to \"advance and unlock the full potential of mRNA.\" This strategy includes expanding its COVID-19 vaccine franchise and developing mRNA candidates targeting other infectious diseases, rare diseases, and cancer.\nAlign Technology has generated impressive growth in recent years. The company, though, still has only captured 11% of the addressable market for clear aligners.\nNano-X doesn't plan to compete for market share in the $21 billion medical imaging market; it fully intends to expand that market. The company's mobile devices cost only a fraction of current X-ray systems. Two-thirds of the world population have no meaningful access to medical imaging. Nano-X's opportunity is wide open.\nGuardant Health targets a $70 billion-plus potential market in cancer therapy selection, recurrence monitoring, and early screening. There are other companies going after this market as well. However, Guardant stands as one of the leaders and already has strong adoption for its initial liquid biopsy products.\nStill some bite left in the FAANG stocks, too\nI think that the PfANG stocks could deliver market-beating returns over the long term. But you don't really need to worry about having already missed out on the FAANG stocks.\nAugmented reality and virtual reality present big growth opportunities for Facebook and Apple. Artificial intelligence should serve as a growth driver for both of these stocks as well as Alphabet. Netflix is moving into gaming. These FAANG stocks should still have some bite left in them.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":805509639,"gmtCreate":1627888353521,"gmtModify":1633755576122,"author":{"id":"4087698744325360","authorId":"4087698744325360","name":"glorify","avatar":"https://static.tigerbbs.com/bb1a0d88b0029e6cb51d7065d6b143e5","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"4087698744325360","idStr":"4087698744325360"},"htmlText":"I strongly support Apple. It has&nbsp;great potential &amp; strong&nbsp;foundamental . 💪💪🍎🚀🚀🚀","listText":"I strongly support Apple. It has&nbsp;great potential &amp; strong&nbsp;foundamental . 💪💪🍎🚀🚀🚀","text":"I strongly support Apple. It has great potential & strong foundamental . 💪💪🍎🚀🚀🚀","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/805509639","repostId":2156169749,"repostType":4,"repost":{"id":"2156169749","pubTimestamp":1627864728,"share":"https://www.laohu8.com/m/news/2156169749?lang=&edition=full","pubTime":"2021-08-02 08:38","market":"us","language":"en","title":"Missed Out on the FAANG Stocks? Consider Buying These PfANG Stocks Instead.","url":"https://stock-news.laohu8.com/highlight/detail?id=2156169749","media":"Motley Fool","summary":"There's both rhyme and reason for checking out these four stocks.","content":"<p>What's worse than the fear of missing out? I'd put the fear of having already missed out high on the list. There's nothing you can do once an opportunity is gone.</p>\n<p>Some investors might be feeling as if they've already missed out on the FAANG stocks. After all, four of them --&nbsp; <b>Apple</b> (NASDAQ:AAPL), <b>Alphabet</b> (NASDAQ:GOOG) (NASDAQ:GOOGL) (whose Google unit is the \"G\" in FAANG), <b>Amazon.com</b> (NASDAQ:AMZN), and&nbsp;<b><a href=\"https://laohu8.com/S/FB\">Facebook</a></b> (NASDAQ:FB) -- rank among the top 10 biggest companies in the world. Only&nbsp;<b>Netflix</b> (NASDAQ:NFLX) lags behind, but the streaming company still has a market cap of close to $230 billion.</p>\n<p>If you're concerned that you've missed out on a great opportunity with the FAANG stocks, don't worry. Consider buying these PfANG stocks instead.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/5160b68a97ec192124c08475ad420b61\" tg-width=\"700\" tg-height=\"467\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>Introducing the PfANG stocks</h2>\n<p>Aside from the fact that they're all now huge, the FAANG stocks have something else in common: They're all tech stocks. While technology remains a hot area for investors, the healthcare sector also offers tremendous growth prospects. Each of the PfANG stocks ranks as a leader in healthcare, albeit in very different ways.</p>\n<p><b>Pfizer</b> (NYSE:PFE) contributes the \"Pf\" in PfANG. The company is by far the best known of the group. Pfizer, of course, markets a blockbuster COVID-19 vaccine along with its partner, <b>BioNTech</b>. The company also has a product lineup that's loaded with other successful drugs and vaccines.</p>\n<p><b>Align Technology </b>(NASDAQ:ALGN) pioneered the clear dental aligner market. The company's Invisalign clear aligners have been used to straighten the teeth of nearly 11 million patients so far. Align also markets intraoral scanners used to create 3D images of teeth.</p>\n<p><b>Nano-X Imaging</b> (NASDAQ:NNOX) expects to disrupt the medical imaging market with its digital X-ray devices. The company recently filed for U.S. Food and Drug Administration (FDA) clearance of the first version of its multisource digital system.</p>\n<p><b>Guardant Health</b> (NASDAQ:GH) is a leader in developing liquid biopsy tests for cancer. The company's first products on the market help match patients with the best cancer therapy and enable drugmakers to develop new therapies.</p>\n<h2>What sets these stocks apart</h2>\n<p>A catchy name that sounds just like FAANG doesn't make these four stocks great picks, of course. However, there are two specific things that set these stocks apart:</p>\n<ol>\n <li>They all target a massive potential market.</li>\n <li>They all have a head start in that market.</li>\n</ol>\n<p>Pfizer has been around a long time and is by far the biggest of the PfANG stocks. The company still has multiple growth opportunities, though. One of the most significant of these is in messenger RNA (mRNA) therapies and vaccines.</p>\n<p>The company continues to work closely with BioNTech on its mRNA COVID-19 vaccine program and an mRNA flu vaccine. Pfizer plans to move forward with mRNA development on its own as well.</p>\n<p>CEO Albert Bourla stated in the company's Q2 conference call last week that Pfizer's strategy is to \"advance and unlock the full potential of mRNA.\" This strategy includes expanding its COVID-19 vaccine franchise and developing mRNA candidates targeting other infectious diseases, rare diseases, and cancer.</p>\n<p>Align Technology has generated impressive growth in recent years. The company, though, still has only captured 11% of the addressable market for clear aligners.</p>\n<p>Nano-X doesn't plan to compete for market share in the $21 billion medical imaging market; it fully intends to expand that market. The company's mobile devices cost only a fraction of current X-ray systems. <a href=\"https://laohu8.com/S/TWOA.U\">Two</a>-thirds of the world population have no meaningful access to medical imaging. Nano-X's opportunity is wide open.</p>\n<p>Guardant Health targets a $70 billion-plus potential market in cancer therapy selection, recurrence monitoring, and early screening. There are other companies going after this market as well. However, Guardant stands as <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the leaders and already has strong adoption for its initial liquid biopsy products.</p>\n<h2>Still some bite left in the FAANG stocks, too</h2>\n<p>I think that the PfANG stocks could deliver market-beating returns over the long term. But you don't really need to worry about having already missed out on the FAANG stocks.</p>\n<p>Augmented reality and virtual reality present big growth opportunities for Facebook and Apple. Artificial intelligence should serve as a growth driver for both of these stocks as well as Alphabet. Netflix is moving into gaming. These FAANG stocks should still have some bite left in them.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Missed Out on the FAANG Stocks? Consider Buying These PfANG Stocks Instead.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMissed Out on the FAANG Stocks? Consider Buying These PfANG Stocks Instead.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-02 08:38 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/01/missed-out-on-the-faang-stocks-consider-buying-the/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>What's worse than the fear of missing out? I'd put the fear of having already missed out high on the list. There's nothing you can do once an opportunity is gone.\nSome investors might be feeling as if...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/01/missed-out-on-the-faang-stocks-consider-buying-the/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMZN":"亚马逊","AAPL":"苹果","NFLX":"奈飞","GH":"Guardant Health Inc.","GOOG":"谷歌","PFE":"辉瑞","ALGN":"艾利科技","GOOGL":"谷歌A","NNOX":"Nano-X Imaging Ltd."},"source_url":"https://www.fool.com/investing/2021/08/01/missed-out-on-the-faang-stocks-consider-buying-the/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2156169749","content_text":"What's worse than the fear of missing out? I'd put the fear of having already missed out high on the list. There's nothing you can do once an opportunity is gone.\nSome investors might be feeling as if they've already missed out on the FAANG stocks. After all, four of them --  Apple (NASDAQ:AAPL), Alphabet (NASDAQ:GOOG) (NASDAQ:GOOGL) (whose Google unit is the \"G\" in FAANG), Amazon.com (NASDAQ:AMZN), and Facebook (NASDAQ:FB) -- rank among the top 10 biggest companies in the world. Only Netflix (NASDAQ:NFLX) lags behind, but the streaming company still has a market cap of close to $230 billion.\nIf you're concerned that you've missed out on a great opportunity with the FAANG stocks, don't worry. Consider buying these PfANG stocks instead.\nImage source: Getty Images.\nIntroducing the PfANG stocks\nAside from the fact that they're all now huge, the FAANG stocks have something else in common: They're all tech stocks. While technology remains a hot area for investors, the healthcare sector also offers tremendous growth prospects. Each of the PfANG stocks ranks as a leader in healthcare, albeit in very different ways.\nPfizer (NYSE:PFE) contributes the \"Pf\" in PfANG. The company is by far the best known of the group. Pfizer, of course, markets a blockbuster COVID-19 vaccine along with its partner, BioNTech. The company also has a product lineup that's loaded with other successful drugs and vaccines.\nAlign Technology (NASDAQ:ALGN) pioneered the clear dental aligner market. The company's Invisalign clear aligners have been used to straighten the teeth of nearly 11 million patients so far. Align also markets intraoral scanners used to create 3D images of teeth.\nNano-X Imaging (NASDAQ:NNOX) expects to disrupt the medical imaging market with its digital X-ray devices. The company recently filed for U.S. Food and Drug Administration (FDA) clearance of the first version of its multisource digital system.\nGuardant Health (NASDAQ:GH) is a leader in developing liquid biopsy tests for cancer. The company's first products on the market help match patients with the best cancer therapy and enable drugmakers to develop new therapies.\nWhat sets these stocks apart\nA catchy name that sounds just like FAANG doesn't make these four stocks great picks, of course. However, there are two specific things that set these stocks apart:\n\nThey all target a massive potential market.\nThey all have a head start in that market.\n\nPfizer has been around a long time and is by far the biggest of the PfANG stocks. The company still has multiple growth opportunities, though. One of the most significant of these is in messenger RNA (mRNA) therapies and vaccines.\nThe company continues to work closely with BioNTech on its mRNA COVID-19 vaccine program and an mRNA flu vaccine. Pfizer plans to move forward with mRNA development on its own as well.\nCEO Albert Bourla stated in the company's Q2 conference call last week that Pfizer's strategy is to \"advance and unlock the full potential of mRNA.\" This strategy includes expanding its COVID-19 vaccine franchise and developing mRNA candidates targeting other infectious diseases, rare diseases, and cancer.\nAlign Technology has generated impressive growth in recent years. The company, though, still has only captured 11% of the addressable market for clear aligners.\nNano-X doesn't plan to compete for market share in the $21 billion medical imaging market; it fully intends to expand that market. The company's mobile devices cost only a fraction of current X-ray systems. Two-thirds of the world population have no meaningful access to medical imaging. Nano-X's opportunity is wide open.\nGuardant Health targets a $70 billion-plus potential market in cancer therapy selection, recurrence monitoring, and early screening. There are other companies going after this market as well. However, Guardant stands as one of the leaders and already has strong adoption for its initial liquid biopsy products.\nStill some bite left in the FAANG stocks, too\nI think that the PfANG stocks could deliver market-beating returns over the long term. But you don't really need to worry about having already missed out on the FAANG stocks.\nAugmented reality and virtual reality present big growth opportunities for Facebook and Apple. Artificial intelligence should serve as a growth driver for both of these stocks as well as Alphabet. Netflix is moving into gaming. These FAANG stocks should still have some bite left in them.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5402316,"gmtCreate":1627897777850,"gmtModify":1635162047262,"authorId":3581490787994555,"author":{"id":3581490787994555,"idStr":"3581490787994555","authorId":3581490787994555,"name":"Willretard8","avatar":"https://static.tigerbbs.com/55d367736decafe822ab65564b27b8a2","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":805509639,"type":1,"supId":0,"prevId":0,"content":"Good M1 chip","text":"Good M1 chip","html":"Good M1 chip"}],"langContent":"EN"},{"id":805273360,"gmtCreate":1627887610950,"gmtModify":1631890036011,"author":{"id":"4087890904031420","authorId":"4087890904031420","name":"1moretime","avatar":"https://static.tigerbbs.com/8f4021db7dfd5e5a08edfc57ea25e740","vip":1,"crmLevel":3,"crmLevelSwitch":0,"authorIdStr":"4087890904031420","idStr":"4087890904031420"},"htmlText":"Nice!","listText":"Nice!","text":"Nice!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/805273360","repostId":2156169749,"repostType":4,"repost":{"id":"2156169749","pubTimestamp":1627864728,"share":"https://www.laohu8.com/m/news/2156169749?lang=&edition=full","pubTime":"2021-08-02 08:38","market":"us","language":"en","title":"Missed Out on the FAANG Stocks? Consider Buying These PfANG Stocks Instead.","url":"https://stock-news.laohu8.com/highlight/detail?id=2156169749","media":"Motley Fool","summary":"There's both rhyme and reason for checking out these four stocks.","content":"<p>What's worse than the fear of missing out? I'd put the fear of having already missed out high on the list. There's nothing you can do once an opportunity is gone.</p>\n<p>Some investors might be feeling as if they've already missed out on the FAANG stocks. After all, four of them --&nbsp; <b>Apple</b> (NASDAQ:AAPL), <b>Alphabet</b> (NASDAQ:GOOG) (NASDAQ:GOOGL) (whose Google unit is the \"G\" in FAANG), <b>Amazon.com</b> (NASDAQ:AMZN), and&nbsp;<b><a href=\"https://laohu8.com/S/FB\">Facebook</a></b> (NASDAQ:FB) -- rank among the top 10 biggest companies in the world. Only&nbsp;<b>Netflix</b> (NASDAQ:NFLX) lags behind, but the streaming company still has a market cap of close to $230 billion.</p>\n<p>If you're concerned that you've missed out on a great opportunity with the FAANG stocks, don't worry. Consider buying these PfANG stocks instead.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/5160b68a97ec192124c08475ad420b61\" tg-width=\"700\" tg-height=\"467\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>Introducing the PfANG stocks</h2>\n<p>Aside from the fact that they're all now huge, the FAANG stocks have something else in common: They're all tech stocks. While technology remains a hot area for investors, the healthcare sector also offers tremendous growth prospects. Each of the PfANG stocks ranks as a leader in healthcare, albeit in very different ways.</p>\n<p><b>Pfizer</b> (NYSE:PFE) contributes the \"Pf\" in PfANG. The company is by far the best known of the group. Pfizer, of course, markets a blockbuster COVID-19 vaccine along with its partner, <b>BioNTech</b>. The company also has a product lineup that's loaded with other successful drugs and vaccines.</p>\n<p><b>Align Technology </b>(NASDAQ:ALGN) pioneered the clear dental aligner market. The company's Invisalign clear aligners have been used to straighten the teeth of nearly 11 million patients so far. Align also markets intraoral scanners used to create 3D images of teeth.</p>\n<p><b>Nano-X Imaging</b> (NASDAQ:NNOX) expects to disrupt the medical imaging market with its digital X-ray devices. The company recently filed for U.S. Food and Drug Administration (FDA) clearance of the first version of its multisource digital system.</p>\n<p><b>Guardant Health</b> (NASDAQ:GH) is a leader in developing liquid biopsy tests for cancer. The company's first products on the market help match patients with the best cancer therapy and enable drugmakers to develop new therapies.</p>\n<h2>What sets these stocks apart</h2>\n<p>A catchy name that sounds just like FAANG doesn't make these four stocks great picks, of course. However, there are two specific things that set these stocks apart:</p>\n<ol>\n <li>They all target a massive potential market.</li>\n <li>They all have a head start in that market.</li>\n</ol>\n<p>Pfizer has been around a long time and is by far the biggest of the PfANG stocks. The company still has multiple growth opportunities, though. One of the most significant of these is in messenger RNA (mRNA) therapies and vaccines.</p>\n<p>The company continues to work closely with BioNTech on its mRNA COVID-19 vaccine program and an mRNA flu vaccine. Pfizer plans to move forward with mRNA development on its own as well.</p>\n<p>CEO Albert Bourla stated in the company's Q2 conference call last week that Pfizer's strategy is to \"advance and unlock the full potential of mRNA.\" This strategy includes expanding its COVID-19 vaccine franchise and developing mRNA candidates targeting other infectious diseases, rare diseases, and cancer.</p>\n<p>Align Technology has generated impressive growth in recent years. The company, though, still has only captured 11% of the addressable market for clear aligners.</p>\n<p>Nano-X doesn't plan to compete for market share in the $21 billion medical imaging market; it fully intends to expand that market. The company's mobile devices cost only a fraction of current X-ray systems. <a href=\"https://laohu8.com/S/TWOA.U\">Two</a>-thirds of the world population have no meaningful access to medical imaging. Nano-X's opportunity is wide open.</p>\n<p>Guardant Health targets a $70 billion-plus potential market in cancer therapy selection, recurrence monitoring, and early screening. There are other companies going after this market as well. However, Guardant stands as <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the leaders and already has strong adoption for its initial liquid biopsy products.</p>\n<h2>Still some bite left in the FAANG stocks, too</h2>\n<p>I think that the PfANG stocks could deliver market-beating returns over the long term. But you don't really need to worry about having already missed out on the FAANG stocks.</p>\n<p>Augmented reality and virtual reality present big growth opportunities for Facebook and Apple. Artificial intelligence should serve as a growth driver for both of these stocks as well as Alphabet. Netflix is moving into gaming. These FAANG stocks should still have some bite left in them.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Missed Out on the FAANG Stocks? Consider Buying These PfANG Stocks Instead.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMissed Out on the FAANG Stocks? Consider Buying These PfANG Stocks Instead.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-02 08:38 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/01/missed-out-on-the-faang-stocks-consider-buying-the/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>What's worse than the fear of missing out? I'd put the fear of having already missed out high on the list. There's nothing you can do once an opportunity is gone.\nSome investors might be feeling as if...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/01/missed-out-on-the-faang-stocks-consider-buying-the/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMZN":"亚马逊","AAPL":"苹果","NFLX":"奈飞","GH":"Guardant Health Inc.","GOOG":"谷歌","PFE":"辉瑞","ALGN":"艾利科技","GOOGL":"谷歌A","NNOX":"Nano-X Imaging Ltd."},"source_url":"https://www.fool.com/investing/2021/08/01/missed-out-on-the-faang-stocks-consider-buying-the/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2156169749","content_text":"What's worse than the fear of missing out? I'd put the fear of having already missed out high on the list. There's nothing you can do once an opportunity is gone.\nSome investors might be feeling as if they've already missed out on the FAANG stocks. After all, four of them --  Apple (NASDAQ:AAPL), Alphabet (NASDAQ:GOOG) (NASDAQ:GOOGL) (whose Google unit is the \"G\" in FAANG), Amazon.com (NASDAQ:AMZN), and Facebook (NASDAQ:FB) -- rank among the top 10 biggest companies in the world. Only Netflix (NASDAQ:NFLX) lags behind, but the streaming company still has a market cap of close to $230 billion.\nIf you're concerned that you've missed out on a great opportunity with the FAANG stocks, don't worry. Consider buying these PfANG stocks instead.\nImage source: Getty Images.\nIntroducing the PfANG stocks\nAside from the fact that they're all now huge, the FAANG stocks have something else in common: They're all tech stocks. While technology remains a hot area for investors, the healthcare sector also offers tremendous growth prospects. Each of the PfANG stocks ranks as a leader in healthcare, albeit in very different ways.\nPfizer (NYSE:PFE) contributes the \"Pf\" in PfANG. The company is by far the best known of the group. Pfizer, of course, markets a blockbuster COVID-19 vaccine along with its partner, BioNTech. The company also has a product lineup that's loaded with other successful drugs and vaccines.\nAlign Technology (NASDAQ:ALGN) pioneered the clear dental aligner market. The company's Invisalign clear aligners have been used to straighten the teeth of nearly 11 million patients so far. Align also markets intraoral scanners used to create 3D images of teeth.\nNano-X Imaging (NASDAQ:NNOX) expects to disrupt the medical imaging market with its digital X-ray devices. The company recently filed for U.S. Food and Drug Administration (FDA) clearance of the first version of its multisource digital system.\nGuardant Health (NASDAQ:GH) is a leader in developing liquid biopsy tests for cancer. The company's first products on the market help match patients with the best cancer therapy and enable drugmakers to develop new therapies.\nWhat sets these stocks apart\nA catchy name that sounds just like FAANG doesn't make these four stocks great picks, of course. However, there are two specific things that set these stocks apart:\n\nThey all target a massive potential market.\nThey all have a head start in that market.\n\nPfizer has been around a long time and is by far the biggest of the PfANG stocks. The company still has multiple growth opportunities, though. One of the most significant of these is in messenger RNA (mRNA) therapies and vaccines.\nThe company continues to work closely with BioNTech on its mRNA COVID-19 vaccine program and an mRNA flu vaccine. Pfizer plans to move forward with mRNA development on its own as well.\nCEO Albert Bourla stated in the company's Q2 conference call last week that Pfizer's strategy is to \"advance and unlock the full potential of mRNA.\" This strategy includes expanding its COVID-19 vaccine franchise and developing mRNA candidates targeting other infectious diseases, rare diseases, and cancer.\nAlign Technology has generated impressive growth in recent years. The company, though, still has only captured 11% of the addressable market for clear aligners.\nNano-X doesn't plan to compete for market share in the $21 billion medical imaging market; it fully intends to expand that market. The company's mobile devices cost only a fraction of current X-ray systems. Two-thirds of the world population have no meaningful access to medical imaging. Nano-X's opportunity is wide open.\nGuardant Health targets a $70 billion-plus potential market in cancer therapy selection, recurrence monitoring, and early screening. There are other companies going after this market as well. However, Guardant stands as one of the leaders and already has strong adoption for its initial liquid biopsy products.\nStill some bite left in the FAANG stocks, too\nI think that the PfANG stocks could deliver market-beating returns over the long term. But you don't really need to worry about having already missed out on the FAANG stocks.\nAugmented reality and virtual reality present big growth opportunities for Facebook and Apple. Artificial intelligence should serve as a growth driver for both of these stocks as well as Alphabet. Netflix is moving into gaming. These FAANG stocks should still have some bite left in them.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":805270124,"gmtCreate":1627887419068,"gmtModify":1631884081558,"author":{"id":"3580689210488653","authorId":"3580689210488653","name":"SilentWarrio","avatar":"https://static.tigerbbs.com/c904a9b7d64fe6eb5230d2a57a74ffee","vip":1,"crmLevel":6,"crmLevelSwitch":0,"authorIdStr":"3580689210488653","idStr":"3580689210488653"},"htmlText":"New opportunities...","listText":"New opportunities...","text":"New opportunities...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/805270124","repostId":2156169749,"repostType":4,"repost":{"id":"2156169749","pubTimestamp":1627864728,"share":"https://www.laohu8.com/m/news/2156169749?lang=&edition=full","pubTime":"2021-08-02 08:38","market":"us","language":"en","title":"Missed Out on the FAANG Stocks? Consider Buying These PfANG Stocks Instead.","url":"https://stock-news.laohu8.com/highlight/detail?id=2156169749","media":"Motley Fool","summary":"There's both rhyme and reason for checking out these four stocks.","content":"<p>What's worse than the fear of missing out? I'd put the fear of having already missed out high on the list. There's nothing you can do once an opportunity is gone.</p>\n<p>Some investors might be feeling as if they've already missed out on the FAANG stocks. After all, four of them --&nbsp; <b>Apple</b> (NASDAQ:AAPL), <b>Alphabet</b> (NASDAQ:GOOG) (NASDAQ:GOOGL) (whose Google unit is the \"G\" in FAANG), <b>Amazon.com</b> (NASDAQ:AMZN), and&nbsp;<b><a href=\"https://laohu8.com/S/FB\">Facebook</a></b> (NASDAQ:FB) -- rank among the top 10 biggest companies in the world. Only&nbsp;<b>Netflix</b> (NASDAQ:NFLX) lags behind, but the streaming company still has a market cap of close to $230 billion.</p>\n<p>If you're concerned that you've missed out on a great opportunity with the FAANG stocks, don't worry. Consider buying these PfANG stocks instead.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/5160b68a97ec192124c08475ad420b61\" tg-width=\"700\" tg-height=\"467\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>Introducing the PfANG stocks</h2>\n<p>Aside from the fact that they're all now huge, the FAANG stocks have something else in common: They're all tech stocks. While technology remains a hot area for investors, the healthcare sector also offers tremendous growth prospects. Each of the PfANG stocks ranks as a leader in healthcare, albeit in very different ways.</p>\n<p><b>Pfizer</b> (NYSE:PFE) contributes the \"Pf\" in PfANG. The company is by far the best known of the group. Pfizer, of course, markets a blockbuster COVID-19 vaccine along with its partner, <b>BioNTech</b>. The company also has a product lineup that's loaded with other successful drugs and vaccines.</p>\n<p><b>Align Technology </b>(NASDAQ:ALGN) pioneered the clear dental aligner market. The company's Invisalign clear aligners have been used to straighten the teeth of nearly 11 million patients so far. Align also markets intraoral scanners used to create 3D images of teeth.</p>\n<p><b>Nano-X Imaging</b> (NASDAQ:NNOX) expects to disrupt the medical imaging market with its digital X-ray devices. The company recently filed for U.S. Food and Drug Administration (FDA) clearance of the first version of its multisource digital system.</p>\n<p><b>Guardant Health</b> (NASDAQ:GH) is a leader in developing liquid biopsy tests for cancer. The company's first products on the market help match patients with the best cancer therapy and enable drugmakers to develop new therapies.</p>\n<h2>What sets these stocks apart</h2>\n<p>A catchy name that sounds just like FAANG doesn't make these four stocks great picks, of course. However, there are two specific things that set these stocks apart:</p>\n<ol>\n <li>They all target a massive potential market.</li>\n <li>They all have a head start in that market.</li>\n</ol>\n<p>Pfizer has been around a long time and is by far the biggest of the PfANG stocks. The company still has multiple growth opportunities, though. One of the most significant of these is in messenger RNA (mRNA) therapies and vaccines.</p>\n<p>The company continues to work closely with BioNTech on its mRNA COVID-19 vaccine program and an mRNA flu vaccine. Pfizer plans to move forward with mRNA development on its own as well.</p>\n<p>CEO Albert Bourla stated in the company's Q2 conference call last week that Pfizer's strategy is to \"advance and unlock the full potential of mRNA.\" This strategy includes expanding its COVID-19 vaccine franchise and developing mRNA candidates targeting other infectious diseases, rare diseases, and cancer.</p>\n<p>Align Technology has generated impressive growth in recent years. The company, though, still has only captured 11% of the addressable market for clear aligners.</p>\n<p>Nano-X doesn't plan to compete for market share in the $21 billion medical imaging market; it fully intends to expand that market. The company's mobile devices cost only a fraction of current X-ray systems. <a href=\"https://laohu8.com/S/TWOA.U\">Two</a>-thirds of the world population have no meaningful access to medical imaging. Nano-X's opportunity is wide open.</p>\n<p>Guardant Health targets a $70 billion-plus potential market in cancer therapy selection, recurrence monitoring, and early screening. There are other companies going after this market as well. However, Guardant stands as <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the leaders and already has strong adoption for its initial liquid biopsy products.</p>\n<h2>Still some bite left in the FAANG stocks, too</h2>\n<p>I think that the PfANG stocks could deliver market-beating returns over the long term. But you don't really need to worry about having already missed out on the FAANG stocks.</p>\n<p>Augmented reality and virtual reality present big growth opportunities for Facebook and Apple. Artificial intelligence should serve as a growth driver for both of these stocks as well as Alphabet. Netflix is moving into gaming. These FAANG stocks should still have some bite left in them.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Missed Out on the FAANG Stocks? Consider Buying These PfANG Stocks Instead.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMissed Out on the FAANG Stocks? Consider Buying These PfANG Stocks Instead.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-02 08:38 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/01/missed-out-on-the-faang-stocks-consider-buying-the/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>What's worse than the fear of missing out? I'd put the fear of having already missed out high on the list. There's nothing you can do once an opportunity is gone.\nSome investors might be feeling as if...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/01/missed-out-on-the-faang-stocks-consider-buying-the/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMZN":"亚马逊","AAPL":"苹果","NFLX":"奈飞","GH":"Guardant Health Inc.","GOOG":"谷歌","PFE":"辉瑞","ALGN":"艾利科技","GOOGL":"谷歌A","NNOX":"Nano-X Imaging Ltd."},"source_url":"https://www.fool.com/investing/2021/08/01/missed-out-on-the-faang-stocks-consider-buying-the/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2156169749","content_text":"What's worse than the fear of missing out? I'd put the fear of having already missed out high on the list. There's nothing you can do once an opportunity is gone.\nSome investors might be feeling as if they've already missed out on the FAANG stocks. After all, four of them --  Apple (NASDAQ:AAPL), Alphabet (NASDAQ:GOOG) (NASDAQ:GOOGL) (whose Google unit is the \"G\" in FAANG), Amazon.com (NASDAQ:AMZN), and Facebook (NASDAQ:FB) -- rank among the top 10 biggest companies in the world. Only Netflix (NASDAQ:NFLX) lags behind, but the streaming company still has a market cap of close to $230 billion.\nIf you're concerned that you've missed out on a great opportunity with the FAANG stocks, don't worry. Consider buying these PfANG stocks instead.\nImage source: Getty Images.\nIntroducing the PfANG stocks\nAside from the fact that they're all now huge, the FAANG stocks have something else in common: They're all tech stocks. While technology remains a hot area for investors, the healthcare sector also offers tremendous growth prospects. Each of the PfANG stocks ranks as a leader in healthcare, albeit in very different ways.\nPfizer (NYSE:PFE) contributes the \"Pf\" in PfANG. The company is by far the best known of the group. Pfizer, of course, markets a blockbuster COVID-19 vaccine along with its partner, BioNTech. The company also has a product lineup that's loaded with other successful drugs and vaccines.\nAlign Technology (NASDAQ:ALGN) pioneered the clear dental aligner market. The company's Invisalign clear aligners have been used to straighten the teeth of nearly 11 million patients so far. Align also markets intraoral scanners used to create 3D images of teeth.\nNano-X Imaging (NASDAQ:NNOX) expects to disrupt the medical imaging market with its digital X-ray devices. The company recently filed for U.S. Food and Drug Administration (FDA) clearance of the first version of its multisource digital system.\nGuardant Health (NASDAQ:GH) is a leader in developing liquid biopsy tests for cancer. The company's first products on the market help match patients with the best cancer therapy and enable drugmakers to develop new therapies.\nWhat sets these stocks apart\nA catchy name that sounds just like FAANG doesn't make these four stocks great picks, of course. However, there are two specific things that set these stocks apart:\n\nThey all target a massive potential market.\nThey all have a head start in that market.\n\nPfizer has been around a long time and is by far the biggest of the PfANG stocks. The company still has multiple growth opportunities, though. One of the most significant of these is in messenger RNA (mRNA) therapies and vaccines.\nThe company continues to work closely with BioNTech on its mRNA COVID-19 vaccine program and an mRNA flu vaccine. Pfizer plans to move forward with mRNA development on its own as well.\nCEO Albert Bourla stated in the company's Q2 conference call last week that Pfizer's strategy is to \"advance and unlock the full potential of mRNA.\" This strategy includes expanding its COVID-19 vaccine franchise and developing mRNA candidates targeting other infectious diseases, rare diseases, and cancer.\nAlign Technology has generated impressive growth in recent years. The company, though, still has only captured 11% of the addressable market for clear aligners.\nNano-X doesn't plan to compete for market share in the $21 billion medical imaging market; it fully intends to expand that market. The company's mobile devices cost only a fraction of current X-ray systems. Two-thirds of the world population have no meaningful access to medical imaging. Nano-X's opportunity is wide open.\nGuardant Health targets a $70 billion-plus potential market in cancer therapy selection, recurrence monitoring, and early screening. There are other companies going after this market as well. However, Guardant stands as one of the leaders and already has strong adoption for its initial liquid biopsy products.\nStill some bite left in the FAANG stocks, too\nI think that the PfANG stocks could deliver market-beating returns over the long term. But you don't really need to worry about having already missed out on the FAANG stocks.\nAugmented reality and virtual reality present big growth opportunities for Facebook and Apple. Artificial intelligence should serve as a growth driver for both of these stocks as well as Alphabet. Netflix is moving into gaming. These FAANG stocks should still have some bite left in them.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":805256282,"gmtCreate":1627886203446,"gmtModify":1633755591224,"author":{"id":"3579932836090058","authorId":"3579932836090058","name":"Bry8950","avatar":"https://static.tigerbbs.com/a9521192817425a7661a2344c9ae4687","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3579932836090058","idStr":"3579932836090058"},"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/805256282","repostId":2156169749,"repostType":4,"repost":{"id":"2156169749","pubTimestamp":1627864728,"share":"https://www.laohu8.com/m/news/2156169749?lang=&edition=full","pubTime":"2021-08-02 08:38","market":"us","language":"en","title":"Missed Out on the FAANG Stocks? Consider Buying These PfANG Stocks Instead.","url":"https://stock-news.laohu8.com/highlight/detail?id=2156169749","media":"Motley Fool","summary":"There's both rhyme and reason for checking out these four stocks.","content":"<p>What's worse than the fear of missing out? I'd put the fear of having already missed out high on the list. There's nothing you can do once an opportunity is gone.</p>\n<p>Some investors might be feeling as if they've already missed out on the FAANG stocks. After all, four of them --&nbsp; <b>Apple</b> (NASDAQ:AAPL), <b>Alphabet</b> (NASDAQ:GOOG) (NASDAQ:GOOGL) (whose Google unit is the \"G\" in FAANG), <b>Amazon.com</b> (NASDAQ:AMZN), and&nbsp;<b><a href=\"https://laohu8.com/S/FB\">Facebook</a></b> (NASDAQ:FB) -- rank among the top 10 biggest companies in the world. Only&nbsp;<b>Netflix</b> (NASDAQ:NFLX) lags behind, but the streaming company still has a market cap of close to $230 billion.</p>\n<p>If you're concerned that you've missed out on a great opportunity with the FAANG stocks, don't worry. Consider buying these PfANG stocks instead.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/5160b68a97ec192124c08475ad420b61\" tg-width=\"700\" tg-height=\"467\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>Introducing the PfANG stocks</h2>\n<p>Aside from the fact that they're all now huge, the FAANG stocks have something else in common: They're all tech stocks. While technology remains a hot area for investors, the healthcare sector also offers tremendous growth prospects. Each of the PfANG stocks ranks as a leader in healthcare, albeit in very different ways.</p>\n<p><b>Pfizer</b> (NYSE:PFE) contributes the \"Pf\" in PfANG. The company is by far the best known of the group. Pfizer, of course, markets a blockbuster COVID-19 vaccine along with its partner, <b>BioNTech</b>. The company also has a product lineup that's loaded with other successful drugs and vaccines.</p>\n<p><b>Align Technology </b>(NASDAQ:ALGN) pioneered the clear dental aligner market. The company's Invisalign clear aligners have been used to straighten the teeth of nearly 11 million patients so far. Align also markets intraoral scanners used to create 3D images of teeth.</p>\n<p><b>Nano-X Imaging</b> (NASDAQ:NNOX) expects to disrupt the medical imaging market with its digital X-ray devices. The company recently filed for U.S. Food and Drug Administration (FDA) clearance of the first version of its multisource digital system.</p>\n<p><b>Guardant Health</b> (NASDAQ:GH) is a leader in developing liquid biopsy tests for cancer. The company's first products on the market help match patients with the best cancer therapy and enable drugmakers to develop new therapies.</p>\n<h2>What sets these stocks apart</h2>\n<p>A catchy name that sounds just like FAANG doesn't make these four stocks great picks, of course. However, there are two specific things that set these stocks apart:</p>\n<ol>\n <li>They all target a massive potential market.</li>\n <li>They all have a head start in that market.</li>\n</ol>\n<p>Pfizer has been around a long time and is by far the biggest of the PfANG stocks. The company still has multiple growth opportunities, though. One of the most significant of these is in messenger RNA (mRNA) therapies and vaccines.</p>\n<p>The company continues to work closely with BioNTech on its mRNA COVID-19 vaccine program and an mRNA flu vaccine. Pfizer plans to move forward with mRNA development on its own as well.</p>\n<p>CEO Albert Bourla stated in the company's Q2 conference call last week that Pfizer's strategy is to \"advance and unlock the full potential of mRNA.\" This strategy includes expanding its COVID-19 vaccine franchise and developing mRNA candidates targeting other infectious diseases, rare diseases, and cancer.</p>\n<p>Align Technology has generated impressive growth in recent years. The company, though, still has only captured 11% of the addressable market for clear aligners.</p>\n<p>Nano-X doesn't plan to compete for market share in the $21 billion medical imaging market; it fully intends to expand that market. The company's mobile devices cost only a fraction of current X-ray systems. <a href=\"https://laohu8.com/S/TWOA.U\">Two</a>-thirds of the world population have no meaningful access to medical imaging. Nano-X's opportunity is wide open.</p>\n<p>Guardant Health targets a $70 billion-plus potential market in cancer therapy selection, recurrence monitoring, and early screening. There are other companies going after this market as well. However, Guardant stands as <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the leaders and already has strong adoption for its initial liquid biopsy products.</p>\n<h2>Still some bite left in the FAANG stocks, too</h2>\n<p>I think that the PfANG stocks could deliver market-beating returns over the long term. But you don't really need to worry about having already missed out on the FAANG stocks.</p>\n<p>Augmented reality and virtual reality present big growth opportunities for Facebook and Apple. Artificial intelligence should serve as a growth driver for both of these stocks as well as Alphabet. Netflix is moving into gaming. These FAANG stocks should still have some bite left in them.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Missed Out on the FAANG Stocks? Consider Buying These PfANG Stocks Instead.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMissed Out on the FAANG Stocks? Consider Buying These PfANG Stocks Instead.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-02 08:38 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/01/missed-out-on-the-faang-stocks-consider-buying-the/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>What's worse than the fear of missing out? I'd put the fear of having already missed out high on the list. There's nothing you can do once an opportunity is gone.\nSome investors might be feeling as if...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/01/missed-out-on-the-faang-stocks-consider-buying-the/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMZN":"亚马逊","AAPL":"苹果","NFLX":"奈飞","GH":"Guardant Health Inc.","GOOG":"谷歌","PFE":"辉瑞","ALGN":"艾利科技","GOOGL":"谷歌A","NNOX":"Nano-X Imaging Ltd."},"source_url":"https://www.fool.com/investing/2021/08/01/missed-out-on-the-faang-stocks-consider-buying-the/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2156169749","content_text":"What's worse than the fear of missing out? I'd put the fear of having already missed out high on the list. There's nothing you can do once an opportunity is gone.\nSome investors might be feeling as if they've already missed out on the FAANG stocks. After all, four of them --  Apple (NASDAQ:AAPL), Alphabet (NASDAQ:GOOG) (NASDAQ:GOOGL) (whose Google unit is the \"G\" in FAANG), Amazon.com (NASDAQ:AMZN), and Facebook (NASDAQ:FB) -- rank among the top 10 biggest companies in the world. Only Netflix (NASDAQ:NFLX) lags behind, but the streaming company still has a market cap of close to $230 billion.\nIf you're concerned that you've missed out on a great opportunity with the FAANG stocks, don't worry. Consider buying these PfANG stocks instead.\nImage source: Getty Images.\nIntroducing the PfANG stocks\nAside from the fact that they're all now huge, the FAANG stocks have something else in common: They're all tech stocks. While technology remains a hot area for investors, the healthcare sector also offers tremendous growth prospects. Each of the PfANG stocks ranks as a leader in healthcare, albeit in very different ways.\nPfizer (NYSE:PFE) contributes the \"Pf\" in PfANG. The company is by far the best known of the group. Pfizer, of course, markets a blockbuster COVID-19 vaccine along with its partner, BioNTech. The company also has a product lineup that's loaded with other successful drugs and vaccines.\nAlign Technology (NASDAQ:ALGN) pioneered the clear dental aligner market. The company's Invisalign clear aligners have been used to straighten the teeth of nearly 11 million patients so far. Align also markets intraoral scanners used to create 3D images of teeth.\nNano-X Imaging (NASDAQ:NNOX) expects to disrupt the medical imaging market with its digital X-ray devices. The company recently filed for U.S. Food and Drug Administration (FDA) clearance of the first version of its multisource digital system.\nGuardant Health (NASDAQ:GH) is a leader in developing liquid biopsy tests for cancer. The company's first products on the market help match patients with the best cancer therapy and enable drugmakers to develop new therapies.\nWhat sets these stocks apart\nA catchy name that sounds just like FAANG doesn't make these four stocks great picks, of course. However, there are two specific things that set these stocks apart:\n\nThey all target a massive potential market.\nThey all have a head start in that market.\n\nPfizer has been around a long time and is by far the biggest of the PfANG stocks. The company still has multiple growth opportunities, though. One of the most significant of these is in messenger RNA (mRNA) therapies and vaccines.\nThe company continues to work closely with BioNTech on its mRNA COVID-19 vaccine program and an mRNA flu vaccine. Pfizer plans to move forward with mRNA development on its own as well.\nCEO Albert Bourla stated in the company's Q2 conference call last week that Pfizer's strategy is to \"advance and unlock the full potential of mRNA.\" This strategy includes expanding its COVID-19 vaccine franchise and developing mRNA candidates targeting other infectious diseases, rare diseases, and cancer.\nAlign Technology has generated impressive growth in recent years. The company, though, still has only captured 11% of the addressable market for clear aligners.\nNano-X doesn't plan to compete for market share in the $21 billion medical imaging market; it fully intends to expand that market. The company's mobile devices cost only a fraction of current X-ray systems. Two-thirds of the world population have no meaningful access to medical imaging. Nano-X's opportunity is wide open.\nGuardant Health targets a $70 billion-plus potential market in cancer therapy selection, recurrence monitoring, and early screening. There are other companies going after this market as well. However, Guardant stands as one of the leaders and already has strong adoption for its initial liquid biopsy products.\nStill some bite left in the FAANG stocks, too\nI think that the PfANG stocks could deliver market-beating returns over the long term. But you don't really need to worry about having already missed out on the FAANG stocks.\nAugmented reality and virtual reality present big growth opportunities for Facebook and Apple. Artificial intelligence should serve as a growth driver for both of these stocks as well as Alphabet. Netflix is moving into gaming. These FAANG stocks should still have some bite left in them.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":805259271,"gmtCreate":1627885973193,"gmtModify":1631890036061,"author":{"id":"3576308035119524","authorId":"3576308035119524","name":"simivan154","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":3,"crmLevelSwitch":0,"authorIdStr":"3576308035119524","idStr":"3576308035119524"},"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/805259271","repostId":2156169749,"repostType":4,"repost":{"id":"2156169749","pubTimestamp":1627864728,"share":"https://www.laohu8.com/m/news/2156169749?lang=&edition=full","pubTime":"2021-08-02 08:38","market":"us","language":"en","title":"Missed Out on the FAANG Stocks? Consider Buying These PfANG Stocks Instead.","url":"https://stock-news.laohu8.com/highlight/detail?id=2156169749","media":"Motley Fool","summary":"There's both rhyme and reason for checking out these four stocks.","content":"<p>What's worse than the fear of missing out? I'd put the fear of having already missed out high on the list. There's nothing you can do once an opportunity is gone.</p>\n<p>Some investors might be feeling as if they've already missed out on the FAANG stocks. After all, four of them --&nbsp; <b>Apple</b> (NASDAQ:AAPL), <b>Alphabet</b> (NASDAQ:GOOG) (NASDAQ:GOOGL) (whose Google unit is the \"G\" in FAANG), <b>Amazon.com</b> (NASDAQ:AMZN), and&nbsp;<b><a href=\"https://laohu8.com/S/FB\">Facebook</a></b> (NASDAQ:FB) -- rank among the top 10 biggest companies in the world. Only&nbsp;<b>Netflix</b> (NASDAQ:NFLX) lags behind, but the streaming company still has a market cap of close to $230 billion.</p>\n<p>If you're concerned that you've missed out on a great opportunity with the FAANG stocks, don't worry. Consider buying these PfANG stocks instead.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/5160b68a97ec192124c08475ad420b61\" tg-width=\"700\" tg-height=\"467\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>Introducing the PfANG stocks</h2>\n<p>Aside from the fact that they're all now huge, the FAANG stocks have something else in common: They're all tech stocks. While technology remains a hot area for investors, the healthcare sector also offers tremendous growth prospects. Each of the PfANG stocks ranks as a leader in healthcare, albeit in very different ways.</p>\n<p><b>Pfizer</b> (NYSE:PFE) contributes the \"Pf\" in PfANG. The company is by far the best known of the group. Pfizer, of course, markets a blockbuster COVID-19 vaccine along with its partner, <b>BioNTech</b>. The company also has a product lineup that's loaded with other successful drugs and vaccines.</p>\n<p><b>Align Technology </b>(NASDAQ:ALGN) pioneered the clear dental aligner market. The company's Invisalign clear aligners have been used to straighten the teeth of nearly 11 million patients so far. Align also markets intraoral scanners used to create 3D images of teeth.</p>\n<p><b>Nano-X Imaging</b> (NASDAQ:NNOX) expects to disrupt the medical imaging market with its digital X-ray devices. The company recently filed for U.S. Food and Drug Administration (FDA) clearance of the first version of its multisource digital system.</p>\n<p><b>Guardant Health</b> (NASDAQ:GH) is a leader in developing liquid biopsy tests for cancer. The company's first products on the market help match patients with the best cancer therapy and enable drugmakers to develop new therapies.</p>\n<h2>What sets these stocks apart</h2>\n<p>A catchy name that sounds just like FAANG doesn't make these four stocks great picks, of course. However, there are two specific things that set these stocks apart:</p>\n<ol>\n <li>They all target a massive potential market.</li>\n <li>They all have a head start in that market.</li>\n</ol>\n<p>Pfizer has been around a long time and is by far the biggest of the PfANG stocks. The company still has multiple growth opportunities, though. One of the most significant of these is in messenger RNA (mRNA) therapies and vaccines.</p>\n<p>The company continues to work closely with BioNTech on its mRNA COVID-19 vaccine program and an mRNA flu vaccine. Pfizer plans to move forward with mRNA development on its own as well.</p>\n<p>CEO Albert Bourla stated in the company's Q2 conference call last week that Pfizer's strategy is to \"advance and unlock the full potential of mRNA.\" This strategy includes expanding its COVID-19 vaccine franchise and developing mRNA candidates targeting other infectious diseases, rare diseases, and cancer.</p>\n<p>Align Technology has generated impressive growth in recent years. The company, though, still has only captured 11% of the addressable market for clear aligners.</p>\n<p>Nano-X doesn't plan to compete for market share in the $21 billion medical imaging market; it fully intends to expand that market. The company's mobile devices cost only a fraction of current X-ray systems. <a href=\"https://laohu8.com/S/TWOA.U\">Two</a>-thirds of the world population have no meaningful access to medical imaging. Nano-X's opportunity is wide open.</p>\n<p>Guardant Health targets a $70 billion-plus potential market in cancer therapy selection, recurrence monitoring, and early screening. There are other companies going after this market as well. However, Guardant stands as <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the leaders and already has strong adoption for its initial liquid biopsy products.</p>\n<h2>Still some bite left in the FAANG stocks, too</h2>\n<p>I think that the PfANG stocks could deliver market-beating returns over the long term. But you don't really need to worry about having already missed out on the FAANG stocks.</p>\n<p>Augmented reality and virtual reality present big growth opportunities for Facebook and Apple. Artificial intelligence should serve as a growth driver for both of these stocks as well as Alphabet. Netflix is moving into gaming. These FAANG stocks should still have some bite left in them.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Missed Out on the FAANG Stocks? Consider Buying These PfANG Stocks Instead.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMissed Out on the FAANG Stocks? Consider Buying These PfANG Stocks Instead.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-02 08:38 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/01/missed-out-on-the-faang-stocks-consider-buying-the/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>What's worse than the fear of missing out? I'd put the fear of having already missed out high on the list. There's nothing you can do once an opportunity is gone.\nSome investors might be feeling as if...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/01/missed-out-on-the-faang-stocks-consider-buying-the/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMZN":"亚马逊","AAPL":"苹果","NFLX":"奈飞","GH":"Guardant Health Inc.","GOOG":"谷歌","PFE":"辉瑞","ALGN":"艾利科技","GOOGL":"谷歌A","NNOX":"Nano-X Imaging Ltd."},"source_url":"https://www.fool.com/investing/2021/08/01/missed-out-on-the-faang-stocks-consider-buying-the/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2156169749","content_text":"What's worse than the fear of missing out? I'd put the fear of having already missed out high on the list. There's nothing you can do once an opportunity is gone.\nSome investors might be feeling as if they've already missed out on the FAANG stocks. After all, four of them --  Apple (NASDAQ:AAPL), Alphabet (NASDAQ:GOOG) (NASDAQ:GOOGL) (whose Google unit is the \"G\" in FAANG), Amazon.com (NASDAQ:AMZN), and Facebook (NASDAQ:FB) -- rank among the top 10 biggest companies in the world. Only Netflix (NASDAQ:NFLX) lags behind, but the streaming company still has a market cap of close to $230 billion.\nIf you're concerned that you've missed out on a great opportunity with the FAANG stocks, don't worry. Consider buying these PfANG stocks instead.\nImage source: Getty Images.\nIntroducing the PfANG stocks\nAside from the fact that they're all now huge, the FAANG stocks have something else in common: They're all tech stocks. While technology remains a hot area for investors, the healthcare sector also offers tremendous growth prospects. Each of the PfANG stocks ranks as a leader in healthcare, albeit in very different ways.\nPfizer (NYSE:PFE) contributes the \"Pf\" in PfANG. The company is by far the best known of the group. Pfizer, of course, markets a blockbuster COVID-19 vaccine along with its partner, BioNTech. The company also has a product lineup that's loaded with other successful drugs and vaccines.\nAlign Technology (NASDAQ:ALGN) pioneered the clear dental aligner market. The company's Invisalign clear aligners have been used to straighten the teeth of nearly 11 million patients so far. Align also markets intraoral scanners used to create 3D images of teeth.\nNano-X Imaging (NASDAQ:NNOX) expects to disrupt the medical imaging market with its digital X-ray devices. The company recently filed for U.S. Food and Drug Administration (FDA) clearance of the first version of its multisource digital system.\nGuardant Health (NASDAQ:GH) is a leader in developing liquid biopsy tests for cancer. The company's first products on the market help match patients with the best cancer therapy and enable drugmakers to develop new therapies.\nWhat sets these stocks apart\nA catchy name that sounds just like FAANG doesn't make these four stocks great picks, of course. However, there are two specific things that set these stocks apart:\n\nThey all target a massive potential market.\nThey all have a head start in that market.\n\nPfizer has been around a long time and is by far the biggest of the PfANG stocks. The company still has multiple growth opportunities, though. One of the most significant of these is in messenger RNA (mRNA) therapies and vaccines.\nThe company continues to work closely with BioNTech on its mRNA COVID-19 vaccine program and an mRNA flu vaccine. Pfizer plans to move forward with mRNA development on its own as well.\nCEO Albert Bourla stated in the company's Q2 conference call last week that Pfizer's strategy is to \"advance and unlock the full potential of mRNA.\" This strategy includes expanding its COVID-19 vaccine franchise and developing mRNA candidates targeting other infectious diseases, rare diseases, and cancer.\nAlign Technology has generated impressive growth in recent years. The company, though, still has only captured 11% of the addressable market for clear aligners.\nNano-X doesn't plan to compete for market share in the $21 billion medical imaging market; it fully intends to expand that market. The company's mobile devices cost only a fraction of current X-ray systems. Two-thirds of the world population have no meaningful access to medical imaging. Nano-X's opportunity is wide open.\nGuardant Health targets a $70 billion-plus potential market in cancer therapy selection, recurrence monitoring, and early screening. There are other companies going after this market as well. However, Guardant stands as one of the leaders and already has strong adoption for its initial liquid biopsy products.\nStill some bite left in the FAANG stocks, too\nI think that the PfANG stocks could deliver market-beating returns over the long term. But you don't really need to worry about having already missed out on the FAANG stocks.\nAugmented reality and virtual reality present big growth opportunities for Facebook and Apple. Artificial intelligence should serve as a growth driver for both of these stocks as well as Alphabet. Netflix is moving into gaming. These FAANG stocks should still have some bite left in them.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5408325,"gmtCreate":1627951112560,"gmtModify":1635161557173,"authorId":3561094934768918,"author":{"id":3561094934768918,"idStr":"3561094934768918","authorId":3561094934768918,"name":"Andrew168","avatar":"https://static.tigerbbs.com/f4cc55956fe095a06faa15e17f083db1","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":805259271,"type":1,"supId":0,"prevId":0,"content":"Like back","text":"Like back","html":"Like back"},{"id":5410460,"gmtCreate":1627962347410,"gmtModify":1635161375353,"authorId":3576308035119524,"author":{"id":3576308035119524,"idStr":"3576308035119524","authorId":3576308035119524,"name":"simivan154","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":805259271,"type":1,"supId":5408325,"prevId":0,"content":"Yes","text":"Yes","html":"Yes"},{"id":5617311,"gmtCreate":1629689089981,"gmtModify":1635144829241,"authorId":3561094934768918,"author":{"id":3561094934768918,"idStr":"3561094934768918","authorId":3561094934768918,"name":"Andrew168","avatar":"https://static.tigerbbs.com/f4cc55956fe095a06faa15e17f083db1","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":805259271,"type":1,"supId":0,"prevId":0,"content":"👌","text":"👌","html":"👌"}],"langContent":"EN"},{"id":805268955,"gmtCreate":1627884472777,"gmtModify":1633755602398,"author":{"id":"3561892717259406","authorId":"3561892717259406","name":"GGWP","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":6,"crmLevelSwitch":0,"authorIdStr":"3561892717259406","idStr":"3561892717259406"},"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/805268955","repostId":2156169749,"repostType":4,"repost":{"id":"2156169749","pubTimestamp":1627864728,"share":"https://www.laohu8.com/m/news/2156169749?lang=&edition=full","pubTime":"2021-08-02 08:38","market":"us","language":"en","title":"Missed Out on the FAANG Stocks? Consider Buying These PfANG Stocks Instead.","url":"https://stock-news.laohu8.com/highlight/detail?id=2156169749","media":"Motley Fool","summary":"There's both rhyme and reason for checking out these four stocks.","content":"<p>What's worse than the fear of missing out? I'd put the fear of having already missed out high on the list. There's nothing you can do once an opportunity is gone.</p>\n<p>Some investors might be feeling as if they've already missed out on the FAANG stocks. After all, four of them --&nbsp; <b>Apple</b> (NASDAQ:AAPL), <b>Alphabet</b> (NASDAQ:GOOG) (NASDAQ:GOOGL) (whose Google unit is the \"G\" in FAANG), <b>Amazon.com</b> (NASDAQ:AMZN), and&nbsp;<b><a href=\"https://laohu8.com/S/FB\">Facebook</a></b> (NASDAQ:FB) -- rank among the top 10 biggest companies in the world. Only&nbsp;<b>Netflix</b> (NASDAQ:NFLX) lags behind, but the streaming company still has a market cap of close to $230 billion.</p>\n<p>If you're concerned that you've missed out on a great opportunity with the FAANG stocks, don't worry. Consider buying these PfANG stocks instead.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/5160b68a97ec192124c08475ad420b61\" tg-width=\"700\" tg-height=\"467\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>Introducing the PfANG stocks</h2>\n<p>Aside from the fact that they're all now huge, the FAANG stocks have something else in common: They're all tech stocks. While technology remains a hot area for investors, the healthcare sector also offers tremendous growth prospects. Each of the PfANG stocks ranks as a leader in healthcare, albeit in very different ways.</p>\n<p><b>Pfizer</b> (NYSE:PFE) contributes the \"Pf\" in PfANG. The company is by far the best known of the group. Pfizer, of course, markets a blockbuster COVID-19 vaccine along with its partner, <b>BioNTech</b>. The company also has a product lineup that's loaded with other successful drugs and vaccines.</p>\n<p><b>Align Technology </b>(NASDAQ:ALGN) pioneered the clear dental aligner market. The company's Invisalign clear aligners have been used to straighten the teeth of nearly 11 million patients so far. Align also markets intraoral scanners used to create 3D images of teeth.</p>\n<p><b>Nano-X Imaging</b> (NASDAQ:NNOX) expects to disrupt the medical imaging market with its digital X-ray devices. The company recently filed for U.S. Food and Drug Administration (FDA) clearance of the first version of its multisource digital system.</p>\n<p><b>Guardant Health</b> (NASDAQ:GH) is a leader in developing liquid biopsy tests for cancer. The company's first products on the market help match patients with the best cancer therapy and enable drugmakers to develop new therapies.</p>\n<h2>What sets these stocks apart</h2>\n<p>A catchy name that sounds just like FAANG doesn't make these four stocks great picks, of course. However, there are two specific things that set these stocks apart:</p>\n<ol>\n <li>They all target a massive potential market.</li>\n <li>They all have a head start in that market.</li>\n</ol>\n<p>Pfizer has been around a long time and is by far the biggest of the PfANG stocks. The company still has multiple growth opportunities, though. One of the most significant of these is in messenger RNA (mRNA) therapies and vaccines.</p>\n<p>The company continues to work closely with BioNTech on its mRNA COVID-19 vaccine program and an mRNA flu vaccine. Pfizer plans to move forward with mRNA development on its own as well.</p>\n<p>CEO Albert Bourla stated in the company's Q2 conference call last week that Pfizer's strategy is to \"advance and unlock the full potential of mRNA.\" This strategy includes expanding its COVID-19 vaccine franchise and developing mRNA candidates targeting other infectious diseases, rare diseases, and cancer.</p>\n<p>Align Technology has generated impressive growth in recent years. The company, though, still has only captured 11% of the addressable market for clear aligners.</p>\n<p>Nano-X doesn't plan to compete for market share in the $21 billion medical imaging market; it fully intends to expand that market. The company's mobile devices cost only a fraction of current X-ray systems. <a href=\"https://laohu8.com/S/TWOA.U\">Two</a>-thirds of the world population have no meaningful access to medical imaging. Nano-X's opportunity is wide open.</p>\n<p>Guardant Health targets a $70 billion-plus potential market in cancer therapy selection, recurrence monitoring, and early screening. There are other companies going after this market as well. However, Guardant stands as <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the leaders and already has strong adoption for its initial liquid biopsy products.</p>\n<h2>Still some bite left in the FAANG stocks, too</h2>\n<p>I think that the PfANG stocks could deliver market-beating returns over the long term. But you don't really need to worry about having already missed out on the FAANG stocks.</p>\n<p>Augmented reality and virtual reality present big growth opportunities for Facebook and Apple. Artificial intelligence should serve as a growth driver for both of these stocks as well as Alphabet. Netflix is moving into gaming. These FAANG stocks should still have some bite left in them.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Missed Out on the FAANG Stocks? Consider Buying These PfANG Stocks Instead.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMissed Out on the FAANG Stocks? Consider Buying These PfANG Stocks Instead.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-02 08:38 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/01/missed-out-on-the-faang-stocks-consider-buying-the/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>What's worse than the fear of missing out? I'd put the fear of having already missed out high on the list. There's nothing you can do once an opportunity is gone.\nSome investors might be feeling as if...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/01/missed-out-on-the-faang-stocks-consider-buying-the/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMZN":"亚马逊","AAPL":"苹果","NFLX":"奈飞","GH":"Guardant Health Inc.","GOOG":"谷歌","PFE":"辉瑞","ALGN":"艾利科技","GOOGL":"谷歌A","NNOX":"Nano-X Imaging Ltd."},"source_url":"https://www.fool.com/investing/2021/08/01/missed-out-on-the-faang-stocks-consider-buying-the/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2156169749","content_text":"What's worse than the fear of missing out? I'd put the fear of having already missed out high on the list. There's nothing you can do once an opportunity is gone.\nSome investors might be feeling as if they've already missed out on the FAANG stocks. After all, four of them --  Apple (NASDAQ:AAPL), Alphabet (NASDAQ:GOOG) (NASDAQ:GOOGL) (whose Google unit is the \"G\" in FAANG), Amazon.com (NASDAQ:AMZN), and Facebook (NASDAQ:FB) -- rank among the top 10 biggest companies in the world. Only Netflix (NASDAQ:NFLX) lags behind, but the streaming company still has a market cap of close to $230 billion.\nIf you're concerned that you've missed out on a great opportunity with the FAANG stocks, don't worry. Consider buying these PfANG stocks instead.\nImage source: Getty Images.\nIntroducing the PfANG stocks\nAside from the fact that they're all now huge, the FAANG stocks have something else in common: They're all tech stocks. While technology remains a hot area for investors, the healthcare sector also offers tremendous growth prospects. Each of the PfANG stocks ranks as a leader in healthcare, albeit in very different ways.\nPfizer (NYSE:PFE) contributes the \"Pf\" in PfANG. The company is by far the best known of the group. Pfizer, of course, markets a blockbuster COVID-19 vaccine along with its partner, BioNTech. The company also has a product lineup that's loaded with other successful drugs and vaccines.\nAlign Technology (NASDAQ:ALGN) pioneered the clear dental aligner market. The company's Invisalign clear aligners have been used to straighten the teeth of nearly 11 million patients so far. Align also markets intraoral scanners used to create 3D images of teeth.\nNano-X Imaging (NASDAQ:NNOX) expects to disrupt the medical imaging market with its digital X-ray devices. The company recently filed for U.S. Food and Drug Administration (FDA) clearance of the first version of its multisource digital system.\nGuardant Health (NASDAQ:GH) is a leader in developing liquid biopsy tests for cancer. The company's first products on the market help match patients with the best cancer therapy and enable drugmakers to develop new therapies.\nWhat sets these stocks apart\nA catchy name that sounds just like FAANG doesn't make these four stocks great picks, of course. However, there are two specific things that set these stocks apart:\n\nThey all target a massive potential market.\nThey all have a head start in that market.\n\nPfizer has been around a long time and is by far the biggest of the PfANG stocks. The company still has multiple growth opportunities, though. One of the most significant of these is in messenger RNA (mRNA) therapies and vaccines.\nThe company continues to work closely with BioNTech on its mRNA COVID-19 vaccine program and an mRNA flu vaccine. Pfizer plans to move forward with mRNA development on its own as well.\nCEO Albert Bourla stated in the company's Q2 conference call last week that Pfizer's strategy is to \"advance and unlock the full potential of mRNA.\" This strategy includes expanding its COVID-19 vaccine franchise and developing mRNA candidates targeting other infectious diseases, rare diseases, and cancer.\nAlign Technology has generated impressive growth in recent years. The company, though, still has only captured 11% of the addressable market for clear aligners.\nNano-X doesn't plan to compete for market share in the $21 billion medical imaging market; it fully intends to expand that market. The company's mobile devices cost only a fraction of current X-ray systems. Two-thirds of the world population have no meaningful access to medical imaging. Nano-X's opportunity is wide open.\nGuardant Health targets a $70 billion-plus potential market in cancer therapy selection, recurrence monitoring, and early screening. There are other companies going after this market as well. However, Guardant stands as one of the leaders and already has strong adoption for its initial liquid biopsy products.\nStill some bite left in the FAANG stocks, too\nI think that the PfANG stocks could deliver market-beating returns over the long term. But you don't really need to worry about having already missed out on the FAANG stocks.\nAugmented reality and virtual reality present big growth opportunities for Facebook and Apple. Artificial intelligence should serve as a growth driver for both of these stocks as well as Alphabet. Netflix is moving into gaming. These FAANG stocks should still have some bite left in them.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5403069,"gmtCreate":1627904994480,"gmtModify":1635161993195,"authorId":3561892717259406,"author":{"id":3561892717259406,"idStr":"3561892717259406","authorId":3561892717259406,"name":"GGWP","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":805268955,"type":1,"supId":0,"prevId":0,"content":"A","text":"A","html":"A"}],"langContent":"EN"},{"id":805214239,"gmtCreate":1627883364121,"gmtModify":1633755612727,"author":{"id":"3585617155516823","authorId":"3585617155516823","name":"Baby Step 4","avatar":"https://static.tigerbbs.com/8ee1c9c06b2929c88e9f5bb3a24cf2d2","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3585617155516823","idStr":"3585617155516823"},"htmlText":"👍🏽👍🏽","listText":"👍🏽👍🏽","text":"👍🏽👍🏽","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/805214239","repostId":2156169749,"repostType":4,"repost":{"id":"2156169749","pubTimestamp":1627864728,"share":"https://www.laohu8.com/m/news/2156169749?lang=&edition=full","pubTime":"2021-08-02 08:38","market":"us","language":"en","title":"Missed Out on the FAANG Stocks? Consider Buying These PfANG Stocks Instead.","url":"https://stock-news.laohu8.com/highlight/detail?id=2156169749","media":"Motley Fool","summary":"There's both rhyme and reason for checking out these four stocks.","content":"<p>What's worse than the fear of missing out? I'd put the fear of having already missed out high on the list. There's nothing you can do once an opportunity is gone.</p>\n<p>Some investors might be feeling as if they've already missed out on the FAANG stocks. After all, four of them --&nbsp; <b>Apple</b> (NASDAQ:AAPL), <b>Alphabet</b> (NASDAQ:GOOG) (NASDAQ:GOOGL) (whose Google unit is the \"G\" in FAANG), <b>Amazon.com</b> (NASDAQ:AMZN), and&nbsp;<b><a href=\"https://laohu8.com/S/FB\">Facebook</a></b> (NASDAQ:FB) -- rank among the top 10 biggest companies in the world. Only&nbsp;<b>Netflix</b> (NASDAQ:NFLX) lags behind, but the streaming company still has a market cap of close to $230 billion.</p>\n<p>If you're concerned that you've missed out on a great opportunity with the FAANG stocks, don't worry. Consider buying these PfANG stocks instead.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/5160b68a97ec192124c08475ad420b61\" tg-width=\"700\" tg-height=\"467\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>Introducing the PfANG stocks</h2>\n<p>Aside from the fact that they're all now huge, the FAANG stocks have something else in common: They're all tech stocks. While technology remains a hot area for investors, the healthcare sector also offers tremendous growth prospects. Each of the PfANG stocks ranks as a leader in healthcare, albeit in very different ways.</p>\n<p><b>Pfizer</b> (NYSE:PFE) contributes the \"Pf\" in PfANG. The company is by far the best known of the group. Pfizer, of course, markets a blockbuster COVID-19 vaccine along with its partner, <b>BioNTech</b>. The company also has a product lineup that's loaded with other successful drugs and vaccines.</p>\n<p><b>Align Technology </b>(NASDAQ:ALGN) pioneered the clear dental aligner market. The company's Invisalign clear aligners have been used to straighten the teeth of nearly 11 million patients so far. Align also markets intraoral scanners used to create 3D images of teeth.</p>\n<p><b>Nano-X Imaging</b> (NASDAQ:NNOX) expects to disrupt the medical imaging market with its digital X-ray devices. The company recently filed for U.S. Food and Drug Administration (FDA) clearance of the first version of its multisource digital system.</p>\n<p><b>Guardant Health</b> (NASDAQ:GH) is a leader in developing liquid biopsy tests for cancer. The company's first products on the market help match patients with the best cancer therapy and enable drugmakers to develop new therapies.</p>\n<h2>What sets these stocks apart</h2>\n<p>A catchy name that sounds just like FAANG doesn't make these four stocks great picks, of course. However, there are two specific things that set these stocks apart:</p>\n<ol>\n <li>They all target a massive potential market.</li>\n <li>They all have a head start in that market.</li>\n</ol>\n<p>Pfizer has been around a long time and is by far the biggest of the PfANG stocks. The company still has multiple growth opportunities, though. One of the most significant of these is in messenger RNA (mRNA) therapies and vaccines.</p>\n<p>The company continues to work closely with BioNTech on its mRNA COVID-19 vaccine program and an mRNA flu vaccine. Pfizer plans to move forward with mRNA development on its own as well.</p>\n<p>CEO Albert Bourla stated in the company's Q2 conference call last week that Pfizer's strategy is to \"advance and unlock the full potential of mRNA.\" This strategy includes expanding its COVID-19 vaccine franchise and developing mRNA candidates targeting other infectious diseases, rare diseases, and cancer.</p>\n<p>Align Technology has generated impressive growth in recent years. The company, though, still has only captured 11% of the addressable market for clear aligners.</p>\n<p>Nano-X doesn't plan to compete for market share in the $21 billion medical imaging market; it fully intends to expand that market. The company's mobile devices cost only a fraction of current X-ray systems. <a href=\"https://laohu8.com/S/TWOA.U\">Two</a>-thirds of the world population have no meaningful access to medical imaging. Nano-X's opportunity is wide open.</p>\n<p>Guardant Health targets a $70 billion-plus potential market in cancer therapy selection, recurrence monitoring, and early screening. There are other companies going after this market as well. However, Guardant stands as <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the leaders and already has strong adoption for its initial liquid biopsy products.</p>\n<h2>Still some bite left in the FAANG stocks, too</h2>\n<p>I think that the PfANG stocks could deliver market-beating returns over the long term. But you don't really need to worry about having already missed out on the FAANG stocks.</p>\n<p>Augmented reality and virtual reality present big growth opportunities for Facebook and Apple. Artificial intelligence should serve as a growth driver for both of these stocks as well as Alphabet. Netflix is moving into gaming. These FAANG stocks should still have some bite left in them.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Missed Out on the FAANG Stocks? Consider Buying These PfANG Stocks Instead.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMissed Out on the FAANG Stocks? Consider Buying These PfANG Stocks Instead.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-02 08:38 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/01/missed-out-on-the-faang-stocks-consider-buying-the/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>What's worse than the fear of missing out? I'd put the fear of having already missed out high on the list. There's nothing you can do once an opportunity is gone.\nSome investors might be feeling as if...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/01/missed-out-on-the-faang-stocks-consider-buying-the/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMZN":"亚马逊","AAPL":"苹果","NFLX":"奈飞","GH":"Guardant Health Inc.","GOOG":"谷歌","PFE":"辉瑞","ALGN":"艾利科技","GOOGL":"谷歌A","NNOX":"Nano-X Imaging Ltd."},"source_url":"https://www.fool.com/investing/2021/08/01/missed-out-on-the-faang-stocks-consider-buying-the/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2156169749","content_text":"What's worse than the fear of missing out? I'd put the fear of having already missed out high on the list. There's nothing you can do once an opportunity is gone.\nSome investors might be feeling as if they've already missed out on the FAANG stocks. After all, four of them --  Apple (NASDAQ:AAPL), Alphabet (NASDAQ:GOOG) (NASDAQ:GOOGL) (whose Google unit is the \"G\" in FAANG), Amazon.com (NASDAQ:AMZN), and Facebook (NASDAQ:FB) -- rank among the top 10 biggest companies in the world. Only Netflix (NASDAQ:NFLX) lags behind, but the streaming company still has a market cap of close to $230 billion.\nIf you're concerned that you've missed out on a great opportunity with the FAANG stocks, don't worry. Consider buying these PfANG stocks instead.\nImage source: Getty Images.\nIntroducing the PfANG stocks\nAside from the fact that they're all now huge, the FAANG stocks have something else in common: They're all tech stocks. While technology remains a hot area for investors, the healthcare sector also offers tremendous growth prospects. Each of the PfANG stocks ranks as a leader in healthcare, albeit in very different ways.\nPfizer (NYSE:PFE) contributes the \"Pf\" in PfANG. The company is by far the best known of the group. Pfizer, of course, markets a blockbuster COVID-19 vaccine along with its partner, BioNTech. The company also has a product lineup that's loaded with other successful drugs and vaccines.\nAlign Technology (NASDAQ:ALGN) pioneered the clear dental aligner market. The company's Invisalign clear aligners have been used to straighten the teeth of nearly 11 million patients so far. Align also markets intraoral scanners used to create 3D images of teeth.\nNano-X Imaging (NASDAQ:NNOX) expects to disrupt the medical imaging market with its digital X-ray devices. The company recently filed for U.S. Food and Drug Administration (FDA) clearance of the first version of its multisource digital system.\nGuardant Health (NASDAQ:GH) is a leader in developing liquid biopsy tests for cancer. The company's first products on the market help match patients with the best cancer therapy and enable drugmakers to develop new therapies.\nWhat sets these stocks apart\nA catchy name that sounds just like FAANG doesn't make these four stocks great picks, of course. However, there are two specific things that set these stocks apart:\n\nThey all target a massive potential market.\nThey all have a head start in that market.\n\nPfizer has been around a long time and is by far the biggest of the PfANG stocks. The company still has multiple growth opportunities, though. One of the most significant of these is in messenger RNA (mRNA) therapies and vaccines.\nThe company continues to work closely with BioNTech on its mRNA COVID-19 vaccine program and an mRNA flu vaccine. Pfizer plans to move forward with mRNA development on its own as well.\nCEO Albert Bourla stated in the company's Q2 conference call last week that Pfizer's strategy is to \"advance and unlock the full potential of mRNA.\" This strategy includes expanding its COVID-19 vaccine franchise and developing mRNA candidates targeting other infectious diseases, rare diseases, and cancer.\nAlign Technology has generated impressive growth in recent years. The company, though, still has only captured 11% of the addressable market for clear aligners.\nNano-X doesn't plan to compete for market share in the $21 billion medical imaging market; it fully intends to expand that market. The company's mobile devices cost only a fraction of current X-ray systems. Two-thirds of the world population have no meaningful access to medical imaging. Nano-X's opportunity is wide open.\nGuardant Health targets a $70 billion-plus potential market in cancer therapy selection, recurrence monitoring, and early screening. There are other companies going after this market as well. However, Guardant stands as one of the leaders and already has strong adoption for its initial liquid biopsy products.\nStill some bite left in the FAANG stocks, too\nI think that the PfANG stocks could deliver market-beating returns over the long term. But you don't really need to worry about having already missed out on the FAANG stocks.\nAugmented reality and virtual reality present big growth opportunities for Facebook and Apple. Artificial intelligence should serve as a growth driver for both of these stocks as well as Alphabet. Netflix is moving into gaming. These FAANG stocks should still have some bite left in them.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5401204,"gmtCreate":1627888843268,"gmtModify":1635162124178,"authorId":3573124416025977,"author":{"id":3573124416025977,"idStr":"3573124416025977","authorId":3573124416025977,"name":"NEWBIE","avatar":"https://static.tigerbbs.com/3efe20248e6d34805e6c7befc3ae66a0","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":805214239,"type":1,"supId":0,"prevId":0,"content":"<u>yes</u>","text":"<u>yes</u>","html":"<u>yes</u>"}],"langContent":"EN"},{"id":805231769,"gmtCreate":1627882186351,"gmtModify":1633755622369,"author":{"id":"4090502512947490","authorId":"4090502512947490","name":"Yingyingloo","avatar":"https://static.tigerbbs.com/da58afbd656809ec183af4a539b38af6","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"4090502512947490","idStr":"4090502512947490"},"htmlText":"Like and commment","listText":"Like and commment","text":"Like and commment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/805231769","repostId":2156169749,"repostType":4,"repost":{"id":"2156169749","pubTimestamp":1627864728,"share":"https://www.laohu8.com/m/news/2156169749?lang=&edition=full","pubTime":"2021-08-02 08:38","market":"us","language":"en","title":"Missed Out on the FAANG Stocks? Consider Buying These PfANG Stocks Instead.","url":"https://stock-news.laohu8.com/highlight/detail?id=2156169749","media":"Motley Fool","summary":"There's both rhyme and reason for checking out these four stocks.","content":"<p>What's worse than the fear of missing out? I'd put the fear of having already missed out high on the list. There's nothing you can do once an opportunity is gone.</p>\n<p>Some investors might be feeling as if they've already missed out on the FAANG stocks. After all, four of them --&nbsp; <b>Apple</b> (NASDAQ:AAPL), <b>Alphabet</b> (NASDAQ:GOOG) (NASDAQ:GOOGL) (whose Google unit is the \"G\" in FAANG), <b>Amazon.com</b> (NASDAQ:AMZN), and&nbsp;<b><a href=\"https://laohu8.com/S/FB\">Facebook</a></b> (NASDAQ:FB) -- rank among the top 10 biggest companies in the world. Only&nbsp;<b>Netflix</b> (NASDAQ:NFLX) lags behind, but the streaming company still has a market cap of close to $230 billion.</p>\n<p>If you're concerned that you've missed out on a great opportunity with the FAANG stocks, don't worry. Consider buying these PfANG stocks instead.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/5160b68a97ec192124c08475ad420b61\" tg-width=\"700\" tg-height=\"467\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>Introducing the PfANG stocks</h2>\n<p>Aside from the fact that they're all now huge, the FAANG stocks have something else in common: They're all tech stocks. While technology remains a hot area for investors, the healthcare sector also offers tremendous growth prospects. Each of the PfANG stocks ranks as a leader in healthcare, albeit in very different ways.</p>\n<p><b>Pfizer</b> (NYSE:PFE) contributes the \"Pf\" in PfANG. The company is by far the best known of the group. Pfizer, of course, markets a blockbuster COVID-19 vaccine along with its partner, <b>BioNTech</b>. The company also has a product lineup that's loaded with other successful drugs and vaccines.</p>\n<p><b>Align Technology </b>(NASDAQ:ALGN) pioneered the clear dental aligner market. The company's Invisalign clear aligners have been used to straighten the teeth of nearly 11 million patients so far. Align also markets intraoral scanners used to create 3D images of teeth.</p>\n<p><b>Nano-X Imaging</b> (NASDAQ:NNOX) expects to disrupt the medical imaging market with its digital X-ray devices. The company recently filed for U.S. Food and Drug Administration (FDA) clearance of the first version of its multisource digital system.</p>\n<p><b>Guardant Health</b> (NASDAQ:GH) is a leader in developing liquid biopsy tests for cancer. The company's first products on the market help match patients with the best cancer therapy and enable drugmakers to develop new therapies.</p>\n<h2>What sets these stocks apart</h2>\n<p>A catchy name that sounds just like FAANG doesn't make these four stocks great picks, of course. However, there are two specific things that set these stocks apart:</p>\n<ol>\n <li>They all target a massive potential market.</li>\n <li>They all have a head start in that market.</li>\n</ol>\n<p>Pfizer has been around a long time and is by far the biggest of the PfANG stocks. The company still has multiple growth opportunities, though. One of the most significant of these is in messenger RNA (mRNA) therapies and vaccines.</p>\n<p>The company continues to work closely with BioNTech on its mRNA COVID-19 vaccine program and an mRNA flu vaccine. Pfizer plans to move forward with mRNA development on its own as well.</p>\n<p>CEO Albert Bourla stated in the company's Q2 conference call last week that Pfizer's strategy is to \"advance and unlock the full potential of mRNA.\" This strategy includes expanding its COVID-19 vaccine franchise and developing mRNA candidates targeting other infectious diseases, rare diseases, and cancer.</p>\n<p>Align Technology has generated impressive growth in recent years. The company, though, still has only captured 11% of the addressable market for clear aligners.</p>\n<p>Nano-X doesn't plan to compete for market share in the $21 billion medical imaging market; it fully intends to expand that market. The company's mobile devices cost only a fraction of current X-ray systems. <a href=\"https://laohu8.com/S/TWOA.U\">Two</a>-thirds of the world population have no meaningful access to medical imaging. Nano-X's opportunity is wide open.</p>\n<p>Guardant Health targets a $70 billion-plus potential market in cancer therapy selection, recurrence monitoring, and early screening. There are other companies going after this market as well. However, Guardant stands as <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the leaders and already has strong adoption for its initial liquid biopsy products.</p>\n<h2>Still some bite left in the FAANG stocks, too</h2>\n<p>I think that the PfANG stocks could deliver market-beating returns over the long term. But you don't really need to worry about having already missed out on the FAANG stocks.</p>\n<p>Augmented reality and virtual reality present big growth opportunities for Facebook and Apple. Artificial intelligence should serve as a growth driver for both of these stocks as well as Alphabet. Netflix is moving into gaming. These FAANG stocks should still have some bite left in them.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Missed Out on the FAANG Stocks? Consider Buying These PfANG Stocks Instead.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMissed Out on the FAANG Stocks? Consider Buying These PfANG Stocks Instead.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-02 08:38 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/01/missed-out-on-the-faang-stocks-consider-buying-the/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>What's worse than the fear of missing out? I'd put the fear of having already missed out high on the list. There's nothing you can do once an opportunity is gone.\nSome investors might be feeling as if...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/01/missed-out-on-the-faang-stocks-consider-buying-the/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMZN":"亚马逊","AAPL":"苹果","NFLX":"奈飞","GH":"Guardant Health Inc.","GOOG":"谷歌","PFE":"辉瑞","ALGN":"艾利科技","GOOGL":"谷歌A","NNOX":"Nano-X Imaging Ltd."},"source_url":"https://www.fool.com/investing/2021/08/01/missed-out-on-the-faang-stocks-consider-buying-the/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2156169749","content_text":"What's worse than the fear of missing out? I'd put the fear of having already missed out high on the list. There's nothing you can do once an opportunity is gone.\nSome investors might be feeling as if they've already missed out on the FAANG stocks. After all, four of them --  Apple (NASDAQ:AAPL), Alphabet (NASDAQ:GOOG) (NASDAQ:GOOGL) (whose Google unit is the \"G\" in FAANG), Amazon.com (NASDAQ:AMZN), and Facebook (NASDAQ:FB) -- rank among the top 10 biggest companies in the world. Only Netflix (NASDAQ:NFLX) lags behind, but the streaming company still has a market cap of close to $230 billion.\nIf you're concerned that you've missed out on a great opportunity with the FAANG stocks, don't worry. Consider buying these PfANG stocks instead.\nImage source: Getty Images.\nIntroducing the PfANG stocks\nAside from the fact that they're all now huge, the FAANG stocks have something else in common: They're all tech stocks. While technology remains a hot area for investors, the healthcare sector also offers tremendous growth prospects. Each of the PfANG stocks ranks as a leader in healthcare, albeit in very different ways.\nPfizer (NYSE:PFE) contributes the \"Pf\" in PfANG. The company is by far the best known of the group. Pfizer, of course, markets a blockbuster COVID-19 vaccine along with its partner, BioNTech. The company also has a product lineup that's loaded with other successful drugs and vaccines.\nAlign Technology (NASDAQ:ALGN) pioneered the clear dental aligner market. The company's Invisalign clear aligners have been used to straighten the teeth of nearly 11 million patients so far. Align also markets intraoral scanners used to create 3D images of teeth.\nNano-X Imaging (NASDAQ:NNOX) expects to disrupt the medical imaging market with its digital X-ray devices. The company recently filed for U.S. Food and Drug Administration (FDA) clearance of the first version of its multisource digital system.\nGuardant Health (NASDAQ:GH) is a leader in developing liquid biopsy tests for cancer. The company's first products on the market help match patients with the best cancer therapy and enable drugmakers to develop new therapies.\nWhat sets these stocks apart\nA catchy name that sounds just like FAANG doesn't make these four stocks great picks, of course. However, there are two specific things that set these stocks apart:\n\nThey all target a massive potential market.\nThey all have a head start in that market.\n\nPfizer has been around a long time and is by far the biggest of the PfANG stocks. The company still has multiple growth opportunities, though. One of the most significant of these is in messenger RNA (mRNA) therapies and vaccines.\nThe company continues to work closely with BioNTech on its mRNA COVID-19 vaccine program and an mRNA flu vaccine. Pfizer plans to move forward with mRNA development on its own as well.\nCEO Albert Bourla stated in the company's Q2 conference call last week that Pfizer's strategy is to \"advance and unlock the full potential of mRNA.\" This strategy includes expanding its COVID-19 vaccine franchise and developing mRNA candidates targeting other infectious diseases, rare diseases, and cancer.\nAlign Technology has generated impressive growth in recent years. The company, though, still has only captured 11% of the addressable market for clear aligners.\nNano-X doesn't plan to compete for market share in the $21 billion medical imaging market; it fully intends to expand that market. The company's mobile devices cost only a fraction of current X-ray systems. Two-thirds of the world population have no meaningful access to medical imaging. Nano-X's opportunity is wide open.\nGuardant Health targets a $70 billion-plus potential market in cancer therapy selection, recurrence monitoring, and early screening. There are other companies going after this market as well. However, Guardant stands as one of the leaders and already has strong adoption for its initial liquid biopsy products.\nStill some bite left in the FAANG stocks, too\nI think that the PfANG stocks could deliver market-beating returns over the long term. But you don't really need to worry about having already missed out on the FAANG stocks.\nAugmented reality and virtual reality present big growth opportunities for Facebook and Apple. Artificial intelligence should serve as a growth driver for both of these stocks as well as Alphabet. Netflix is moving into gaming. These FAANG stocks should still have some bite left in them.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5400661,"gmtCreate":1627882688784,"gmtModify":1635162168450,"authorId":3578966425599850,"author":{"id":3578966425599850,"idStr":"3578966425599850","authorId":3578966425599850,"name":"Brsje","avatar":"https://static.tigerbbs.com/3dbbcbc87a1aacdd702502ff32693a39","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":805231769,"type":1,"supId":0,"prevId":0,"content":"DOnE","text":"DOnE","html":"DOnE"},{"id":5400818,"gmtCreate":1627884512269,"gmtModify":1635162154519,"authorId":4087484128087530,"author":{"id":4087484128087530,"idStr":"4087484128087530","authorId":4087484128087530,"name":"492a70ed","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":805231769,"type":1,"supId":0,"prevId":0,"content":"<u>ok</u>","text":"<u>ok</u>","html":"<u>ok</u>"},{"id":5401105,"gmtCreate":1627887814727,"gmtModify":1635162132340,"authorId":3573472992263411,"author":{"id":3573472992263411,"idStr":"3573472992263411","authorId":3573472992263411,"name":"Huathk","avatar":"https://static.tigerbbs.com/43c7168c646d9ea6805194ed0003f1cc","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":805231769,"type":1,"supId":0,"prevId":0,"content":"Gd","text":"Gd","html":"Gd"}],"langContent":"EN"},{"id":805230106,"gmtCreate":1627881912805,"gmtModify":1633755626025,"author":{"id":"3580987013176063","authorId":"3580987013176063","name":"JKKT","avatar":"https://static.tigerbbs.com/91ccb056daebba610931b73977bf4746","vip":1,"crmLevel":6,"crmLevelSwitch":0,"authorIdStr":"3580987013176063","idStr":"3580987013176063"},"htmlText":"Pls like and comment&nbsp;","listText":"Pls like and comment&nbsp;","text":"Pls like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/805230106","repostId":2156169749,"repostType":4,"repost":{"id":"2156169749","pubTimestamp":1627864728,"share":"https://www.laohu8.com/m/news/2156169749?lang=&edition=full","pubTime":"2021-08-02 08:38","market":"us","language":"en","title":"Missed Out on the FAANG Stocks? Consider Buying These PfANG Stocks Instead.","url":"https://stock-news.laohu8.com/highlight/detail?id=2156169749","media":"Motley Fool","summary":"There's both rhyme and reason for checking out these four stocks.","content":"<p>What's worse than the fear of missing out? I'd put the fear of having already missed out high on the list. There's nothing you can do once an opportunity is gone.</p>\n<p>Some investors might be feeling as if they've already missed out on the FAANG stocks. After all, four of them --&nbsp; <b>Apple</b> (NASDAQ:AAPL), <b>Alphabet</b> (NASDAQ:GOOG) (NASDAQ:GOOGL) (whose Google unit is the \"G\" in FAANG), <b>Amazon.com</b> (NASDAQ:AMZN), and&nbsp;<b><a href=\"https://laohu8.com/S/FB\">Facebook</a></b> (NASDAQ:FB) -- rank among the top 10 biggest companies in the world. Only&nbsp;<b>Netflix</b> (NASDAQ:NFLX) lags behind, but the streaming company still has a market cap of close to $230 billion.</p>\n<p>If you're concerned that you've missed out on a great opportunity with the FAANG stocks, don't worry. Consider buying these PfANG stocks instead.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/5160b68a97ec192124c08475ad420b61\" tg-width=\"700\" tg-height=\"467\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>Introducing the PfANG stocks</h2>\n<p>Aside from the fact that they're all now huge, the FAANG stocks have something else in common: They're all tech stocks. While technology remains a hot area for investors, the healthcare sector also offers tremendous growth prospects. Each of the PfANG stocks ranks as a leader in healthcare, albeit in very different ways.</p>\n<p><b>Pfizer</b> (NYSE:PFE) contributes the \"Pf\" in PfANG. The company is by far the best known of the group. Pfizer, of course, markets a blockbuster COVID-19 vaccine along with its partner, <b>BioNTech</b>. The company also has a product lineup that's loaded with other successful drugs and vaccines.</p>\n<p><b>Align Technology </b>(NASDAQ:ALGN) pioneered the clear dental aligner market. The company's Invisalign clear aligners have been used to straighten the teeth of nearly 11 million patients so far. Align also markets intraoral scanners used to create 3D images of teeth.</p>\n<p><b>Nano-X Imaging</b> (NASDAQ:NNOX) expects to disrupt the medical imaging market with its digital X-ray devices. The company recently filed for U.S. Food and Drug Administration (FDA) clearance of the first version of its multisource digital system.</p>\n<p><b>Guardant Health</b> (NASDAQ:GH) is a leader in developing liquid biopsy tests for cancer. The company's first products on the market help match patients with the best cancer therapy and enable drugmakers to develop new therapies.</p>\n<h2>What sets these stocks apart</h2>\n<p>A catchy name that sounds just like FAANG doesn't make these four stocks great picks, of course. However, there are two specific things that set these stocks apart:</p>\n<ol>\n <li>They all target a massive potential market.</li>\n <li>They all have a head start in that market.</li>\n</ol>\n<p>Pfizer has been around a long time and is by far the biggest of the PfANG stocks. The company still has multiple growth opportunities, though. One of the most significant of these is in messenger RNA (mRNA) therapies and vaccines.</p>\n<p>The company continues to work closely with BioNTech on its mRNA COVID-19 vaccine program and an mRNA flu vaccine. Pfizer plans to move forward with mRNA development on its own as well.</p>\n<p>CEO Albert Bourla stated in the company's Q2 conference call last week that Pfizer's strategy is to \"advance and unlock the full potential of mRNA.\" This strategy includes expanding its COVID-19 vaccine franchise and developing mRNA candidates targeting other infectious diseases, rare diseases, and cancer.</p>\n<p>Align Technology has generated impressive growth in recent years. The company, though, still has only captured 11% of the addressable market for clear aligners.</p>\n<p>Nano-X doesn't plan to compete for market share in the $21 billion medical imaging market; it fully intends to expand that market. The company's mobile devices cost only a fraction of current X-ray systems. <a href=\"https://laohu8.com/S/TWOA.U\">Two</a>-thirds of the world population have no meaningful access to medical imaging. Nano-X's opportunity is wide open.</p>\n<p>Guardant Health targets a $70 billion-plus potential market in cancer therapy selection, recurrence monitoring, and early screening. There are other companies going after this market as well. However, Guardant stands as <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the leaders and already has strong adoption for its initial liquid biopsy products.</p>\n<h2>Still some bite left in the FAANG stocks, too</h2>\n<p>I think that the PfANG stocks could deliver market-beating returns over the long term. But you don't really need to worry about having already missed out on the FAANG stocks.</p>\n<p>Augmented reality and virtual reality present big growth opportunities for Facebook and Apple. Artificial intelligence should serve as a growth driver for both of these stocks as well as Alphabet. Netflix is moving into gaming. These FAANG stocks should still have some bite left in them.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Missed Out on the FAANG Stocks? Consider Buying These PfANG Stocks Instead.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMissed Out on the FAANG Stocks? Consider Buying These PfANG Stocks Instead.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-02 08:38 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/01/missed-out-on-the-faang-stocks-consider-buying-the/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>What's worse than the fear of missing out? I'd put the fear of having already missed out high on the list. There's nothing you can do once an opportunity is gone.\nSome investors might be feeling as if...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/01/missed-out-on-the-faang-stocks-consider-buying-the/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMZN":"亚马逊","AAPL":"苹果","NFLX":"奈飞","GH":"Guardant Health Inc.","GOOG":"谷歌","PFE":"辉瑞","ALGN":"艾利科技","GOOGL":"谷歌A","NNOX":"Nano-X Imaging Ltd."},"source_url":"https://www.fool.com/investing/2021/08/01/missed-out-on-the-faang-stocks-consider-buying-the/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2156169749","content_text":"What's worse than the fear of missing out? I'd put the fear of having already missed out high on the list. There's nothing you can do once an opportunity is gone.\nSome investors might be feeling as if they've already missed out on the FAANG stocks. After all, four of them --  Apple (NASDAQ:AAPL), Alphabet (NASDAQ:GOOG) (NASDAQ:GOOGL) (whose Google unit is the \"G\" in FAANG), Amazon.com (NASDAQ:AMZN), and Facebook (NASDAQ:FB) -- rank among the top 10 biggest companies in the world. Only Netflix (NASDAQ:NFLX) lags behind, but the streaming company still has a market cap of close to $230 billion.\nIf you're concerned that you've missed out on a great opportunity with the FAANG stocks, don't worry. Consider buying these PfANG stocks instead.\nImage source: Getty Images.\nIntroducing the PfANG stocks\nAside from the fact that they're all now huge, the FAANG stocks have something else in common: They're all tech stocks. While technology remains a hot area for investors, the healthcare sector also offers tremendous growth prospects. Each of the PfANG stocks ranks as a leader in healthcare, albeit in very different ways.\nPfizer (NYSE:PFE) contributes the \"Pf\" in PfANG. The company is by far the best known of the group. Pfizer, of course, markets a blockbuster COVID-19 vaccine along with its partner, BioNTech. The company also has a product lineup that's loaded with other successful drugs and vaccines.\nAlign Technology (NASDAQ:ALGN) pioneered the clear dental aligner market. The company's Invisalign clear aligners have been used to straighten the teeth of nearly 11 million patients so far. Align also markets intraoral scanners used to create 3D images of teeth.\nNano-X Imaging (NASDAQ:NNOX) expects to disrupt the medical imaging market with its digital X-ray devices. The company recently filed for U.S. Food and Drug Administration (FDA) clearance of the first version of its multisource digital system.\nGuardant Health (NASDAQ:GH) is a leader in developing liquid biopsy tests for cancer. The company's first products on the market help match patients with the best cancer therapy and enable drugmakers to develop new therapies.\nWhat sets these stocks apart\nA catchy name that sounds just like FAANG doesn't make these four stocks great picks, of course. However, there are two specific things that set these stocks apart:\n\nThey all target a massive potential market.\nThey all have a head start in that market.\n\nPfizer has been around a long time and is by far the biggest of the PfANG stocks. The company still has multiple growth opportunities, though. One of the most significant of these is in messenger RNA (mRNA) therapies and vaccines.\nThe company continues to work closely with BioNTech on its mRNA COVID-19 vaccine program and an mRNA flu vaccine. Pfizer plans to move forward with mRNA development on its own as well.\nCEO Albert Bourla stated in the company's Q2 conference call last week that Pfizer's strategy is to \"advance and unlock the full potential of mRNA.\" This strategy includes expanding its COVID-19 vaccine franchise and developing mRNA candidates targeting other infectious diseases, rare diseases, and cancer.\nAlign Technology has generated impressive growth in recent years. The company, though, still has only captured 11% of the addressable market for clear aligners.\nNano-X doesn't plan to compete for market share in the $21 billion medical imaging market; it fully intends to expand that market. The company's mobile devices cost only a fraction of current X-ray systems. Two-thirds of the world population have no meaningful access to medical imaging. Nano-X's opportunity is wide open.\nGuardant Health targets a $70 billion-plus potential market in cancer therapy selection, recurrence monitoring, and early screening. There are other companies going after this market as well. However, Guardant stands as one of the leaders and already has strong adoption for its initial liquid biopsy products.\nStill some bite left in the FAANG stocks, too\nI think that the PfANG stocks could deliver market-beating returns over the long term. But you don't really need to worry about having already missed out on the FAANG stocks.\nAugmented reality and virtual reality present big growth opportunities for Facebook and Apple. Artificial intelligence should serve as a growth driver for both of these stocks as well as Alphabet. Netflix is moving into gaming. These FAANG stocks should still have some bite left in them.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5400632,"gmtCreate":1627882372235,"gmtModify":1635162171392,"authorId":4090502512947490,"author":{"id":4090502512947490,"idStr":"4090502512947490","authorId":4090502512947490,"name":"Yingyingloo","avatar":"https://static.tigerbbs.com/da58afbd656809ec183af4a539b38af6","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":805230106,"type":1,"supId":0,"prevId":0,"content":"<u>Like</u>","text":"<u>Like</u>","html":"<u>Like</u>"},{"id":5400662,"gmtCreate":1627882694667,"gmtModify":1635162168328,"authorId":3578966425599850,"author":{"id":3578966425599850,"idStr":"3578966425599850","authorId":3578966425599850,"name":"Brsje","avatar":"https://static.tigerbbs.com/3dbbcbc87a1aacdd702502ff32693a39","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":805230106,"type":1,"supId":0,"prevId":0,"content":"Done","text":"Done","html":"Done"},{"id":5400819,"gmtCreate":1627884517998,"gmtModify":1635162154396,"authorId":4087484128087530,"author":{"id":4087484128087530,"idStr":"4087484128087530","authorId":4087484128087530,"name":"492a70ed","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":805230106,"type":1,"supId":0,"prevId":0,"content":"<u>ok</u>","text":"<u>ok</u>","html":"<u>ok</u>"},{"id":5401103,"gmtCreate":1627887800549,"gmtModify":1635162132583,"authorId":3573472992263411,"author":{"id":3573472992263411,"idStr":"3573472992263411","authorId":3573472992263411,"name":"Huathk","avatar":"https://static.tigerbbs.com/43c7168c646d9ea6805194ed0003f1cc","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":805230106,"type":1,"supId":0,"prevId":0,"content":"Gd","text":"Gd","html":"Gd"}],"langContent":"EN"},{"id":805295244,"gmtCreate":1627881567588,"gmtModify":1633755628452,"author":{"id":"3575091423649914","authorId":"3575091423649914","name":"kungpao","avatar":"https://static.tigerbbs.com/f469169ddf2122a6445250fcaea5382c","vip":1,"crmLevel":7,"crmLevelSwitch":0,"authorIdStr":"3575091423649914","idStr":"3575091423649914"},"htmlText":"This is funny&nbsp;[开心]&nbsp;","listText":"This is funny&nbsp;[开心]&nbsp;","text":"This is funny [开心]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/805295244","repostId":2156169749,"repostType":4,"repost":{"id":"2156169749","pubTimestamp":1627864728,"share":"https://www.laohu8.com/m/news/2156169749?lang=&edition=full","pubTime":"2021-08-02 08:38","market":"us","language":"en","title":"Missed Out on the FAANG Stocks? Consider Buying These PfANG Stocks Instead.","url":"https://stock-news.laohu8.com/highlight/detail?id=2156169749","media":"Motley Fool","summary":"There's both rhyme and reason for checking out these four stocks.","content":"<p>What's worse than the fear of missing out? I'd put the fear of having already missed out high on the list. There's nothing you can do once an opportunity is gone.</p>\n<p>Some investors might be feeling as if they've already missed out on the FAANG stocks. After all, four of them --&nbsp; <b>Apple</b> (NASDAQ:AAPL), <b>Alphabet</b> (NASDAQ:GOOG) (NASDAQ:GOOGL) (whose Google unit is the \"G\" in FAANG), <b>Amazon.com</b> (NASDAQ:AMZN), and&nbsp;<b><a href=\"https://laohu8.com/S/FB\">Facebook</a></b> (NASDAQ:FB) -- rank among the top 10 biggest companies in the world. Only&nbsp;<b>Netflix</b> (NASDAQ:NFLX) lags behind, but the streaming company still has a market cap of close to $230 billion.</p>\n<p>If you're concerned that you've missed out on a great opportunity with the FAANG stocks, don't worry. Consider buying these PfANG stocks instead.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/5160b68a97ec192124c08475ad420b61\" tg-width=\"700\" tg-height=\"467\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>Introducing the PfANG stocks</h2>\n<p>Aside from the fact that they're all now huge, the FAANG stocks have something else in common: They're all tech stocks. While technology remains a hot area for investors, the healthcare sector also offers tremendous growth prospects. Each of the PfANG stocks ranks as a leader in healthcare, albeit in very different ways.</p>\n<p><b>Pfizer</b> (NYSE:PFE) contributes the \"Pf\" in PfANG. The company is by far the best known of the group. Pfizer, of course, markets a blockbuster COVID-19 vaccine along with its partner, <b>BioNTech</b>. The company also has a product lineup that's loaded with other successful drugs and vaccines.</p>\n<p><b>Align Technology </b>(NASDAQ:ALGN) pioneered the clear dental aligner market. The company's Invisalign clear aligners have been used to straighten the teeth of nearly 11 million patients so far. Align also markets intraoral scanners used to create 3D images of teeth.</p>\n<p><b>Nano-X Imaging</b> (NASDAQ:NNOX) expects to disrupt the medical imaging market with its digital X-ray devices. The company recently filed for U.S. Food and Drug Administration (FDA) clearance of the first version of its multisource digital system.</p>\n<p><b>Guardant Health</b> (NASDAQ:GH) is a leader in developing liquid biopsy tests for cancer. The company's first products on the market help match patients with the best cancer therapy and enable drugmakers to develop new therapies.</p>\n<h2>What sets these stocks apart</h2>\n<p>A catchy name that sounds just like FAANG doesn't make these four stocks great picks, of course. However, there are two specific things that set these stocks apart:</p>\n<ol>\n <li>They all target a massive potential market.</li>\n <li>They all have a head start in that market.</li>\n</ol>\n<p>Pfizer has been around a long time and is by far the biggest of the PfANG stocks. The company still has multiple growth opportunities, though. One of the most significant of these is in messenger RNA (mRNA) therapies and vaccines.</p>\n<p>The company continues to work closely with BioNTech on its mRNA COVID-19 vaccine program and an mRNA flu vaccine. Pfizer plans to move forward with mRNA development on its own as well.</p>\n<p>CEO Albert Bourla stated in the company's Q2 conference call last week that Pfizer's strategy is to \"advance and unlock the full potential of mRNA.\" This strategy includes expanding its COVID-19 vaccine franchise and developing mRNA candidates targeting other infectious diseases, rare diseases, and cancer.</p>\n<p>Align Technology has generated impressive growth in recent years. The company, though, still has only captured 11% of the addressable market for clear aligners.</p>\n<p>Nano-X doesn't plan to compete for market share in the $21 billion medical imaging market; it fully intends to expand that market. The company's mobile devices cost only a fraction of current X-ray systems. <a href=\"https://laohu8.com/S/TWOA.U\">Two</a>-thirds of the world population have no meaningful access to medical imaging. Nano-X's opportunity is wide open.</p>\n<p>Guardant Health targets a $70 billion-plus potential market in cancer therapy selection, recurrence monitoring, and early screening. There are other companies going after this market as well. However, Guardant stands as <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the leaders and already has strong adoption for its initial liquid biopsy products.</p>\n<h2>Still some bite left in the FAANG stocks, too</h2>\n<p>I think that the PfANG stocks could deliver market-beating returns over the long term. But you don't really need to worry about having already missed out on the FAANG stocks.</p>\n<p>Augmented reality and virtual reality present big growth opportunities for Facebook and Apple. Artificial intelligence should serve as a growth driver for both of these stocks as well as Alphabet. Netflix is moving into gaming. These FAANG stocks should still have some bite left in them.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Missed Out on the FAANG Stocks? Consider Buying These PfANG Stocks Instead.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMissed Out on the FAANG Stocks? Consider Buying These PfANG Stocks Instead.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-02 08:38 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/01/missed-out-on-the-faang-stocks-consider-buying-the/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>What's worse than the fear of missing out? I'd put the fear of having already missed out high on the list. There's nothing you can do once an opportunity is gone.\nSome investors might be feeling as if...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/01/missed-out-on-the-faang-stocks-consider-buying-the/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMZN":"亚马逊","AAPL":"苹果","NFLX":"奈飞","GH":"Guardant Health Inc.","GOOG":"谷歌","PFE":"辉瑞","ALGN":"艾利科技","GOOGL":"谷歌A","NNOX":"Nano-X Imaging Ltd."},"source_url":"https://www.fool.com/investing/2021/08/01/missed-out-on-the-faang-stocks-consider-buying-the/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2156169749","content_text":"What's worse than the fear of missing out? I'd put the fear of having already missed out high on the list. There's nothing you can do once an opportunity is gone.\nSome investors might be feeling as if they've already missed out on the FAANG stocks. After all, four of them --  Apple (NASDAQ:AAPL), Alphabet (NASDAQ:GOOG) (NASDAQ:GOOGL) (whose Google unit is the \"G\" in FAANG), Amazon.com (NASDAQ:AMZN), and Facebook (NASDAQ:FB) -- rank among the top 10 biggest companies in the world. Only Netflix (NASDAQ:NFLX) lags behind, but the streaming company still has a market cap of close to $230 billion.\nIf you're concerned that you've missed out on a great opportunity with the FAANG stocks, don't worry. Consider buying these PfANG stocks instead.\nImage source: Getty Images.\nIntroducing the PfANG stocks\nAside from the fact that they're all now huge, the FAANG stocks have something else in common: They're all tech stocks. While technology remains a hot area for investors, the healthcare sector also offers tremendous growth prospects. Each of the PfANG stocks ranks as a leader in healthcare, albeit in very different ways.\nPfizer (NYSE:PFE) contributes the \"Pf\" in PfANG. The company is by far the best known of the group. Pfizer, of course, markets a blockbuster COVID-19 vaccine along with its partner, BioNTech. The company also has a product lineup that's loaded with other successful drugs and vaccines.\nAlign Technology (NASDAQ:ALGN) pioneered the clear dental aligner market. The company's Invisalign clear aligners have been used to straighten the teeth of nearly 11 million patients so far. Align also markets intraoral scanners used to create 3D images of teeth.\nNano-X Imaging (NASDAQ:NNOX) expects to disrupt the medical imaging market with its digital X-ray devices. The company recently filed for U.S. Food and Drug Administration (FDA) clearance of the first version of its multisource digital system.\nGuardant Health (NASDAQ:GH) is a leader in developing liquid biopsy tests for cancer. The company's first products on the market help match patients with the best cancer therapy and enable drugmakers to develop new therapies.\nWhat sets these stocks apart\nA catchy name that sounds just like FAANG doesn't make these four stocks great picks, of course. However, there are two specific things that set these stocks apart:\n\nThey all target a massive potential market.\nThey all have a head start in that market.\n\nPfizer has been around a long time and is by far the biggest of the PfANG stocks. The company still has multiple growth opportunities, though. One of the most significant of these is in messenger RNA (mRNA) therapies and vaccines.\nThe company continues to work closely with BioNTech on its mRNA COVID-19 vaccine program and an mRNA flu vaccine. Pfizer plans to move forward with mRNA development on its own as well.\nCEO Albert Bourla stated in the company's Q2 conference call last week that Pfizer's strategy is to \"advance and unlock the full potential of mRNA.\" This strategy includes expanding its COVID-19 vaccine franchise and developing mRNA candidates targeting other infectious diseases, rare diseases, and cancer.\nAlign Technology has generated impressive growth in recent years. The company, though, still has only captured 11% of the addressable market for clear aligners.\nNano-X doesn't plan to compete for market share in the $21 billion medical imaging market; it fully intends to expand that market. The company's mobile devices cost only a fraction of current X-ray systems. Two-thirds of the world population have no meaningful access to medical imaging. Nano-X's opportunity is wide open.\nGuardant Health targets a $70 billion-plus potential market in cancer therapy selection, recurrence monitoring, and early screening. There are other companies going after this market as well. However, Guardant stands as one of the leaders and already has strong adoption for its initial liquid biopsy products.\nStill some bite left in the FAANG stocks, too\nI think that the PfANG stocks could deliver market-beating returns over the long term. But you don't really need to worry about having already missed out on the FAANG stocks.\nAugmented reality and virtual reality present big growth opportunities for Facebook and Apple. Artificial intelligence should serve as a growth driver for both of these stocks as well as Alphabet. Netflix is moving into gaming. These FAANG stocks should still have some bite left in them.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5400587,"gmtCreate":1627881898557,"gmtModify":1635162175986,"authorId":3580987013176063,"author":{"id":3580987013176063,"idStr":"3580987013176063","authorId":3580987013176063,"name":"JKKT","avatar":"https://static.tigerbbs.com/91ccb056daebba610931b73977bf4746","vip":1,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":805295244,"type":1,"supId":0,"prevId":0,"content":"Yeah  Damn funny","text":"Yeah  Damn funny","html":"Yeah  Damn funny"}],"langContent":"CN"},{"id":805296575,"gmtCreate":1627881415397,"gmtModify":1633755630106,"author":{"id":"4087908883537940","authorId":"4087908883537940","name":"money2me","avatar":"https://static.tigerbbs.com/24ba16178b7eb0b1f8e861f82940dd5e","vip":1,"crmLevel":4,"crmLevelSwitch":0,"authorIdStr":"4087908883537940","idStr":"4087908883537940"},"htmlText":"😂😂😂 any chance for 10x?","listText":"😂😂😂 any chance for 10x?","text":"😂😂😂 any chance for 10x?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/805296575","repostId":2156169749,"repostType":4,"repost":{"id":"2156169749","pubTimestamp":1627864728,"share":"https://www.laohu8.com/m/news/2156169749?lang=&edition=full","pubTime":"2021-08-02 08:38","market":"us","language":"en","title":"Missed Out on the FAANG Stocks? Consider Buying These PfANG Stocks Instead.","url":"https://stock-news.laohu8.com/highlight/detail?id=2156169749","media":"Motley Fool","summary":"There's both rhyme and reason for checking out these four stocks.","content":"<p>What's worse than the fear of missing out? I'd put the fear of having already missed out high on the list. There's nothing you can do once an opportunity is gone.</p>\n<p>Some investors might be feeling as if they've already missed out on the FAANG stocks. After all, four of them --&nbsp; <b>Apple</b> (NASDAQ:AAPL), <b>Alphabet</b> (NASDAQ:GOOG) (NASDAQ:GOOGL) (whose Google unit is the \"G\" in FAANG), <b>Amazon.com</b> (NASDAQ:AMZN), and&nbsp;<b><a href=\"https://laohu8.com/S/FB\">Facebook</a></b> (NASDAQ:FB) -- rank among the top 10 biggest companies in the world. Only&nbsp;<b>Netflix</b> (NASDAQ:NFLX) lags behind, but the streaming company still has a market cap of close to $230 billion.</p>\n<p>If you're concerned that you've missed out on a great opportunity with the FAANG stocks, don't worry. Consider buying these PfANG stocks instead.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/5160b68a97ec192124c08475ad420b61\" tg-width=\"700\" tg-height=\"467\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>Introducing the PfANG stocks</h2>\n<p>Aside from the fact that they're all now huge, the FAANG stocks have something else in common: They're all tech stocks. While technology remains a hot area for investors, the healthcare sector also offers tremendous growth prospects. Each of the PfANG stocks ranks as a leader in healthcare, albeit in very different ways.</p>\n<p><b>Pfizer</b> (NYSE:PFE) contributes the \"Pf\" in PfANG. The company is by far the best known of the group. Pfizer, of course, markets a blockbuster COVID-19 vaccine along with its partner, <b>BioNTech</b>. The company also has a product lineup that's loaded with other successful drugs and vaccines.</p>\n<p><b>Align Technology </b>(NASDAQ:ALGN) pioneered the clear dental aligner market. The company's Invisalign clear aligners have been used to straighten the teeth of nearly 11 million patients so far. Align also markets intraoral scanners used to create 3D images of teeth.</p>\n<p><b>Nano-X Imaging</b> (NASDAQ:NNOX) expects to disrupt the medical imaging market with its digital X-ray devices. The company recently filed for U.S. Food and Drug Administration (FDA) clearance of the first version of its multisource digital system.</p>\n<p><b>Guardant Health</b> (NASDAQ:GH) is a leader in developing liquid biopsy tests for cancer. The company's first products on the market help match patients with the best cancer therapy and enable drugmakers to develop new therapies.</p>\n<h2>What sets these stocks apart</h2>\n<p>A catchy name that sounds just like FAANG doesn't make these four stocks great picks, of course. However, there are two specific things that set these stocks apart:</p>\n<ol>\n <li>They all target a massive potential market.</li>\n <li>They all have a head start in that market.</li>\n</ol>\n<p>Pfizer has been around a long time and is by far the biggest of the PfANG stocks. The company still has multiple growth opportunities, though. One of the most significant of these is in messenger RNA (mRNA) therapies and vaccines.</p>\n<p>The company continues to work closely with BioNTech on its mRNA COVID-19 vaccine program and an mRNA flu vaccine. Pfizer plans to move forward with mRNA development on its own as well.</p>\n<p>CEO Albert Bourla stated in the company's Q2 conference call last week that Pfizer's strategy is to \"advance and unlock the full potential of mRNA.\" This strategy includes expanding its COVID-19 vaccine franchise and developing mRNA candidates targeting other infectious diseases, rare diseases, and cancer.</p>\n<p>Align Technology has generated impressive growth in recent years. The company, though, still has only captured 11% of the addressable market for clear aligners.</p>\n<p>Nano-X doesn't plan to compete for market share in the $21 billion medical imaging market; it fully intends to expand that market. The company's mobile devices cost only a fraction of current X-ray systems. <a href=\"https://laohu8.com/S/TWOA.U\">Two</a>-thirds of the world population have no meaningful access to medical imaging. Nano-X's opportunity is wide open.</p>\n<p>Guardant Health targets a $70 billion-plus potential market in cancer therapy selection, recurrence monitoring, and early screening. There are other companies going after this market as well. However, Guardant stands as <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the leaders and already has strong adoption for its initial liquid biopsy products.</p>\n<h2>Still some bite left in the FAANG stocks, too</h2>\n<p>I think that the PfANG stocks could deliver market-beating returns over the long term. But you don't really need to worry about having already missed out on the FAANG stocks.</p>\n<p>Augmented reality and virtual reality present big growth opportunities for Facebook and Apple. Artificial intelligence should serve as a growth driver for both of these stocks as well as Alphabet. Netflix is moving into gaming. These FAANG stocks should still have some bite left in them.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Missed Out on the FAANG Stocks? Consider Buying These PfANG Stocks Instead.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMissed Out on the FAANG Stocks? Consider Buying These PfANG Stocks Instead.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-02 08:38 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/01/missed-out-on-the-faang-stocks-consider-buying-the/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>What's worse than the fear of missing out? I'd put the fear of having already missed out high on the list. There's nothing you can do once an opportunity is gone.\nSome investors might be feeling as if...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/01/missed-out-on-the-faang-stocks-consider-buying-the/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMZN":"亚马逊","AAPL":"苹果","NFLX":"奈飞","GH":"Guardant Health Inc.","GOOG":"谷歌","PFE":"辉瑞","ALGN":"艾利科技","GOOGL":"谷歌A","NNOX":"Nano-X Imaging Ltd."},"source_url":"https://www.fool.com/investing/2021/08/01/missed-out-on-the-faang-stocks-consider-buying-the/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2156169749","content_text":"What's worse than the fear of missing out? I'd put the fear of having already missed out high on the list. There's nothing you can do once an opportunity is gone.\nSome investors might be feeling as if they've already missed out on the FAANG stocks. After all, four of them --  Apple (NASDAQ:AAPL), Alphabet (NASDAQ:GOOG) (NASDAQ:GOOGL) (whose Google unit is the \"G\" in FAANG), Amazon.com (NASDAQ:AMZN), and Facebook (NASDAQ:FB) -- rank among the top 10 biggest companies in the world. Only Netflix (NASDAQ:NFLX) lags behind, but the streaming company still has a market cap of close to $230 billion.\nIf you're concerned that you've missed out on a great opportunity with the FAANG stocks, don't worry. Consider buying these PfANG stocks instead.\nImage source: Getty Images.\nIntroducing the PfANG stocks\nAside from the fact that they're all now huge, the FAANG stocks have something else in common: They're all tech stocks. While technology remains a hot area for investors, the healthcare sector also offers tremendous growth prospects. Each of the PfANG stocks ranks as a leader in healthcare, albeit in very different ways.\nPfizer (NYSE:PFE) contributes the \"Pf\" in PfANG. The company is by far the best known of the group. Pfizer, of course, markets a blockbuster COVID-19 vaccine along with its partner, BioNTech. The company also has a product lineup that's loaded with other successful drugs and vaccines.\nAlign Technology (NASDAQ:ALGN) pioneered the clear dental aligner market. The company's Invisalign clear aligners have been used to straighten the teeth of nearly 11 million patients so far. Align also markets intraoral scanners used to create 3D images of teeth.\nNano-X Imaging (NASDAQ:NNOX) expects to disrupt the medical imaging market with its digital X-ray devices. The company recently filed for U.S. Food and Drug Administration (FDA) clearance of the first version of its multisource digital system.\nGuardant Health (NASDAQ:GH) is a leader in developing liquid biopsy tests for cancer. The company's first products on the market help match patients with the best cancer therapy and enable drugmakers to develop new therapies.\nWhat sets these stocks apart\nA catchy name that sounds just like FAANG doesn't make these four stocks great picks, of course. However, there are two specific things that set these stocks apart:\n\nThey all target a massive potential market.\nThey all have a head start in that market.\n\nPfizer has been around a long time and is by far the biggest of the PfANG stocks. The company still has multiple growth opportunities, though. One of the most significant of these is in messenger RNA (mRNA) therapies and vaccines.\nThe company continues to work closely with BioNTech on its mRNA COVID-19 vaccine program and an mRNA flu vaccine. Pfizer plans to move forward with mRNA development on its own as well.\nCEO Albert Bourla stated in the company's Q2 conference call last week that Pfizer's strategy is to \"advance and unlock the full potential of mRNA.\" This strategy includes expanding its COVID-19 vaccine franchise and developing mRNA candidates targeting other infectious diseases, rare diseases, and cancer.\nAlign Technology has generated impressive growth in recent years. The company, though, still has only captured 11% of the addressable market for clear aligners.\nNano-X doesn't plan to compete for market share in the $21 billion medical imaging market; it fully intends to expand that market. The company's mobile devices cost only a fraction of current X-ray systems. Two-thirds of the world population have no meaningful access to medical imaging. Nano-X's opportunity is wide open.\nGuardant Health targets a $70 billion-plus potential market in cancer therapy selection, recurrence monitoring, and early screening. There are other companies going after this market as well. However, Guardant stands as one of the leaders and already has strong adoption for its initial liquid biopsy products.\nStill some bite left in the FAANG stocks, too\nI think that the PfANG stocks could deliver market-beating returns over the long term. But you don't really need to worry about having already missed out on the FAANG stocks.\nAugmented reality and virtual reality present big growth opportunities for Facebook and Apple. Artificial intelligence should serve as a growth driver for both of these stocks as well as Alphabet. Netflix is moving into gaming. These FAANG stocks should still have some bite left in them.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5400554,"gmtCreate":1627881516037,"gmtModify":1635162178997,"authorId":3575091423649914,"author":{"id":3575091423649914,"idStr":"3575091423649914","authorId":3575091423649914,"name":"kungpao","avatar":"https://static.tigerbbs.com/f469169ddf2122a6445250fcaea5382c","vip":1,"crmLevel":7,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":805296575,"type":1,"supId":0,"prevId":0,"content":"lol <u>idk</u>","text":"lol <u>idk</u>","html":"lol <u>idk</u>"}],"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":282,"commentSize":55,"repostSize":0,"favoriteSize":1,"likeStatus":false,"favoriteStatus":false}}